The development and implementation of biomarker assays for estrogenic endocrine disruptors by Swart, Johannes Cornelius
The development and implementation of 
biomarker assays for estrogenic 
endocrine disruptors 
 
 
 
 
 
by 
Johannes Cornelius Swart 
 
 
 
 
 
 
 
Thesis presented in fulfillment of the requirements for the degree  
Doctor of Philosophy in Science at the University of the Western Cape 
August 2008 
 
 
 
 
 
 
 
Supervisor: Prof EJ Pool 
Co-Supervisor: Prof JH Van Wyk 
 
 
 
 
 
                                                                                                                                    Declaration 
 II 
DECLARATION 
I, the undersigned, hereby declare that the work contained in the thesis is my own original 
work, and that I have not previously in it’s entirely or in part submitted it at any university for 
a degree. 
 
Johannes Cornelius Swart 
 
_____________________ 
 
27 August 2008 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                                    Declaration 
 III 
ACKNOWLEDGEMENTS 
 
To my supervisor Prof Pool, this was truly an amazing journey. Your supervision, support and 
friendship have made me a better scientist and better person. Thanks for giving me the 
opportunity to prove myself and explore my capabilities.  
 
To my co-supervisor Prof Van Wyk, thanks so much for all your support and encouragement. 
All the interesting discussions and debates have really helped me a lot in finishing this thesis. 
Your inputs are truly appreciated.  
 
To my mom, dad and two brothers, thanks for all your love and support during the last 10 
years of university. Thanks for always understanding and supporting me in the choices that I 
make. Without your continues support and encouragement, this degree would not have been 
possible. 
 
To my two best friends, Tertius Boshoff and Kobie van der Westhuizen. Your first hand 
support and encouragement through all the ups and downs during the last two years are truly 
appreciated.  
 
Thanks to the students and staff of the Department of Medical Biosciences at the University 
of the Western Cape for all your help and support. 
 
I would like to thank the National Research Foundation of South Africa as well as the Water 
Research Commission of South Africa for supporting this study.  
 
Special thanks to the National Research Foundation and the Ernst and Ethel Eriksen Trust for 
awarding me scholarships throughout since my honours degree. Without the financial support, 
this degree would not have been possible. 
 
 
 
 
                                                                                                                          Table of Contents 
 IV 
TABLE OF CONTENTS 
 Page 
DECLARATION II 
ACKNOWLDEGEMENTS III 
TABLE OF CONTENTS IV 
LIST OF FIGURES  X 
LIST OF TABLES XII 
LIST OF ABBREVIATIONS XIII 
ABSTRACT XVI 
 
 
CHAPTER 1 
General Introduction 
1 
1.1. Background 1 
1.2. References 3 
 
 
CHAPTER 2 
Literature Review 
6 
2.1. Introduction to EDCs 6 
2.2. Estrogenic EDCs 6 
2.3. General Endocrinology 14 
2.3.1. Overview of the HPG Axis in mammals 14 
2.3.2. Steroidogenesis 16 
2.3.2.1. Sites of steroidogenesis 16 
2.3.2.2. Steroidogenic enzyme reactions 17 
2.3.2.3. Hormonal control of steroidogenesis 20 
2.4. Mechanisms of estrogenic endocrine disruptors 22 
2.4.1. Specific examples of e-EDCs and their mode of action 24 
2.4.1.1. Estrogen Receptor mediated chemicals 24 
2.4.1.2. Chemicals that can interact with specific steroidogenic enzymes 25 
2.5. Effect of e-EDCs on health 27 
2.5.1. Wildlife health 28 
2.5.2. Human health 30 
2.5.2.1. Developmental defects 30 
2.5.2.2. Decreased sperm production in men 30 
 
 
 
 
                                                                                                                          Table of Contents 
 V 
2.5.2.3. Testicular- and prostate cancer in men 32 
2.5.2.4. Breast cancer  32 
2.5.2.5.. Endometrioses 32 
2.5.2.6.. Male to female sex ratio of new born 33 
2.5.2.7. Effects caused by natural compounds 33 
2.6. Development of test systems for estrogenic EDCs 34 
2.7. Current assays for e-EDC analysis 34 
2.7.1. Analytical mass based assays 34 
2.7.2. Bio-assays 35 
2.7.2.1. In Vitro bio-assays 35 
2.7.2.2. Receptor Binding Assays 33 
2.7.2.3. Cell proliferation assays 36 
2.7.2.4. Reporter gene assays 37 
2.7.2.5. Non-cellular bio-assays 37 
2.7.3. In vivo assays for e-EDC detection 38 
2.8. Objectives of the current study 40 
2.9. References 42 
  
CHAPTER 3 
The rapid detection of selected steroid hormones in sewage effluent 64 
3.1. Abstract 65 
3.2. Introduction 66 
3.3. Methods and materials 69 
3.3.1. Collection of samples 69 
3.3.2. Extraction of water samples 69 
3.3.3. ELISA Reagents 70 
3.3.4. ELISA for Estrone 70 
3.3.5. ELISA for 17β-estradiol 70 
3.3.6. ELISA for Estriol 71 
3.3.7. Validation of assays 71 
3.4. Results 73 
3.4.1 Validation of assays 73 
3.4.2 The detection of estriol in sewage effluent 75 
3.4.3 The detection of estrone in sewage effluent 76 
 
 
 
 
                                                                                                                          Table of Contents 
 VI 
3.4.4 The detection of estradiol in sewage effluent 77 
3.5 Discussion 78 
3.6. References 80 
 
 
CHAPTER 4 
MCF-7 total LDH,  XTT and total protein as biomarkers for estrogenicity 83 
4.1. Abstract 84 
4.2. Introduction 85 
4.3. Methods and Materials 88 
4.3.1. Hydrophobic phase extraction of water samples 88 
4.3.2. Cell culture reagents 88 
4.3.3. MCF-7 experimental cell culture 88 
4.3.4. Lactate dehydrogenase (LDH) detection 89 
4.3.4.1. Culture supernatant LDH for cytotoxicity 89 
4.3.4.2. Total cellular LDH indicative of cell number 89 
4.3.5. Total protein yield by MCF-7 culture determinations 89 
4.3.6. XTT determinations 90 
4.3.7. Cell number determination 90 
4.3.8. Statistical analysis 90 
4.4. Results 91 
4.4.1 The effect of estrogen on MCF-7 cell growth 91 
4.4.2. E2 dose response on MCF-7 proliferation 91 
4.4.3. Correlation of total LDH with total protein and XTT 94 
4.4.4. Analysis of environmental water extracts for estrogenicity and cytotoxicity 94 
4.4.4.1 Cytotoxicity of environmental water extracts 95 
4.4.4.2 Estrogenicity of environmental water extracts 95 
4.5. Discussion 97 
4.6. References 100 
  
CHAPTER 5  
Development of a bioassay for estrogens using estrogen receptor alpha gene 
expression by MCF7 cells as biomarker 
103 
5.1. Abstract 104 
5.2. Introduction 105 
 
 
 
 
                                                                                                                          Table of Contents 
 VII 
5.3. Methods and Materials 107 
5.3.1. Reagents 107 
5.3.2. solid phase extraction of hydrophobic molecules from water samples 107 
5.3.3. MCF-7 cell culture 108 
5.3.4. SDS PAGE and protein blotting of ERα 108 
5.3.5. ERα ELISA 109 
5.3.6. Determination of total cellular protein 110 
5.3.7. Determination of total cellular lactate dehydrogenase (LDH) 110 
5.3.8. Statistical analysis 110 
5.4. Results 111 
5.4.1. Anti-ERα specificity 111 
5.4.2. ERα ELISA validation 111 
5.4.3. The effect of E2 concentration on the ERα level 113 
5.4.4. Correlation of ERα and total LDH  levels  113 
5.4.5. Analysis of environmental water extracts for estrogenicity  114 
5.5. Discussion 116 
5.6. References 119 
  
CHAPTER 6 
The development and validation of a quantitative ELISA for in vivo and in vitro 
synthesized vitellogenin from Mossambicus tilapia (Oreochromis mossambicus) 
123 
6.1. Abstract 124 
6.2. Introduction 125 
6.3. Methods and Materials 127 
6.3.1. Experimental animals 127 
6.3.2. Chemicals  127 
6.3.3. Juvenile diethylstilbestrol (DES) exposure 127 
6.3.4. Tissue culture 127 
6.3.5. Tissue sampling 128 
6.3.6. Protein determinations 128 
6.3.7. SDS PAGE and protein blotting 128 
6.3.8. Tilapia vitellogenin competition ELISA 129 
6.3.9. Expression of results and statistical analysis 129 
  
 
 
 
 
                                                                                                                          Table of Contents 
 VIII 
6.4. Results 131 
6.4.1. Specificity of the Anti-VTG  131 
6.4.2. ELISA Validation 131 
6.4.2.1. Anti-VTG and VTG antigen titration 131 
6.4.2.2. VTG antiserum specificity 132 
6.4.3. VTG competition ELISA  133 
6.4.4. Implementation of ELISA for in vivo induced VTG 134 
6.4.5. Implementation of ELISA for in vitro induced VTG 135 
6.5. Discussion 136 
6.6 References 138 
 
 
Chapter 7 
The use of Mossambicus tilapia (Oreochromis mossambicus) juveniles as bio-
indicators for environmental estrogenicity 
141 
7.1. Abstract 142 
7.2. Introduction 143 
7.3 Methods and Materials 147 
7.3.1. Test Fish 147 
7.3.2. Test chemicals and exposure design 147 
7.3.3. Fish weight and length measurement 148 
7.3.4. Protein extraction and quantification 148 
7.3.5. Vitellogenin quantification 148 
7.3.6. 17β-estradiol quantification 149 
7.3.7. Statistical analysis 149 
7.4. Results 150 
7.4.1. Growth of juvenile Mozambique tilapia  150 
7.4.2. Wet weight of juvenile tilapias 151 
7.4.3. Total protein yield of juvenile tilapias 151 
7.4.4. Vitellogenin in juvenile tilapias 152 
7.4.5. Fold VTG induction 154 
7.4.6. Albumin levels in juvenile tilapias 155 
7.4.7. 17β-estradiol (E2) levels in juvenile tilapia 155 
7.4.8. The effect of DES dose on VTG induction by tilapia juveniles 156 
7.5. Discussion 158 
7.6. References 162 
 
 
 
 
                                                                                                                          Table of Contents 
 IX 
Chapter 8 
Assessment of water collected from the Eerste River for estrogenicity 170 
8.1. Abstract 171 
8.2. Introduction 172 
8.3. Methods and Materials 174 
8.3.1. Study Area  174 
8.3.2. Water collections  174 
8.3.3. Water hydrophobic content extraction 175 
8.3.4. Estrone ELISA 175 
8.3.5. MCF-7 assays 175 
8.3.6. Juvenile tilapia in vivo bio-assay for estrogenicity 175 
8.3.7. Tilapia VTG ELISA 175 
8.3.8. Statistical analysis 176 
8.4. Results 177 
8.4.1. Jonkershoek analysed for estrogenicity 177 
8.4.2. Stellenbosch STWs analysed for estrogenicity 179 
8.4.3. Spier analysed for estrogenicity 181 
8.5. Discussion 183 
8.6. References 186 
 
 
Chapter 9 189 
9.1. General Conclusion 189 
9.2. References 193 
 
 
 
 
                                                                                                                               List of Figures 
 X 
LIST OF FIGURES  
  Page  
2.1. Diagrammatic representation of the main components of the mammalian HPG  
axis (IPCS Global Assessment of EDCs). 
15 
2.2. Testosterone conversion in peripheral tissue (Federman, 1981). 17 
2.3. Ezymatic convervions of cholesterol and intermediate/end-product hormones 
(EPA, 2005). 
21 
2.4. Schematic diagram depicting several key steps of steroid hormone synthesis as 
well as steps that may be sensitive to disruption by environmental chemicals 
(Reviewed in IPCS, WHO, 2002). 
23 
3.1. Water was collected from four sites along the Eerste- and Kuilsriver water 
catcment area. 
69 
3.2. Standard curves for the ELISAs to determine estriol, estradiol and estrone 
concentrations in sewage effluent. 
73 
3.3. Parallelism between kit standard and sewage effluent sample.   74 
3.4. Estriol quantification in water extracts. 76 
3.5. Estrone quantification in water extracts. 76 
3.6. 17β-estradiol quantification in water extracts. 77 
4.1. Culture of MCF-7 cells with serum replacement solution. 92 
4.2. MCF-7 E2 dose responsiveness. 93 
4.3. Correlation of total LDH activity with XTT and total protein yield. 94 
4.4. Cytotoxicity of water samples. 95 
4.5. Estrogen induced proliferation of MCF-7 cells exposed to environmental water 
samples. 
96 
5.1. SDS-Page and protein blotting of MCF-7 whole cell lysates. 111 
5.2. Anti-ERα ELISA validation. 112 
5.3. ERα-ELISA and E2 dose responsiveness. 113 
5.4. Correlation of ERα ELISA and total LDH activity. 114 
5.5. ERα protein levels of MCF-7 cells exposed to environmental water samples. 115 
6.1. Specificity of the Anti-VTG antiserum. 131 
6.2. Determination of optimal concentrations of tilapia vitellogenin and antiserum 
for the validation of the tilapia ELISA. 
132 
6.3. Screen for VTG induction in sexually mature female tilapia blood exposed to 
DES as well as untreated males. 
133 
 
 
 
 
                                                                                                                               List of Figures 
 XI 
6.4. A typical tilapia VTG competition ELISA standard curve. 133 
6.5. VTG concentration of four-week-old juvenile tilapia whole body homogenates. 134 
6.6 Vitellogenin synthesis by sliced liver cultures exposed to 0.5 µg/ml DES over a period 
of four days 
135 
7.1. Length of juvenile tilapias determined at 5 day intervals. 150 
7.2. Wet weight of juvenile tilapias weighed at 5 day intervals. 151 
7.3. Total protein yield of juvenile tilapias determined at 5 day intervals. 152 
7.4. VTG protein levels in juvenile tilapias. 153 
7.5. Fold VTG induction of juveniles during development. 154 
7.6. Albumin protein levels in juvenile tilapias. 155 
7.7. 17β-Estradiol levels in juvenile fish. 156 
7.8. DES dose responsive induction of VTG in tilapia juveniles. 157 
8.1. Map of the Eerste River in Stellenbosch, South Africa. 174 
 
 
 
 
 
 
 
 
 
                                                                                                                               List of Tables 
 XII 
LIST OF TABLES 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Page 
2.1.  Examples of endocrine disrupting compounds: natural products (Giesy et al., 
2002) 
9 
2.2.  Examples of endocrine disrupting compounds: synthetic compounds (Giesy et 
al., 2002) 
10 
2.3.  Substance that directly alter steroidogenesis (EPA, 2005) 26 
2.4.  Examples of the health effects of endocrine disrupters in wildlife and humans 
(Solomon  and Schettler, 2000) 
29 
2.5.  Trends in human health effects potentially related to endocrine function 31 
2.6.  Main types of in vitro test systems for the detection of endocrine disrupters 36 
2.7.  Examples of whole organism studies as in vivo assay for e-EDCs 39 
3.1.  Estriol ELISA validation 75 
3.2. Estrone ELISA validation. 75 
3.3. 17β-Estradiol ELISA validation. 75 
6.1. Characteristics of the tilapia VTG competition ELISA 134 
8.1. Rainfall and temperature recorded. 177 
8.2. Jonkershoek analysed for estrogenicity using the battery of assays 178 
8.3. Stellenbosch STWs analysed for estrogenicity using the battery of assays 180 
8.4. Spier analysed for estrogenicity using the battery of assays 182 
 
  
 
 
 
 
                                                                                                                    List of Abbreviations 
 XIII 
LIST OF ABBREVIATIONS 
 
17KSR 17-ketosteroid reductase  
°C centigrade 
17β-HSD 17β-hydroxysteroid dehydrogenase  
3β-HSD 3β-hydroxysteroid dehydrogenase/∆5-∆4 isomerase  
aa amino acids 
ANOVA analysis of variance 
APEs alkylphenol polyethoxylates 
AV–HRP avadin horse radish peroxidase  
BBA biological based assay 
BPA bisphenol A 
BSA biovine serum albumin 
CB-ER in vitro competitive receptor binding assay 
CV coefficient of variation 
Da Dalton  
DDE dichlorodiphenyldichloroethylene 
DDT dichlorodiphenyl trichloroethane 
DES diethylstilbestrol 
DHEA dehydroepiandrosterone 
DHT dihydrotestosterone 
DMSO dimethyl sulfoxide  
DPF days post fertilization 
E2 17β-estradiol 
EA estrogen ligands 
EDCs endocrine disrupting chemicals 
EDSP Endocrine Disruptor Screening Program  
EDSTAC Endocrine Disruptor Screening and Testing Advisory 
Committee  
EDTA ethylene diamine tetra-acetic acid 
EE2 17α-ethynylestradiol 
e-EDCs estrogenic endocrine disrupting chemicals 
EGF epidermal growth factor 
E-KRCA Eerste River - Kuilsriver catchment area 
ELISA enzyme linked immunosorbent assay  
 
 
 
 
                                                                                                                    List of Abbreviations 
 XIV 
EPA Environmental Protection Agency  
ER Estrogen receptor 
ERE estrogen response element  
E-Screen MCF-7 cell proliferation 
FBS fetal bovine serum  
FQPA Food Quality Protection Act  
FSH follicle-stimulating hormone  
GnRH gonadotrophin-releasing hormone  
GS gas chromatography 
GTH gonadotropic hormones 
HDL high density protein  
HPA hypothalamic-pituitary-adrenal 
HPG hypothalamic-pituitary-gonadal axis  
HPLC high performance liquid chromatography 
HPT hypothalamic-pituitary-thyroid  
HRE hormone response elements  
IgG immunoglobulin G 
IPCS International Programme on Chemical Safety  
IQ intelligence quotient 
LC liquid 
LDH lactate dehydrogenase  
LDL low density protein  
LH luteinizing hormone  
LOEC lowest observed effect concentration 
MS mass spectometry 
NADPH nicotinamide adenine dinucleotide phosphate-oxidase 
NP nonylphenol 
OD optic density 
OECD Organization for Economic Cooperation and 
Development  
P450c17 cytochrome P450 17α – hydroxylase/C17 – 20 lyase  
P450scc cytochrome P450 cholesterol side-chain cleavage enzyme  
PBS phosphate buffered saline  
PCB polychlorinated biphenyls  
 
 
 
 
                                                                                                                    List of Abbreviations 
 XV 
RER in vitro recombinant receptor-reporter cell bioassay 
RIA radio immuno assay  
RIPA radio-immuno-precipitation-assay-buffer  
rpm revolutions per minute 
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel 
electrophoresis  
SDWA Safe Drinking Water Act  
SHBG sex hormone-binding globulin 
StAR steroid acute regulatory  
STW sewage treatement works 
T3 triiodothyronine 
T4 throxine 
TBT tributyltin 
TF transcription factor 
Tris 2-amino-2-(hydroxymethyl)-1,3-propanediol 
TSH thyroid stimulating hormone 
VMGs Validation Management Groups  
VTG vitellogenin 
x g gravitational force 
YES yeast based recombinant ER-reporter assay 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                                         Abstract 
 XVI 
ABSTRACT 
Endocrine disrupting chemicals (EDCs) are compounds found in the environment that have 
the potential to disrupt normal endocrine function. Estrogenic EDCs (e-EDCs) is a subclass of 
EDCs and is defined as substances contaminating the environment that may mimic or inhibit 
the effect of endogenous estrogen and therefore may influence developmental and 
reproductive health in humans and animals. The aim of this study was to develop, validate 
and implement a battery of in vitro and in vivo screening assays for e-EDCs.  
 
The first objective of this study was the validation of commercially available Enzyme linked 
Immunosorbent Assay (ELISA) kits (designed for hormone quantification in human serum) to 
detect natural estrogenic hormones. These ELISA kits were validated to quantify estrone, 
estriol and 17β-estradiol (E2) in complex environmental water extracts. These ELISAs were 
proved to be very sensitive and reliable with detection limits of 0.3 ng/ml, 15 pg/ml and 25 
pg/ml for estriol, estrone and E2 respectively. The ELISAs showed inter- and intra assay 
variations of less than 10 %.  
 
The second objective was the development of a multi biomarker whole cell bioassay that can 
be used as a rapid, sensitive and inexpensive screen for total environmental estrogenic activity 
as well as cytotoxicity. The human breast cancer cell line, MCF-7 was used to develop this 
assay. Total lactate dehydrogenase (LDH) activity, total protein yield and mitochondrial 
activity (XTT activity) were evaluated as proliferation biomarkers for estrogenic endocrine 
disruption. The current study shows that the total cellular LDH assay is the most sensitive 
assay for E2 dependent proliferation monitoring. The MCF-7 total LDH assay can be used to 
detect estrogens over the range from 0.1-1000 nM E2. It was also showed that the well know 
E-screen assay can be performed in culture medium containing serum replacement factor 
instead of fetal bovine serum.  
 
The third objective of this study was to develop a direct ELISA on cultured MCF-7 cells to 
quantify ERα levels as a biomarker for estrogenicity. This biomarker had a detection range 
between 0.1 - 1000 nM for E2. ERα levels were suppressed in the presence of estrogen. 
Results obtained with the ERα ELISA for estrogenicity showed a good correlation with the 
total cellular LDH assay for estrogenicity in MCF-7 cells. This ELISA was successfully 
employed to assess environmental water extracts for estrogenicity.  
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 XVII 
The forth objective of this study was to setup and validate a competition ELISA to quantify 
vitellogenin (VTG) from Oreochromis mossambicus (tilapia). A competition ELISA for 
tilapia VTG using commercially available antibodies was developed. This tilapia VTG 
competition ELISA has a broad detection range between 80 ng/ml – 5.4 µg/ml VTG and is 
able to detect in vitro and in vivo synthesized VTG.  
 
The fifth objective of the study entailed using this quantitative ELISA to validate the use of 
tilapia juveniles (less than 70 days post fertilization (DPF)) as a short term in vivo screen for 
estrogenicity. Tilapia juveniles between 35 and 45 (DPF) exhibited the maximum ability to 
induce VTG upon estrogen exposure. At this age, 200 ng/l of diethylstilbestrol (DES) was the 
lowest concentration of estrogen that was able to induce significant VTG levels after 10 days 
of exposure. Analysis of the natural VTG levels of a mixed sex population of juveniles at 5 
day intervals between 15 and 70 DPF showed a peak at 50 DPF which coincided with a peak 
in natural whole body homogenate E2 concentrations. 
 
This study was concluded by implementing this battery of assays to assess the Eerste River, 
South Africa at three sampling sites, namely Jonkershoek, Stellenbosch sewage treatment 
works (STW) effluent and Spier for e-EDCs. The control site, Jonkershoek contained very 
low levels of estrone. Water from this site showed no estrogenic activity when the E-screen 
and the ERα induction in MCF-7 cells. Some of the water samples collected at this site tested 
positive for estrogenicity when analysed with the juvenile tilapia VTG assay, whereas the rest 
were negative. The estrone levels in the sewage effluent extracts as well as Spier were 
significantly higher. The assay using ERα protein induction by the MCF-7 cell line, the MCF-
7 proliferation assay and the tilapia in vivo screen for estrogenicity showed that these samples 
are estrogenic. Results obtained for estrogenicity at the three different sampling sites for each 
of the assays in the battery were comparable.   
 
In this study we developed, validated and also implemented a battery of assays encompassing 
both in vitro and in vivo assays, based on different biological mechanisms, to detect 
estrogenic EDCs. To our knowledge, this is the first study that has used a battery of bio-
assays to specifically assess a South Africa river for estrogenicity.  
 
 
 
 
 
                                                                                                                          Chapter 1  
 - 1 - 
CHAPTER 1 
1.1. Background 
 
During the past few decades, a rapid increase in the number of reproductive and 
developmental deviations has been observed in humans and wildlife exposed to 
environmental compounds (WHO/IPCS, 2002). This observation has heightened the concerns 
about the potential of some xenobiotics to interfere with normal endocrine function (Kavlock, 
1996). Endocrine disrupting chemicals (EDCs) define a broad group of substances that are 
found in the environment and have the potential to elicit negative effects on the endocrine 
systems of human and wildlife. The US Environmental Protection Agency (EPA) defines 
EDCs as: An exogenous agent that interferes with the synthesis, secretion, transport, binding, 
action, or elimination of natural hormones in the body that are responsible for the 
maintenance of homeostasis, reproduction, development and/or behaviour (USEPA, 1997).  
 
Most of the documented adverse health effects caused by EDCs in humans and wildlife are 
due to estrogenic EDCs (e-EDCs) [Gellert 1978a; Gellert 1978b; Hammond et al., 1979; 
Kupfer and Bulger, 1987; Krishnan et al., 1993; White et al., 1994; Newbold 1995; 
Katzenellenbogen 1995; Nimrod and Benson, 1996]. This broad class of chemicals includes 
both natural and synthetic estrogens. Some specific examples of e-EDCs include pesticides 
like atrazine, dieldrin and toxaphene (Ramamoorthy et al., 1997; Hayes et al., 2002). 
Surfactants such as alkylphenol-ethoxalates (Folmar et al., 2002; Legler et al., 2002a; Ying et 
al., 2002) are other major source of e-EDCs in the environment. Natural hormones and 
pharmaceutical estrogens such as 17β-estradiol and 17α-ethynylestradiol (Folmar et al., 2000; 
Legler et al., 2002a) are also regarded as e-EDCs. Phytoestrogens including isoflavonoids and 
coumestrol (Bacaloni et al., 2005; Stopper et al., 2005) as well as other industrial compounds 
for example bisphenol A (Mocarelli et al., 1996; Ramamoorthy et al., 1997; Howdeshell et al., 
1999) are all e-EDCs. Many of theses e-EDCs have the potential to influence normal 
endocrine function at very low concentrations (parts per billion to parts per trillion) and as a 
result may cause adverse health effects in humans and wildlife (Campbell et al., 2006). The 
concern is that e-EDCs have been found in wastewater, surface waters, sediments, 
groundwater and even drinking water (Benfenati et al., 2003; Petrović et al., 2003; Snyder et 
al., 2003; Petrović et al., 2004).  
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For this reason the development of new assays and screens to monitor e-EDCs in our 
environment has received considerable attention over the last few decades. The US EPA has 
been given the mandate, under the Food Quality Protection Act of 1996, to assess the 
endocrine disruptive activity of over 87,000 chemicals (US EPA, 1998). To this end, the 
Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC) were formed to 
make recommendations to the EPA on how to develop screening strategies. EDSTAC 
presented its final report in 1998, laying out a recommended approach to the problem (US 
EPA, 1998). This program’s aim is to develop a two-tiered approach, e.g. in vitro and in vivo 
mammalian and ecotoxicological screens (Tier 1) and a set of in vivo tests (Tier 2) for the 
identification and characterization of endocrine effects of pesticides, industrial substances and 
environmental contaminants. 
 
The aim of this study was to develop and validate a battery of screening assays encompassing 
both in vitro and in vivo assays to detect e-EDCs. This study was concluded by implementing 
this battery of screening assays to assess the Eerste River, South Africa for environmental e-
EDCs.  
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CHAPTER 2 
Literature Review 
2.1 Introduction to EDCs 
During the last few decades, international concern has been raised regarding the possible 
harmful effects of exposure to certain chemicals in the environment. This concern has initially 
centred on chemicals that may mimic the action of natural female hormones and were thus 
termed “environmental estrogens” (Allen and Doisy, 1923; Burlington and Lindeman, 1950). 
However, this issue has since broadened and now encompass various groups of chemicals 
with the ability to interact and disrupt normal animal and human wellbeing on cellular, 
metabolic and physiological level (Colborn et al., 1993). Some chemicals can also affect the 
progeny of previously exposed parents (Colborn et al., 1993). Moreover, every year hundreds 
of newly developed chemicals are released into the environment. The toxicity and health 
effects of these chemicals on human and animal wildlife are unknown (Rodriquez-Mozaz et 
al., 2004). These chemicals are now referred to as endocrine disrupting chemicals or EDCs. 
EDCs represent a wide range of chemicals that are found in the environment and have the 
potential to elicit negative effects on the endocrine systems of humans and wildlife. Various 
definitions have been proposed for EDCs. The US Environmental Protection Agency (EPA) 
defines EDCs as: an exogenous agent that interferes with the synthesis, secretion, transport, 
binding, action, or elimination of natural hormones in the body that are responsible for the 
maintenance of homeostasis, reproduction, development and/or behaviour (USEPA, 1997).  
 
Some EDCs have structures similar to the natural hormone that they mimic or inhibit, while 
other EDCs have no resemblance at all. Therefore, EDCs belong to a class of substances 
which is defined by biological effect rather than chemical nature. For instance, various natural 
and synthetic chemical compounds including pharmaceuticals, pesticides, industrial chemicals 
and heavy metals have been identified to induce estrogen-like responses (Giesy et al., 2002). 
A wide spectrum of pollutants can therefore collectively be referred to as estrogenic EDCs (e-
EDCs) (Lopez de Alda and Barcelo, 2001). Because of the vast amount of literature available 
on EDCs, this chapter will only focus on e-EDCs. 
 
2.2 Estrogenic EDCs 
Estrogenic endocrine disrupters are ubiquitously found throughout the environment and in 
broad terms are grouped into two major groups (Keith, 1998; Baker, 2001). The one group 
consist of natural compounds such as phytoestrogens, bioflavanoids and mycoestrogens that 
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are naturally found in the environment (Kuiper et al., 1998; Giesy et al., 2002). The other 
group consist of synthetic compounds that are designed for several uses such as pesticides, 
herbicides, plastics etc., which is now suspected to unintentionally disrupt endocrine systems 
of humans and wildlife (Kuiper et al., 1998). This group also includes synthetic hormones 
such as contraceptives that are designed to intentionally disrupt the endocrine system 
(Isselbacher et al., 1994). EDCs can be found in soil, water, air and food as well as in 
commonly used industrial and household products (WHO/IPCS, 2002). Giesy et al, (2002) 
compiled a list of natural (Table 2.1) and synthetic compounds (Table 2.2) that are capable of 
disrupting the endocrine system. This list of EDCs includes: 
 
• Natural products (e.g. Phytoestrogens, Bioflavanoids, Mycoestrogens) 
• Pharmaceuticals (e.g. Ethynylestradiol, Flutamide) 
• Additives (e.g. Parabenes) 
• Insecticides (e.g. Endosulfan, Dieldrin, Lindane) 
• Fungicides (e.g. Vinclozolin) 
• Herbicides (e.g. Atrazine) 
• Industrial chemicals (e.g. Bisphenol A, Phthalates, PCBs) 
• Heavy metals (e.g. Lead, Cadmium)  
 
Some of the best-known man-made endocrine disrupters are products that most of us use 
every day. Specific examples of EDCs include synthetic hormonal drugs, such as birth control 
pills and diethylstilbestrol (DES), dioxins (by-product of waste incineration and industrial 
processes e.g., the production of some pesticides) as well as the bleaching of paper pulp 
(Huisman et al., 1996; Colton and Greenberg, 1993). Polychlorinated biphenyls (PCBs), 
which were once used world wide in electrical equipment, adhesives and plasticizers 
(Jacobson and Jacobson, 1996), is another example of EDCs. Other well known synthetic 
compounds that disrupt hormone activity are alkylphenol and phtalates, which are widely 
used in industrial and household products and some pesticides, fungicides and insecticides 
(Sonnenschein and Soto, 1998). Phytoestrogens occur naturally in the environment and are 
present in grains, legumes, herbs, nuts and a variety of fruits and vegetables (Cassidy, 1988; 
Barnes, 1998). Phytoestrogens induce a weaker estrogenic response than the endogenous 
estrogens (i.e., they do not bind as well to hormone receptors) and are quickly excreted or 
broken down into other compounds and do not accumulated in the body.  
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EDCs that contaminate the aquatic environment originate from point and non-point sources. 
Point source refers to specific sources of contamination for instances sewage treatment plants, 
pulp mills and industrial effluent. Non-point refers to urban and agricultural runoffs (Folmar 
et al., 2002). Both of these two sources may include natural and pharmaceutical chemicals 
from domestic, human and animal origin. Waste water treatment facilities have been widely 
identified as a major source of e-EDCs (Sumpter, 1995a; Kolpin et al., 2002; Legler et al 
2002a) and are classified as a point source of contamination. The actual sources of 
contamination are upstream discharges that end up in these treatment facilities. A few 
examples of the upstream sources include natural hormones and pharmaceutical estrogens 
which are flushed down home toilets. Household cleaning products containing nonylphenol 
(NP), industrial processes that use cleaning reagents containing NP, plastics containing 
bisphenol A (BPA) or agrochemicals containing alkylphenol and nonylphenol ethoxylate 
surfactants are all sources of e-EDCs (Staples et al., 1998; Ying et al., 2002 a,b; Snyder et al., 
2003). Wastewater treatment facilities serve as a focal point where treatment is possible if 
source mitigation is impractical (e.g. removal of e-EDCs from product formulation or 
reducing pharmaceutical estrogens in household waste). Agricultural activity has been 
identified as a nonpoint sources for e-EDC which includes waste waters from dairies and 
aquaculture (Kolodziej et al., 2004). The spawning of fish in aquaculture farms may locally 
increase the concentrations of estrogens in river water (Kolodziej et al., 2004). Livestock feed 
lots have previously also been demonstrated to be potential sources of estrogenic compounds 
from excretion of hormones in manure and urine (Hanselman et al., 2003; Tashiro et al., 2003; 
Soto et al., 2004). Another potential source of e-EDCs from agricultural activity is runoffs 
containing pesticides and fertilizers which may contain estrogenic surfactants (e.g. 
nonylphenol ethoxylates) that make up the chemical formulation (Staples et al., 1998; Ying et 
al., 2002).  
 
In order to have a better understanding of how EDCs may inflict an estrogenic response in 
humans and wildlife, it is necessary to briefly review the basics of endocrinology and the 
pathways involved in estrogen biosynthesis. 
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Table 2.1. Examples of endocrine disrupting compounds: natural products (Giesy et al., 2002) 
 
Compound                              Mode of action  Assay                                                  Reference 
Phytoestrogens 
Indole-3-carbinol    ER agonist.                              RER (MCF-7-luc), YES.     Villeneuve et al., 1998; Gaido 
              et al., 1997a 
β-Sitosterol                                         ER agonist, androgenic           YES, in vivo fish.    Gaido et al., 1997a; 
after metabolization.                                                                            Stahlschmidt- Allner et al., 1997 
Coumestrol     ER agonist.    RER (MCF-7-luc), YES.   Villeneuve et al., 1998; Gaido 
et al., 1997a 
In vitro ER mediated    Markiewicz et al., 1993 
PAP induction. 
Enterolactone, enterodiol   Decrease aromatase   In vitro human cell   Wang et al., 1994 
     enzyme activity.  culture system. 
 
Bioflavanoids 
Genistein     ER agonist.    RER (ER-CALUX).    Markiewicz et al., 1993; 
              Legler et al., 1998 
Estrogenic.    In vitro and in vivo   Nimrod and Benson, 1997 
         vitellogenin production. 
Biochanin A, daidzein, equol  ER agonists, estrogenic.  In vitro and in vivo    Nimrod and Benson, 1997 
         vitellogenin production. 
         In vitro ER mediated   Markiewicz et al., 1993 
         PAP induction. 
Quercetin, naringenin, luteolin Estrogenic, antiestro-  CB-ER, RER, RER   Kuiper et al., 1998, Safe and Gaido, 
apigenin, chrysin,   genic, ER agonists.  (MVLN).    1998; Le Bail et al., 1998 
 
Mycoestrogens 
Zearalenone     ER agonist.    CB-ER, RER, VTG    Kuiper et al., 1998; 
         in vitro.    Celius et al., 1999 
YES, yeast based recombinant ER-reporter assay; E-screen, MCF-7 cell proliferation; CB-ER, in vitro competitive receptor binding assay; RER, 
in vitro recombinant receptor-reporter cell bio-assay; VTG-in vitro, in vitro vitellogenin synthesis in cultured male trout hepatocytes. 
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Table 2.2. Examples of endocrine disrupting compounds: synthetic compounds (Giesy et al., 2002) 
Compound Mode of action Assay Reference 
Pharmaceuticals    
Flutamide Anti-androgenic activity. YES. Sohoni and Soto, 1998 
Tamoxifen Anti-estrogenic drug binding to 
ER, antagonist. 
In vitro cell line tests, in vivo E-
screen and other effects. 
Taylor et al., 1984; Ramkumar 
and Alder, 1995; Shelby et al., 
1996; Favoni and Cupis (1998) 
Hydroxytamoxifen Anti-estrogenic. YES, E-screen and other effects. Sohoni and Soto, 1998; Favoni 
and Cupis, 1998 
Nafoxidine, clomiphene ER agonist. YES. Gaido et al., 1997a 
Ethynylestradiol ER agonist. In vitro, in vivo. Nimrod and Benson, 1997; 
Stahlschmidt-Allner et al., 1997 
Additives    
Parabens ER agonists. CB-ER, YES, in vivo uterotrophic 
response. 
Routledge et al. (1998) 
t-Butylhydroxyanisol Estrogenic. E-screen. Soto et al., 1995 
Insecticides    
o,p΄-DDT ER agonist, anti-androgenic 
activity. 
YES, RER (ER-CALUX), VTG-
in vitro. 
Sohoni and Soto, 1998; Gaido et 
al., 1997a; Legler et al., 1998; 
Sumpter and Jobling, 1995 
o,p΄-DDD, o,p΄-DDE ER agonists. YES. Gaido et al., 1997a 
p,p΄-DDE Androgen receptor antagonist, 
weak ER and androgen receptor 
agonist. Anti-adrogenic and weak 
anti-estrogenic activity. 
CB-androgen receptor, in vivo 
mice study. 
YES. 
Kelce et al., 1995 
 
Sohoni and Soto, 1998 
p,p΄-DDD ER agonist. YES, CB-ER, RER (MCF-7-luc). Klotz et al., 1996 
p,p΄-DDT ER agonist, estrogenic. E-screen. Nimrod and Benson, 1997 
Kepone ER agonist, estrogenic after 
metabolization. 
RER (ER-CALUX), E-screen, 
in vitro and in vivo. 
Legler et al., 1998; Nimrod and 
Benson, 1997; Shelby et al., 1996. 
Endosulfan, Dieldrin, Lindane ER agonist. RER (ER-CALUX). Legler et al., 1998 
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Table 2.2 Continued    
Compound Mode of action Assay Reference 
Toxaphene Estrogenic. E-screen. Soto et al., 1994 
Methyl parathion Estrogenic. YES, VTG - in vitro. 
In vivo effects on estrus cycle in 
mice. 
Petit et al., 1997 
Asmathbanu and Kaliwal, 1997 
Chlordecone Estrogenic. YES, VTG - in vitro. Petit et al., 1997 
Chlordane ER agonist. RER (ER-CALUX). 
In vivo - effects on endocrine 
function in mice. 
Legler et al., 1998 
Cranmer et al., 1984 
Methoxychlor ER agonist – after 
metabolization. 
RER (ER-CALUX) in vitro and 
in vivo. 
Legler et al., 1998; Shelby et al., 
1996 
Carbamate insecticides (Aldicarb, 
Bendiocarb, Cabaryl, Methomyl, 
Oxamyl) 
Endocrine modulators, 
non-ligand binding. 
In vitro modulation of estrogen 
and progesterone receptor in 
human breast and endometrial 
cancer cells. 
Klotz et al., 1996 
Pyrethroid insecticides 
(Sumithrin, Fenvalerate, D-trans 
Allethrin, Permethrin) 
Estrogenic (different 
mechanisms). 
In vitro pS2 gene expression E-
screen. 
Go et al., 1999 
Fungicides    
Vinclozolin Anti-androgen. In vitro androgen receptor binding 
assay, YES. 
Kelce et al., 1994; Sohoni and 
Soto, 1998 
Dodemorph, Triadimefon, 
Biphenyl 
Estrogenic. YES, VTG in vitro. Soto et al., 1994 
Herbicides    
Atrazine Anti-estrogen RER (MCF-7-luc), in vivo. Villeneuve et al., 1998 
Simazine Anti-estrogen. In vivo. Tennant et al., 1994 
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Table 2.2 Continued    
Compound Mode of action Assay Reference 
Alachlor,Nonachlor, Tributyltins ER agonists, Androgenic. YES, CB-ER, RER (MCF-7-luc)  Klotz et al., 1996;  Stahlschmidt-
Allner et al., 1997; Matthiessen 
and Gibbs, 1998  
Industrial chemicals    
Phthalates 
Butylbenzylpthalate 
 
ER agonist, antiandrogenic 
activity. 
 
In vitro and in vivo, E-screen, YES. Sohoni and Soto, 1998; 
Stahlschmidt-Allner et al., 1997; 
Soto et al., 1995; Jobling et al., 
1995 
Dibutylpthalate   
 
ER agonist.  In vitro and in vivo. Stahlschmidt-Allner et al., 1997; 
Jobling et al., 1995 
Alkylphenols 
Nonylphenol 
 
ER agonist, estrogenic. 
 
RER (MCF-7-luc, ER-CALUX), 
YES, number of in vitro and in vivo 
assays, E-screen, VTG- in vitro. 
Villeneuve et al., 1998; Gaido et 
al., 1997a; Legler et al., 1998; 
Servos, 1999; Nimrod and 
Benson, 1997; Shelby et al., 
1996; Soto et al., 1995  
Octylphenol 
 
ER agonist. 
 
RER (MCF-7-luc). Number of in 
vitro and in vivo assays. 
Servos, 1999; Soto et al., 1995 
 
Butylphenol, Pentylphenol 
 
Estrogenic. 
 
E-screen. 
 
Nimrod and Benson, 1997; Soto 
et al., 1995 
Nonylphenol, polyethoxylates, 
and polyethoxycarboxylates 
 
ER agonists. Number of in vitro and in vivo 
assays. 
Servos, 1999 
Pentachlorophenol 
 
Decrease in blood testosterone 
concentration. 
In vivo ewes feeding study. Beard et al., 1999 
Bisphenol A 
 
ER agonist. 
 
RER (MCF-7-luc, ER-CALUX), 
YES, VTG in vitro. 
YES. 
Villeneuve et al., 1998; Gaido et 
al., 1997a; Legler et al., 1998; 
Soto et al., 1995. 
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Tabel 2.2 Continued    
Compound Mode of Action Assay Refernce 
PCBs 
 
ER agonists or antagonists or 
other mechanism - depending on 
the substitution. 
RER (transient MCF-7-luc), E-
screen, in vivo - vaginal cell 
cornification in mice. 
Joyeux et al., 1997; Soto et al., 
1995 
 
Arochlor 1260 (PCBs 
mixture), Arochlor 1260 
 
Estrogenic, effect on sexual 
differentiation, gonadal 
abnormalities.  
VTG in vitro, in vivo trout study.  
 
Soto et al., 1995; Matta et al. 
1998 
Hydroxy-PCBs  
 
 
ER agonists or antagonists. 
 
RER (MCF-7-luc), E-screen, CB-
ER, in vivo - vaginal cell 
cornification in mice. 
Joyeux et al., 1997; Soto et al., 
1995; Beard et al., 1999; Kramer 
et al., 1997 
PAHs  
 
ER agonists - estrogenic, Anti-
estrogenic - different 
mechanisms. 
YES, E-screen RER (MCF-7-luc). Tran et al., 1996a; Chaloupka et 
al., 1992; Santodonato, 1997; 
Clemons et al., 1998. 
6-hydroxy chrysene  Anti-estrogenic. YES. Tran et al., 1996b 
 
Heavy metals    
Cations of cadmium, cobalt, 
copper, mercury, nickel, zinc 
 
Depression or increases 
in testosterone production. 
In vitro substrate stimulated 
testosterone production by Leydig 
cells. 
 
Laskey and Phelps, 1991 
Cadmium  
 
 
Decrease in plasma testosterone 
and cortisol Modification of 
pituitary hormone secretion. 
In vivo juvenile rainbow trout 
exposure.  
In vivo rat feeding exposure. 
Ricard et al., 1998 
 
Lafuente et al., 1997 
Lead  
 
Delayed sexual maturation, 
suppression of sex 
steroid biosynthesis. 
In vivo rat feeding study. Ronis et al., 1998 
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2.3 General Endocrinology  
The endocrine system is also referred to as the hormone system. It regulates chemical 
signalling and gene expression from the time of conception, through development and 
maturation. The endocrine system is one of three very important control systems in 
vertebrates. The nervous system and the immune system are the other two control systems. 
Endocrine systems are found in mammals, non-mammalian vertebrates (e.g., fish, 
amphibians, reptiles and birds), and invertebrates (snails, lobster, insects and other species). In 
vertebrates the function of the endocrine system involves the regulation of a wide range of 
biological processes. Vertebrate endocrine systems consist of three major axis, namely the 
hypothalamic-pituitary-thyroid (HPT), hypothalamic-pituitary-adrenal (HPA) and 
hypothalamic-pituitary-gonadal (HPG) axis. These three axes are responsible for a multitude 
of biological processes for example blood sugar level stability, which is regulated through the 
hormone insulin secreted from the pancreas. Metabolism is regulated by the hormones cortisol 
from the adrenal glands and thyroxin from the thyroid gland. The development and 
functioning of the reproductive systems is regulated by the hormones estradiol and 
testosterone and related compounds from the testis and ovaries. The development of the brain 
and the rest of the nervous system are also regulated through estrogen as well as thyroid 
hormones. The endocrine system regulates the development and sustainment of an organism 
from conception through adulthood and old age. The normal function of the endocrine system 
therefore enables animals to control and regulate reproduction, development and behaviour 
(Payne and Dale, 2004). 
 
2.3.1 Overview of the HPG Axis in mammals 
The HPG axis (Fig. 2.1) involves three major components. The first component is 
gonadotrophin-releasing hormone (GnRH) neurons projecting from the hypothalamus of the 
brain. The second major component is the secretion of the gonadotropins, luteinizing hormone 
(LH) and follicle-stimulating hormone (FSH) by gonadotropes in the anterior pituitary gland 
(adenohypophysis). The third component is the somatic cells of the gonads (theca and 
granulosa cells in the ovary, Leydig and Sertoli cells in the testis). GnRH is secreted in pulses 
by the GnRH neurons (Kimura and Funabashi, 1998; Terasawa, 1998) and acts on the 
gonadotropes to release LH and FSH. These two gonadotropins enter the blood stream where 
they then act on their respective target cells in the gonads (LH on theca/Leydig cells; FSH on 
granulosa/Sertoli cells). The secretion of GnRH can be modified by other neurons (Crowley, 
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1999), and the actions of GnRH on gonadotropin release may be modified by other 
hypothalamic or pituitary peptides (Evans, 1999). Consequently, gonadal sex steroids  
Figure 2.1 Diagrammatic representation of the main components of the mammalian 
HPG axis (IPCS Global Assessment of EDCs). 
 
stimulated by LH and the protein hormone inhibin (the A form in females, the B form in 
males) stimulated by FSH are released back into the bloodstream. Inhibin and the sex steroids 
provide feedback to the hypothalamus and pituitary gonadotropes to reduce the secretion of 
GnRH, LH and FSH (Crowley et al., 1991). Figure 2.1 is a simple diagrammatic 
representation of this system. 
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Nonmammalian vertebrates differ from mammals and also one another in their modes of 
reproduction, with patterns of sequential and simultaneous hermaphroditism, parthenogenesis, 
viviparity and gonochorism found in many species (van Tienhoven, 1983). The HPG axes of 
different animals are surprisingly similar in their operation, in the pattern of feedback 
mechanisms, and in the hormones involved to that described for mammals (Norris, 1997; 
Bentley 1998). Differences in the HPG axes in nonmammalian species will however not be 
discussed in this section. 
 
2.3.2. Steroidogenesis 
In order to understand how estrogenic xenoestrogens may disrupt normal endocrine function, 
it is necessary to give a brief overview of how steroid hormones are synthesized using 
mammals as model. Steroidogenesis is a complex process which involves the conversion of 
cholesterol into biologically active steroid hormones.  
 
2.3.2.1. Sites of steroidogenesis 
The gonads, adrenals and the brain are the major centres for steroid hormone biosynthesis 
(Kime, 1987; Nagahama, 2000; Schumacher et al., 2003). The male steroidogenic pathways 
are found mainly in the testis and to a much lesser extend in the adrenal glands. Within the 
testes, steroidogenesis occurs in the Leydig cells (Chen et al., 1996). Several other peripheral 
tissues are involved in testosterone’s role as a pro-hormone (Fig 2.2). Examples of 
testosterone as a pro-hormone is for instance in the liver and brain (hypothalamus) where its 
converted to estradiol and in the liver, brain, prostate and external genitalia where it is 
converted to dihydrotestosterone. The biosynthesis of female steroid hormones occur in the 
ovary (Carr and Wilson, 1994). Several cell types participate in estrogen synthesis within the 
ovary. These are the follicular-, theca-, interstitial-, and luteal cells. Different cell types have 
the ability to synthesize different amounts of a specific steroid hormone. This is a result of the 
fact that the different cell types contain varying amounts of a given steroidogenic enzyme. 
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Figure 2.2. Testosterone conversion in peripheral tissue (Federman, 1981). 
 
2.3.2.2. Steroidogenic enzyme reactions 
The common precursor for biosynthesis of all gonadal steroid hormones is cholesterol (Miller, 
1988). The primary source for cellular cholesterol is serum. Cholesterol is transported to the 
cell by the serum protein carriers, high density lipoproteins (HDL) and low density 
lipoproteins (LDL). Another source of cholesterol is de novo synthesis through acetate. Once 
cholesterol enters the cell, it can be stored, e.g. lipid droplets or immediately utilized. Upon 
LH-induced stimulation, mobilization of newly synthesized and stored cholesterol (through 
enzymatic hydrolysis of cholesterol esters) in lipid droplets occurs. Cholesterol is then 
transported from the cytosol to the mitochondria. Within the mitochondria cholesterol is 
transported from the outer to the inner membrane. The transport of cholesterol across the 
mitochondrial membranes requires a transport protein and this is the rate limiting step in 
steroid biosynthesis. Upon LH stimulation of steroidogenic cells, these cells initiate the de 
novo synthesis of the cholesterol transport protein. Since this cholesterol transport protein 
mediate the rate limiting step in steroidogenesis, it is referred to as the steroid acute regulatory 
(StAR) protein (Stocco and Clark, 1996). StAR protein is rapidly synthesized, cycloheximide-
sensitive (dependent on de novo protein synthesis), and highly labile (short-life). The StAR 
protein is synthesized in the cytoplasm as a precursor molecule from where it is transported to 
the mitochondria and cleaved to its active form. In the mitochondria, the StAR protein is 
responsible for the transport of cholesterol to the inner mitochondrial membrane, where the 
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first cytochrome P450 enzymatic conversion of cholesterol takes place (Stocco and Clark, 
1996). 
 
The enzymatic conversion of cholesterol to pregnenolone is the first step in a series of 
enzymatic conversions that culminate in the production of hormones. Figure 2.3 illustrates the 
enzymatic pathway for the conversion of cholesterol to steroid hormones. The first enzymatic 
reaction in this final stage of steroidogenic biosynthesis is mediated by cytochrome P450 
cholesterol side-chain cleavage enzyme (P450scc) to convert cholesterol to pregnenolone 
(Boyd and Simpson, 1968; Burstein and Gut, 1976). P450scc activity is also regarded as a 
rate-limiting step of steroid biosynthesis. This reaction occurs in the mitochondrial inner 
membrane and involves three sequential oxidation reactions, each requiring molecular oxygen 
and NADPH. This reaction adds a hydroxyl group at C20 and C22 followed by the cleavage 
between the two hydroxyl groups. Cholesterol, which is a 27- carbon sterol, is thereby cleaved 
of its 6-carbon group side-chain and results in the 21- carbon steroid, pregnenolone (Kagawa 
and Waterman, 1995). 
 
The second enzymatic reaction in the steroidogenic biosynthesis pathway is the conversion of 
pregnenolone to progesterone. This reaction is catalysed by the enzyme 3β-hydroxysteroid 
dehydrogenase/∆5-∆4 isomerase (3β-HSD) (Thomas et al., 1989; Thomas et al., 1995; Thomas 
et al., 2003). This reaction together with P450scc is believed to occur in the mitochondrial 
inner membrane. It is speculated that the StAR protein may interact with the mitochondrial 
inner membrane and thereby initiate the formation of P450scc and 3β-HSD. These reactions 
result in the rapid conversion of cholesterol to pregnenolone and then to progesterone (Stocco, 
1999). 3β-HSD is responsible for the dehydrogenation and isomeration of pregnenolone to 
progesterone. This reaction converts ∆5-3β-hydroxysteroid to a ∆4-3-ketosteroid, which is the 
active form of steroid hormones. The conversion of pregnenolone to progesterone by 3β-HSD 
can also occur in the cytosol. Thus, the steroidogenic pathway splits into a ∆5 – 
hydroxysteroid pathway (starting with pregnenolone) and a ∆4- ketosteroid pathway (starting 
with progesterone). Therefore, although the same enzymes use different substrates along the 
parallel pathways, both pathways converge and result in the production of androstenedione. 
The ∆5 – hydroxysteroid pathway substrates, 17α – hydroxypregnenolone and 
dehydroepiandrosterone (DHEA) are converted by 3β-HSD into their respective ∆4- 
ketosteroids namely, 17α – hydroxyprogesterone and androstenedione, respectively. 
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The third enzymatic reaction of the steroid biosynthesis pathway is mediated by cytochrome 
P450 17α – hydroxylase/C17 – 20 lyase (P450c17) (Robichaud et al., 2004). This enzyme 
requires molecular oxygen and NADPH. It performs two chemical reactions namely, 
hydroxylation and cleavage (conversion of the steroid from a 21- to a 19-carbon molecule). 
The hydroxylation products are considered as intermediates thus, P450c17 initially catalyses 
the conversion of pregnenolone to 17α - hydroxypregnenolone which is then converted to 
dehydroepiandrosterone (DHEA) in the ∆5 – hydroxysteroid pathway.  It was mentioned 
earlier that DHEA is converted to androstenedione by 3β-HSD. Similar, for the ∆4- 
ketosteroids, P450c17 converts progesterone to 17α – hydroprogesterone which is then 
converted to androstenedione by 3β-HSD.  
 
The lyase activity of P450c17 differs for the intermediate substrates among species. In 
humans P450c17 converts 17α – hydroxypregnenolone to DHEA (∆5 – hydroxysteroid 
pathway) whereas in rats, P450c17 converts the intermediates of both the ∆5 – hydroxysteroid 
and ∆4 – ketosteroid pathways equally. P450c17 lyase activity differences between species 
may explain some of the species dependent differences in response to substances that alter 
steroidogenesis.  
 
The following enzyme reaction is responsible for the conversion of androstenedione to 
testosterone. This reaction is mediated by 17-ketosteroid reductase (17KSR) which is also 
known as 17β-hydroxysteroid dehydrogenase (17β-HSD) (Wang and Tuohimaa, 2007). 
Testosterone is considered as an end-point or end-hormone product whereas, a second 
possible reaction involving androstenedione occurs in females. In females androstenedione is 
converted to estrone by aromatase. 17KSR can mediate either the reduction reaction 
(testosterone synthesis) or the oxidation reaction (androstenedione synthesis). This reversible 
reaction is dependent on product concentrations. In males testosterone is further converted to 
dihydrotestosterone (DHT) by 5α-reductase. This enzyme is localized in the cellular 
membranes, nuclear envelope and endoplasmic reticulum. DHT is considered to be 
significantly more potent than testosterone as an androgen and is also a steroidogenesis end-
point. DHT is primarily produced in peripheral tissues but it is also found in the testis. 
 
The last reaction of steroid biosynthesis is mediated by an enzyme named aromatase (Bulun et 
al., 2001). This enzyme is responsible for the conversion of androgens to estrogens. In males, 
aromatase converts testosterone to estradiol, whereas in females androstenedione is converted 
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to estrone. DHT, estradiol and estrone are all considered as steroidogenesis end-points. 
Aromatase is an enzyme complex that consists of two cytochrome P450 enzymes: a reductase 
and an aromatase bound to the endoplasmic reticulum. This enzyme complex catalyses two 
hydroxylation steps and the aromatization of Ring A in the steroid nucleus that results in the 
loss of the C-19 carbon atom and thereby producing a C-18 molecule characteristic of 
estrogens. Aromatase is found in many male and female peripheral gonodal tissues. The 
activity of this enzyme varies with species and age.  
 
2.3.2.3 Hormonal control of steroidogenesis 
Cholesterol is the common precursor for the synthesis of steroid hormones. A series of 
enzymatic actions is responsible for the conversion of cholesterol to end hormone products 
namely testosterone, DHT, estradiol and estrone. The steroidogenic pathway is under 
regulation of gonadotropins and end product hormones. Alteration to the regulatory 
mechanisms, steroidogenic enzymes and/or the substrates and products can effect end 
hormone production and result in reproductive system toxicity. An example of an enzyme 
under gonadotropin regulation is P450scc. Both P450scc and P450c17 are regulated by LH. In 
males FSH stimulates the release of a Sertoli cell factor that increases the effect of LH on 3β-
HSD activity, whereas in females FSH increases aromatase activity and enhances the 
conversion of androstenedione to estrone. In addition to the regulatory effects of 
gonadotropins, gonodal hormones exert feedback regulation loops on steroidogenic enzymes. 
Examples of this are for instance testosterone that inhibits P450c17 activity, which occurs via 
effects on the second messenger cAMP pathway. Testosterone also suppresses 3β-HSD 
through inhibitory effects on the cAMP-mediated 3β-HSD mRNA transcription. 
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Figure 2.3. Enzymatic conversions of cholesterol and intermediate/end-product hormones (EPA, 2005)
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2.4 Mechanisms of estrogenic endocrine disruptors 
The ability of pesticides to act as estrogen agonists have been known for over 40 years 
(Bitman et al., 1968). The estrogenicity of anthropogenic chemicals, for example, bisphenol A 
and diethylstilbestrol (DES), were first described in 1938 (Dodds and Lawson, 1938). EDCs 
typically influence reproductive health of vertebrates by more than one mechanism. Several 
target organs can be impacted, although not necessarily at the same dose or developmental 
stage of life. Considerable homology exists in the endocrine systems of vertebrates. Toxicants 
that alter endocrine function in one species are very likely to produce similar adverse effects 
in another. The endocrine system is very complex and a number of mechanisms have been 
documented whereby EDCs interact and disrupt normal endocrine function (Reviewed in 
IPCS, WHO, 2002). In a summarized version: EDCs can mimic the effect of natural 
hormones (e.g. estradiol) by binding to the hormone receptor, by antagonising the effects of 
natural hormones, by blocking the binding to the hormone receptor (e.g. tamoxifen), by 
reacting directly/indirectly with the hormone structure to alter it, by interfering with hormone 
synthesis; by altering hormone receptor levels and by interfering with the transport and 
elimination of hormones. Figure 2.4 illustrates a schematic diagram depicting several key 
steps of steroid hormone synthesis as well as steps that may be sensitive to disruption by 
environmental chemicals (Reviewed in WHO/IPCS, 2002). 
 
1.) Gonodal cells synthesize steroid hormones such as 17β-estradriol (E2), testosterone 
and progesterone which are collectively referred to as estrogenic ligands (EA). 
Chemicals that inhibit Cyp 450 enzymes, including drugs and pesticides may act at 
this location.  
 
2.) Following the synthesis of hormones in the gonads, it is secreted into the blood 
stream. Hormones in the blood stream are available to target cells through diffusion or 
it may be transported bound to sex hormone-binding globulin (SHBG). The amounts 
of free and bound hormone depend on several mechanisms. Bound hormone 
dissociates from SHBG at a rate depending on the affinity of the steroid for SHBG 
protein. Toxicants may alter blood SHBG and it has been reported that some hormone 
mimics do not bind SHBG as well as natural hormones. This could result that 
hormone mimics may be more available for both the target cell and for liver 
metabolism in comparison with natural hormones. 
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Figure 2.4. Schematic diagram depicting several key steps of steroid hormone synthesis 
as well as steps that may be sensitive to disruption by environmental chemicals 
(Reviewed in WHO/IPCS, 2002). Abbreviations used: Estrogenic ligands (EA); sex 
hormone-binding globulin (SHBG); hormone receptor (R); transcriptional factores (tf); 
hormone response elements (HRE); amino acids (aa). 
 
3.) Steroid hormones diffuse into the cell.  
 
4.) The hormone diffuses into the perinuclear region, where unoccupied receptors (R) are 
located.  
 
5.) At this step, hormone or hormone mimics may bind to the receptor. Many xenobiotics 
have been shown to bind the ER. It has also been reported that the same chemical 
secreted into the blood stream may be a prohormone, which is then metabolized in the 
cell. For example, in some tissues, testosterone is metabolized by aromatase to E2, 
whereas in others the enzyme 5α-reductase converts it to dihydrotestosterone. In some 
tissues such as muscle, testosterone itself is the active hormone. EDCs may inhibit the 
conversion of the prohormone to active hormone in the target tissue.  
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6.) The receptor (R) which is now bound to a natural or synthetic ligand, undergoes a 
conformational change, exposing key protein binding sites and forms homodimers. 
 
7.) The homodimers are responsible for the accumulation of transcriptional factors (tf), 
which forms a transcriptional complex. This complex will bind to specific sequences 
on the DNA of hormone dependent genes, known as hormone response elements 
(HRE). The transcriptional complex then initiates mRNA synthesis (mRNA). Some 
chemicals found in the environment known as anti-hormones interfere with DNA 
binding. 
 
8.) mRNA is transported out of the cell into the cytoplasm. 
 
9.) At this step proteins (the circles on a “string”) are synthesized from the RNA template. 
Initially, amino acids (aa) will bind to specific tRNAs (the thick arrows) which again 
will then bind to ribosomes where translation will occur. 
 
10.) The protein being synthesized (a marker of endocrine action), could be an enzyme, a 
protein hormone or growth factor, or a structural component of the cell. An example 
of a hormone dependent biomarker is vitellogenin, an estrogen-sensitive protein 
produced by oviparous vertebrates. 
 
11.) Toxicants may disrupt endocrine function by altering liver function. It has been shown 
that toxicants can either increase or decrease metabolism of a specific hormone in such 
a way that serum levels are altered. An example of this is some PCBs that stimulate 
metabolism of T4 resulting in dramatic reduction in serum T4 levels. Several 
pesticides have been shown to stimulate the liver and reduce serum steroid hormone 
levels. 
 
2.4.1. Specific examples of e-EDCs and their mode of action 
2.4.1.1. Estrogen Receptor mediated chemicals 
Several chemicals bind hormone receptors and then mimic or block the actions of natural 
hormones. Table 2.1 and 2.2 displays a list of chemicals that mediate endocrine disruption 
through interacting with the ER. Such compounds include some naturally occurring 
chemicals, such as coumestrol and genistein, pharmaceuticals such as diethylstibestrol, 17α-
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ethinylestradiol and tamoxifen, and industrial chemicals such as dichlorodiphenyl 
trichloroethane (DDT), bisphenol-A, nonylphenol and other alkylphenol polyethoxylates 
(APEs) (CMA, 1993; DFG and Eisenbrand, 1996; Shäfer et al., 1996). Methoxychlor, 
chlordecone (kepone) some PCBs and alkylphenols have also been shown to disrupt estrogen 
receptor function (Mueller and Kim, 1978; White et al., 1994). Several instances of endocrine 
disruption via other steroid receptors have also been reported. Metabolites of the fungicide 
vinclozin and the DDT metabolite, DDE have been found to bind to the androgen receptor 
and block testosterone-induced cellular responses in vitro. DDT and chloredecone inhibit 
ligand binding to the estrogen and progesterone receptors (Laws et al., 1995).  
 
2.4.1.2. Chemicals that can interact with specific steroidogenic enzymes 
Several classes of fungicides have been developed to inhibit fungal membrane synthesis and 
growth by specifically inhibiting CYP450 enzymes. However, the process of steroidogenesis 
is sufficiently conserved that these chemicals can also inhibit mammalian steroidogenesis. 
There are several CYP450 enzymes in the steroid pathway. The binding affinity of each of 
these enzymes varies depending on the chemical used. In general, at relatively high 
concentrations, these fungicides are nonspecific inhibitors of CYP450 enzymes. For instance, 
the antifungal imidazole derivative, ketoconazole inhibits various enzymes that belong to the 
CYP450-dependent mono-oxygenases in rodent and humans. Ketoconazole inhibits side chain 
cleavage of cholesterol and 11β-dyroxylase in the adrenal gland and 17α-hydroxylase and C17-
20 lyase in rat and human testes (Schurmeyer and Nieschlag, 1984; Pepper et al., 1990). When 
ketoconazole is administered to adult rodents, it can have dramatic effects even after a single 
dose (Bhasi et al., 1986; Heckman et al., 1992; Waller et al., 1990). A number of 
pharmaceuticals have also been developed that inhibit aromatase enzyme activity. These 
pharmaceuticals are used for the treatment of postmenopausal breast cancer (Brodie et al., 
1999). This P450 enzyme is also highly conserved in a variety of tissues and many species. 
Accidental inhibition of aromatase activity in wildlife may result in adverse effects such as 
abnormal sexual behaviour, fertility problems and extinction. The lists of pharmaceutical 
chemicals that have been developed to inhibit specific steroidogenic enzymes are endless. 
These chemicals may end up in the environment and cause adverse effects on different 
species. Table 2.3 displays a list of substances and the reported steroidogenic enzyme that it 
influences. 
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Table 2.3. Substance that directly alter steroidogenesis (EPA, 2005) 
Site of chemical action Reference 
cyclic-AMP Second Messenger System  
Bisphenol A/octyphenols Nikula et al., 1999 
Nitrate/nitric oxide Panesar, 1999 
Glucocorticoids Orr et al., 1994 
Indomethacin Lopez-Ruiz et al., 1992 
Chloroquine Lopez-Ruiz et al., 1992 
Ethane dimethanesulfonate  Klinefelter et al., 1991 
Dibromoacetic acid Goldman and Murr, 2002 
Nicotine  Patterson et al., 1990 
Cotinine  Patterson et al., 1990 
Tylosin  Meisel et al., 1993 
Gossypol  Pearce et al., 1986 
Lindane  Ronco et al., 2001 
 
 
StAR Protein  
Barbiturates  Gocze and Freeman, 1999 
Lindane  Walsh et al., 2000a 
Dibromoacetic acid  Goldman and Murr, 2002 
Dimethoate  Walsh et al., 2000a 
Diethylumbelliferyl phosphate  Choi et al., 1995 
DMSO  Stocco et al., 1995 
 
 
P450SCC  
Lead  Huang et al., 2002 
Ketoconazole  Kan et al., 1985 
Mibolerone  Fanjul et al., 1989 
Aminoglutethimide  Uzgiris et al., 1977 
Taxol  Rainey et al., 1985 
Cis-platinum  Maines et al., 1990 
Vitamin A deficiency  Jayaram et al., 1973 
 
 
3β-HSD  
Daidzein/genistein/biochanin A  Ohno et al., 2002 
Lithium chloride  Ghosh et al., 1991 
Mibolerone  Fanjul et al., 1989 
Danazol (ethinyltestosterone)  Barbieri et al., 1977 
Cyproterone acetate  Lambert et al., 1987 
Ethionine. Goldberg et al., 1969 
Cyanoketone (WIN-19578)  Goldman et al., 1965 
Mitomycin C  Deb et al., 1980 
Aflatoxin  Verma and Nair, 2002 
 
 
P450c17 (17"-hydroxylase/C17-20 lyase)  
Ethanol (17"-hydroxylase)  Murono, 1984 
Bromocriptine  Kovacevic and Sarac, 1993 
Mibolerone  Fanjul et al., 1989 
Danazol  Barbieri et al., 1977 
Cyproterone acetate  Ayub and Levell, 1987 
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Table 2.3. continued  
Site of chemical action Reference 
Cyclosporin A  Seethalakshmi et al., 1992 
Nicotine  Kasson and Hsueh, 1985 
Flutamide  Ayub and Levell, 1987 
 
 
17KSR  
Cotinine  Yeh et al., 1989 
Danazol  Barbieri et al., 1977 
Cyclosporin A  Kasson and Hsueh, 1985 
Lithium chloride  Ghosh et al., 1991 
  
5α-Reductase  
Finasteride  Morris, 1996 
 
 
Aromatase  
Aminoglutethimide  Johnston, 1997 
MEHP  Thomas, 1996 
Fenarimol  Vinggaard et al., 2000 
Fadrazole  Yue and Brodie, 1997 
Letrozole  Bhatnagar et al., 2001 
Anastrozole  Bhatnagar et al., 2001 
Arimidex  Johnston, 1997 
Flavenoids  Saarinen et al., 2001 
Prochloraz  Andersen et al., 2002 
Enconazole/miconazole/ketoconazole  Doody et al., 1990 
Imizolil  Doody et al., 1990 
4-hydroxyandrostenedione  Doody et al., 1990 
10-propargylestr-4-ene-3,17-dione Doody et al., 1990 
 
 
2.5 Effect of e-EDCs on health 
The hypothesis that chemicals found in the environment may induce estrogenic effects in 
experimental animals and humans is not new at all (Allen and Doisy, 1923; Burlington and 
Lindeman, 1950). The level of concern regarding estrogenic EDCs has intensified during the 
last two decades following a drastic increase in reports of adverse effects in human and 
wildlife reproductive health that is speculated to be due to exposure to endocrine-disrupting 
chemicals. Reported abnormalities in laboratory animals, wildlife and humans exposed to 
endocrine-disrupting chemicals include, feminization of males, abnormal sexual behaviour, 
birth defects, altered sex ratios, decreased sperm density, decreased size of testes, breast 
cancer, testicular cancer, reproductive failure and also thyroid dysfunction (Table 2.4) (Crisp 
et al., 1998; Vom Saal et al., 1998). 
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2.5.1 Wildlife health 
The most consistent evidence for endocrine disruption due to water contaminants has been 
reported from wildlife (Sumpter, 2005). A report by Matthiessen and Gibbs (1998) indicates 
masculinisation (imposex) of female snails exposed to tributyltin (TBT – an antifouling agent 
in paints). Masculinisation of female snails may result in a decline or extinction of snail 
populations. Alligators with impaired sexual development and function were observed in 
Lake Apopka, Florida after a major pesticide spill in 1980. The observed effects were 
hypothesised to have been linked to DDT contamination (Guillette et al., 1994). Reproductive 
defects have also been reported in various fish species in association with sewage effluents, 
paper industry and industrial chemical pollution (Purdom et al., 1994; Sumpter and Jobling, 
1995). Reproductive defects, including reduced fertility (Bortone and Davis, 1994), 
masculinisation of female fish (Denton et al., 1985) and feminisation of male fish (Gimeno et 
al., 1998a, 1998b; Batty and Lim, 1999), as well as variable spawning time (Kramer et al., 
1998) have been reported. Alkyl phenols (e.g., nonylphenol and octylphenol) are breakdown 
products of alkylphenol polyethoxylates, which are used as industrial surfactants and bases for 
household products. The alkylphenols are estrogenic and have been linked to reproductive 
defects in fish (Jobling et al., 1996). Impaired reproduction in Baltic grey, ringed seals (Helle, 
1980) and field studies on harbour seals has been linked to PCBs and its metabolites in their 
food chain. 
 
In birds, egg shell thinning has been linked to exposure to DDE (DDT derivative) (Cooke 
1973). Egg shell thinning, resulting in accidental breakage of eggs, has resulted in population 
declines in a number of species of predatory birds in Europe and North America. Agricultural 
chemicals which are currently used and suspected of having endocrine-disruptive activity are 
atrazine and related herbicides such as simazine, endosulfan, methoxychlor and fenitrothion 
(pesticides) and the fungicides vinclozolin and ketoconazole (WHO/IPCS, 2002). Atrazine, 
which is a herbicide, has been shown to have neuroendocrine effects on reproduction in 
rodents and fish (WHO/IPCS, 2002). Simazine has been demonstrated to impair reproduction 
in the water flea, Daphnia pulex at 4 – 20 mg/L (Fitzmayer et al., 1982). Chemicals like 
fenitrothion, vinclozolin and ketoconazole exhibit anti-androgen effects in mammals by 
inhibiting key enzymes of androgen synthesis (WHO/IPCS, 2002). Methoxychlor is an 
organochlorine pesticide which is used against a range of pests, and it is believed to have 
estrogenic effects on mice (US EPA, 1997). 
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Note: DES = diethylstilbestrol, DDT = dichlorodiphenyltrichloroethane, PCBs = polychlorinated biphenyls, T4 = thyroxine, TSH = thyroid stimulating 
hormone, IQ = intelligence quotient, LH = luteinizing hormone, HPG axis = hypothalamic–pituitary–gonadal axis, T3 = triiodothyronine. 
Table 2.4. Examples of the health effects of endocrine disrupters in wildlife and humans (Solomon  and Schettler, 2000) 
Chemical Use Mechanism Health Effect Reference 
DES Synthetic estrogen Estrogen receptor agonist. Humans (prenatal exposure): vaginal 
cancer, reproductive tract abnormalities 
(females). Cryptorchidism, hypospadias, 
semen abnormalities (males). 
Giusti et al., 1995 
Methozychl Insecticide Metabolite is an estrogen receptor 
agonist. 
Rodents: accelerated puberty, abnormal 
ovarian cycling (females). Aggressive 
behaviour (males). 
Swartz and Corken, 
1992; Vom Saal et 
al., 1995 
DDT Insecticide Metabolite (DDE) is an androgen 
receptor antagonist. 
Rodents (males): delayed puberty, reduced 
sex accessory gland size, altered sex 
differentiation. 
Gray, 1998 
Vinclozolin Fungicide Androgen receptor antagonist. Rodents (males): feminization, nipple 
development, hypospadias. 
Gray et al., 1999a 
PCBs No longer manufactured; still 
in electrical transformers, 
capacitors, toxic waste sites, 
food chain 
Accelerated T4 metabolism, 
decreased T4 levels, elevated TSH 
levels (high doses: thyromimetic). 
Humans (in utero exposure): delayed 
neurological development and IQ deficits. 
Jacobson and 
Jacobson, 1996; 
Zoeller et al., 2000 
Atrazine Herbicide Reduces gonadotropin-releasing 
hormone from hypothalamus, reduces 
pituitary LH levels, interferes with 
metabolism of estradiol, blocks 
estrogen receptor binding. 
Rodents (females): mammary tumours, 
abnormal ovarian cycling.  
Humans: some evidence of breast and 
ovarian  tumours. 
Bradlow et al., 1995; 
Tran et al., 1996b; 
Cooper et al., 1999; 
Donna et al., 1989; 
Kettles et al., 1996 
Dioxin By-product of industrial 
processes including waste 
incineration; food contaminant 
Aryl hydrocarbon receptor agonist; 
increases estrogen metabolism, 
decreases estrogen mediated gene  
transcription, decreases estrogen 
levels, decreases testosterone levels 
by interfering with HPG axis. 
Rodents (in utero exposure): delayed 
puberty, increased susceptibility to 
mammary cancer (females). Decreased 
testosterone, hypospadias, hypospermia, 
delayed testicular descent, feminized 
sexual behaviour (males).  
Humans: decreased T3 and T4 levels, 
decreased testosterone levels. 
Brown et al., 1998; 
Mably et al., 1992; 
Egeland et al., 1994; 
Nagayama et al., 
1998; Steenland et 
al., 1999 
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2.5.2 Human health 
Current human epidemiological data is inadequate for drawing solid conclusions regarding 
correlations between endocrine disrupting compounds and human health. Most of the 
evidence obtained for this possible link is derived from cases of pharmacological dosing, 
accidental exposure and occupational exposure. The first evidence that e-EDCs influence 
human health were found in aviation crop-dusters handling DDT, who had reduced sperm 
counts (Singer, 1949). Following this incident back in 1949, various reports have indicated 
that e-EDCs may have a negative impact on human health, although reports are very 
inconclusive. Table 2.5 lists some trends in human health effects potentially related to 
endocrine disruption (Solomon and Schettler, 2000). 
 
2.5.2.1 Developmental defects 
There appear to be an increase in sexual development defects in recent years and some of 
these may be linked to exposure of e-EDCs. For example, more baby boys have to undergo 
operations to correct undescended testicles (cryptorchidism) now than 30 years ago. The 
numbers affected by cryptochidism have increased 2-3 fold during the past 30 years (Keith 
1998). The incidence of the birth defect called “hypospadias” in which the male urinary canal 
is open underneath the penis is also increasing (Keith 1998). Boys exposed to higher levels of 
toxic chemicals during embryonic development have shorter penises than the average, similar 
to Lake Apopka's alligators in Florida (Keith 1998). Boys born from women who were 
exposed to PCB-poisoned rice bran cooking oil in 1978-79 in central Taiwan, the socalled 
"Yucheng" boys, were found to have significantly shorter than normal penis lengths at ages l l 
to 14 (Guo et al., 1993).  
 
2.5.2.2. Decreased sperm production in men 
It has been speculated that in utero exposure to environmental estrogens may be responsible 
for the decline in sperm production levels seen during the last 50 years (Sharp and 
Skakkebaek, 1993). A meta-analysis of 61 studies that includes about 15 000 men found a 
substantial decrease in sperm concentration from 113 x 106/ml in 1938 to 66 x 106/ml in 1990 
(Carlsen et al., 1992). A follow-up study conducted by Shanna Swan et al. (2000) also 
demonstrated a reduction in sperm count. Decreased sperm counts may result in fertility 
problems as 50 % of all fertility problems can be related to the male reproductive system 
(Swerdloff, 1985).  
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Table 2.5. Trends in human health effects potentially related to endocrine function 
End point Region Trend Degree of change Reference 
Hypospadias  US 
Canada 
Increasing incidence  4.3 % per year 
3.3 % per year 
Paulozzi, 1999  
Cryptorchidism US 
Canada 
Increasing incidence  3.5 % per year 
1.6 % per year 
Burlington and Lindeman, 1950 
Sperm Count Canada Decrease – 0.7 %/mL per year* 
– 3 %/mL per year 
– 5.3 %/mL per year 
Younglai et al., 1998 
Swan et al., 1997 
Swan et al., 1997 
Testicular cancer Canada 
US 
Europe 
Increasing incidence  2.1 % per year 
2.3 % per year 
2.3 % – 5.2 % per year† 
Liu et al., 1999 
McKiernan et al., 1999 
Bergstrom et al., 1996 
Prostate cancer Canada 
US 
Increasing incidence  3 % per year 
5.3 % per year 
Levy et al., 1998 
Haas and Sakr, 1997 
Breast cancer Saskatchewan, US Increasing incidence  3.3 % per year 
1.9 % per year 
Wang and Cao, 1996 
Wolff et al., 1996 
Sex ratio Canada 
US 
Shift towards females – 1.0 males/10 000 per year 
– 0.5 males/10 000 per year 
Allan et al., 1997 
Age at breast 
development 
US Shifting earlier 11.2 – 9.96 years in white 
population 
Herman-Giddens et al., 1997 
*This trend disappears when data from before 1984 are included. †Range is dependent on country, with Sweden at the lower and the former East    
  Germany at the upper end of the range. ‡International trends in prostate cancer are complicated by the introduction of the prostate specific   
antigen screen, but prostate cancer mortality also increased (by about 1 % per year through 1995 in the US and Canada), implying that   improved 
diagnosis may not fully explain the rising incidence trends. 
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2.5.2.3. Testicular- and prostate cancer in men 
The incidence of testicular cancer in men has drastically increased during the last decades 
(Forman and Moller, 1994). Testicular cancer is the most common malignancy among men at 
age 25-34 year in Denmark, while in Finland the incidence is much lower (Adami et al., 
1994). It has not yet been concluded whether the apparent increase in testicular cancer in 
many countries is due to hormonal substances (EDCs), change in life-style conditions or other 
causes. Cancer of the prostate is the second leading cancer cause of death in the USA. Death 
due to prostate cancer has increased 17 % over the last 30 years. More over, there are race 
differences in prostate cancer susceptibility. The prevalence is very rare in Orientals, 20-30 
times higher in Caucasians and even higher in Afro-American males (Crisp et al., 1998). A 
meta-analysis found a positive association between prostate cancer and farming occupation 
(Keller-Byrne et al., 1997). Little is known about the causes of prostate cancer, but age, 
genetics, diet and environmental risk factors have been proposed.  
 
2.5.2.4. Breast cancer 
Breast cancer is the most frequent tumour in women world wide. The incidence of breast 
cancer in Europe has increased steadily over the last few decades (Amaral Mendes, 2002). 
Several factors have been identified as potential risks, but their mechanisms are still unknown. 
One of these proposed factors are exposure to estrogenic chemicals whereas the other is high 
fat diets (Schmidt and Wayne, 1997). This hypothesis is supported by several case studies 
where a correlation between exposures to organochlorine chemicals such as DDT and certain 
PCB congeners and breast cancer incidences have been drawn (Dewailly et al., 1994). 
However, the association between breast cancer and exposure to DDT and its most prevalent 
breakdown product, dichlorodiphenyldichloroethylene (DDE) is also not yet considered 
conclusive (Snedeker, 2001). 
 
2.5.2.5. Endometrioses 
Another disease that can possibly be linked to e-EDCs is endometrioses. There is evidence 
suggesting an increased frequency of endometrioses in female offspring exposed in utero to 
DES (Berger and Alper, 1986). An association between endometrioses and high serum levels 
of PCB have also been reported (Gerhard and Runnebaum, 1992). However, the World Health 
Organization considers the link between endometriosis in females and exposure to 
organochlorines, as well as dioxins, as non conclusive (WHO/IPCS, 2002). 
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2.5.2.6. Male to female sex ratio of new borns 
Male to female sex ratio of newborns has been used as an indicator of environmental effects 
on human reproduction. Evidence, indicating a change in male/female ratios due to e-EDCs 
were seen in Seveso, Italy after dioxin exposure of the local population. Following this 
accident there was an increase in the percentage of females born in the period April 1977 to 
December 1984 (Mocarelli et al., 1996). The percentage female births declined again from 
1985 to 1994 and were thereafter similar to before the spill. Reports also indicate a decline in 
males born in Denmark (Moller, 1996), The Netherlands (Van der Pal-de Bruin et al., 1997), 
England and Wales (Dickinson and Parker, 1996) and Canada (Allan et al., 1997) over the last 
decade. Recent research supports the idea that environmental pollution leads to a decrease in 
the percentage of male births (Hood, 2005; Mackenzie et al., 2005).  
 
2.5.2.7. Effects caused by natural compounds 
Naturally occurring compounds such as phytoestrogens (naturally occurring plant compounds 
are structurally related to steroid hormones) have also been shown to affect normal endocrine 
function. One such case was illustrated by the lactation of castrated male sheep and infertility 
in female sheep grazing on phytoestrogens-rich pasture species (Adams, 1998). Numerous 
plant extracts used in herbal remedies have estrogenic activity. An example is terpenoids, 
which is found in products like neem. This is a pharmacologically active extract derived from 
an Indian tree (Azadirachta indica) that is used medicinally in India as a contraceptive and 
also to induce abortions (National Research Development Corporation of India, 2003). The 
evidence to date for endocrine disruption in humans from exposure to environmental 
chemicals is limited, and the issue remains controversial (Degen and Bolt, 2000; Safe, 2000). 
 
2.6. Development of test systems for estrogenic EDCs 
In order to assess the potential health risk (estrogenic characteristics) water sources, such as 
waste, ground and surface water may pose, assays are required to measure adverse effects. 
The choice and also development of appropriate test systems to identify e-EDCs are very 
complicated. Endocrine disrupters may act via a number of mechanisms including receptor 
dependent and independent processes. In addition, they can demonstrate species, tissue- and 
cell specific effects, as well as being influenced by metabolism. More over, many potential 
endocrine disruptors exist as complex mixtures in the environment that may possibly act 
synergistically. As a result EDCs can produce a wide range of responses. In the last few 
decades increasing attention has been given to the evaluation and development of appropriate 
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test systems for a wide range of endocrine disrupting chemicals (EDCs) and the adverse 
health effects that it may cause. The passage of two laws in 1996, the Food Quality Protection 
Act (FQPA) and Amendments to the Safe Drinking Water Act (SDWA) were the first to 
mandate the United States Environmental Protection Agency (U.S. EPA) to screen pesticides 
for endocrine disrupting characteristics. These two laws also authorized the U.S. EPA to 
screen chemicals found in drinking water to determine whether they are estrogenic or possess 
other endocrine activity (Federal Register, 1998a, 1998b). In order to provide 
recommendations regarding a strategy for the development of a testing paradigm for 
compounds that may interfere with naturally-occurring hormones, the U.S. EPA established 
the Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC). The U.S. 
EPA established the Endocrine Disruptor Screening Program (EDSP) upon recommendations 
made by EDSTAC in its final report (EDSTAC, 1998).  The aim of EDSTAC is to develop a 
screening program to determine whether substances found in the environment have endocrine 
disrupting effects. This screening program must be appropriately validated and be supported 
by relevant scientific information (FQPA, 1996). This program’s aim is to develop a two-
tiered approach, e.g. in vitro and in vivo mammalian and ecotoxicological screens (Tier 1) and 
a set of in vivo tests (Tier 2) for the identification and characterization of endocrine effects of 
pesticides, industrial substances and environmental contaminants. The development of new 
test guidelines and the revision of existing test guidelines for the screening and testing of 
potential endocrine disrupters were initiated as a high-priority activity in 1997 by the 
Organization for Economic Cooperation and Development (OECD). OECD assessments and 
test guidelines is managed by three Validation Management Groups (VMGs) and contain 
mammalian, ecotoxicological and non-animal methods. 
 
2.7 Current assays for e-EDC analysis 
2.7.1. Analytical mass based assays 
The use of mass based analytical test methods, including high performance liquid 
chromatography (HPLC), gas chromatography mass spectrometry (GC/MS), GC MS/MS and 
liquid (LC) MS/MS (Petrović and Barceló, 2000; Huang and Sedlak, 2001; Petrović et al., 
2002) have been very popular for the identification of specific EDCs in the environment. 
These methods have been presented in detail by various studies (Huang and Sedlak 2001; 
Heisterkamp et al., 2004; Wozei, 2004; Zhang et al., 2004; Fan et al., 2005). These analytical 
techniques are very sensitive and provide excellent precision for monitoring e-EDC mass. 
However, these techniques do not provide any data on estrogenic effects, synergistic or anti-
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estrogenic influences from multiple estrogenic compounds found in environmental matrixes. 
Mass based analytical techniques are applicable when the objective is to determine the fate 
and transport of specific e-EDCs in the environment. 
  
2.7.2 Bio-assays 
Bio-assays provide an attractive alternative towards traditional analytical mass based assays. 
Bio-assays may provide useful information regarding the mode of action of specific 
contaminants (Geisy et al., 2002) as well as the integrated possible action of various 
contaminants from different environmental matrices. Bio-assays include various in vitro and 
in vivo assays based on a number of mechanisms including cell proliferation, ligand binding, 
vitellogenin induction, luciferase induction, or antigen-antibody interaction. Bio-assays may 
provide either qualitative or quantitative responses. Bio-assays, which include both in vitro 
and in vivo assays, may use whole organisms, whole cells, or biological materials like 
antibodies or estrogen receptors. 
 
2.7.2.1 In Vitro bio-assays 
A large number of in vitro tests have been developed for the screening of environmental 
EDCs (ECETOC, 1996; Holmes et al., 1998). In general, in vitro assays are designed to be 
sensitive and rapid to facilitate the screening of large numbers of chemicals. The rapid 
response and lower equipment requirements, resulted in in vitro bio-assays being widely used 
as alternative to conventional analytical techniques for environmental monitoring, particularly 
when measuring relative increases in total estrogenic activity is the monitoring objective. The 
most widely used in vitro bio-assays for the prediction of estrogenic endocrine disruption are 
listed in table 2.6. 
 
2.7.2.2 Receptor Binding Assays 
Steroid hormones, such as 17β-estradiol act on their specific target cells by binding to a high 
affinity hormone receptor within the cell nucleus (Fig. 2.4). Receptor binding assays have 
been developed to assess the ability of a substance, or environmental chemical mixture, to 
bind directly to the hormone receptor (Jensen and Jacobson, 1960; Ireland et al., 1980; Baker 
et al., 1999 a, b, 2000). 
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Table 2.6. Main types of in vitro test systems for the detection of endocrine disrupters 
Assay Type Endpoint Measured 
Receptor Binding Assays Binding affinity of a substance to a hormone receptor 
Cell proliferation assays Ability of a substance to stimulate growth of hormone responsive 
cells (e.g. MCF-7, E-screen) 
Reporter gene Assays Ability of a substance to activate transcription of a reporter gene 
construct in cells (mammalian/yeast) 
Analysis of hormone-
sensitive gene expression 
Ability of a substance to induce expression of hormone-sensitive 
genes (e.g. pS2) 
Non-cellular bio-assays A range of assays not requiring viable cells i.e. ELISA, RIA 
 
Receptor binding assays have been widely used because it is rapid, easy to use and also 
relatively cheap. These assays are very appropriate to use when screening a large number of 
samples. However, these assays have some limitations. They cannot distinguish between 
agonistic and antagonistic effects, as binding to the receptor do not necessarily result in 
transcriptional activation. They are also only suitable for the detection of hormone-receptor 
mediated effects and cannot detect pro-estrogens (absence of metabolism in cell-free 
systems). 
 
2.7.2.3 Cell proliferation assays. 
Cell proliferation assays to monitor estrogenicity are well known and used by several research 
groups. These assays are based on the ability of a test substance to stimulate growth of an 
estrogen dependent cell line (Soto et al., 1992, 1995). The most commonly used cancer cell 
lines for cell proliferation assays are MCF-7 and T47D cells. In these assays breast cancer 
cells are exposed to both positive (17β-estradiol) and negative controls (vehicle control) as 
well as to the environmental sample being analysed. The cell proliferation of the 
environmental sample compared to the controls provides the basis for demonstrating 
estrogenic responses. Cell proliferation assays have the advantage over ER binding assays in 
that they take cellular, biological and metabolic responses into account. These assays are 
therefore useful to determine both synergistic and antagonistic estrogenic characteristics of 
complicated biological mixtures. Cell proliferation assays also have some disadvantages. 
Various studies have reported inter laboratory variation of the MCF-7 proliferation assay. 
This is mainly due to differences in culture conditions, as well as different MCF-7 strains 
(Osborne et al., 1987; Villalobos et al., 1995; Jones et al., 1997, 1998; Odum et al., 1998). 
Moreover, some studies have reported that MCF-7 cells can be stimulated to proliferate by a 
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range of non-oestrogenic substances including epidermal growth factor (EGF), progesterone, 
dihydrotestosterone, insulin-like growth factors, lithium, chloride and ethanol (Hackenburg et 
al., 1988; Osborne et al., 1990; Savouret et al., 1990; Jones et al., 1998). 
 
2.7.2.4 Reporter gene assays 
Reporter gene assays measure the ability of a substance to activate the transcription of a 
hormone (estrogen)-sensitive promoter in eukaryotic cells (e.g. yeast and mammalian cells). 
These assays are established using eukaryotic cells that are transfected with an expression 
vector encoding the human estrogen receptor, as well as estrogen response elements, which is 
in reading frame with a reporter gene (e.g. luciferase and β-galactosidase that can be readily 
detected and quantified). When single chemicals or complex environmental mixtures that 
contain e-EDCs are exposed to these cells, it will activate the receptor and response elements 
to stimulate expression of the reporter gene. A large number of reporter gene assays have 
been developed for a range of steroid hormone receptors using both yeast and mammalian 
cells. The use of yeast cells in these assays (Routledge et al., 1998; Gaido et al., 1997a,b) 
offer a number of advantages. Yeast cells are fairly easy to culture, ideal for genetic 
manipulation and also contain some degree of metabolic competence. The yeast reporter gene 
screens also have some limitations as reported by Joyeux et al (1997). The sensitivity of the 
system can depend on the number of receptor protein being expressed, the response element 
and also the reporter gene used. Yeast cell membranes have also been reported to be 
impermeable to some test substances and may result in false negatives (Gray et al., 1997). 
 
2.7.2.5 Non-cellular bio-assays 
Non-cellular bio-assays do not require viable cells in order to test for environmental endocrine 
disruptors. These assays have the advantage of not having difficulties with membrane 
permeability, cell function, and organism life stage, as well as toxicity responses to a given 
sample. Many of these assays are quantitative and provide reasonable detection limits for 
measurement of e-EDCs. Enzyme linked Immunosorbent Assay (ELISA) and Radio Immuno 
Assay (RIA) kits have been developed for many environmentally relevant surfactants and 
estrogenic compounds, as well as for some pesticides, antibiotics, and other personal care 
products (Gascón et al., 1997; Neogen Corp Lexington, KY; ALPCO Diagnostics Salem, NH; 
Assay Designs Inc. Ann Arbor, MI; Bio-Quant Inc., San Diego, CA; BioSource Internacional, 
Camarillo, CA; Cayman Chemical Company, Ann Arbor, MI; Immuno-Biological 
Laboratories, Inc., Minneapolis, MN; Envirologix. Portland, Me: York Nutritional 
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Laboratory, Osbaldwick, York, UK). In addition to these immunosorbent assays, advances 
have been made in electrochemical sensors, fluorescent indicators, and microarray relative 
binding assays (Zhihong et al., 1999; Murata et al., 2001; Awais et al., 2004). 
 
2.7.3 In vivo assays for e-EDC detection 
The use of in vivo assays for the analyses of specific compounds or environmental samples for 
estrogenicity have the advantage that it measures the true effect and impact of the substance 
being analyzed on the target specie. One of the most widely and oldest assays used for the 
detection of estrogenic substances is the uterotrophic assay (Dorfman and Dorfman, 1954). 
The endpoint of this assay measures uterine weight changes in immature or ovariectomised 
rodents (to minimize the effects of endogenous hormones). The compound of interest is 
usually administered for 3-4 days. This assay however requires standardization of protocols 
that specify species, strain, age and route of administration of the test compound (Odum et al., 
1997). Another widely used short-term test designed to investigate reproductive effects in 
males is the Hershberger assay (Hershberger et al., 1953). This assay detects the ability of a 
compound to elicit agonistic or antagonistic effects at the androgen receptor. The assay is 
traditionally conducted using castrated rats and measures an increase in weight of the ventral 
prostate and semical vesicles.  
 
The use of animals for example amphibians, fish, birds and insects are very popular to 
determine endocrine disruption. The US EPA has developed various fish assays for e-EDC 
determination. Fish species being used are rainbow trout (Oncorhynchus mykiss), fathead 
minnow (Pimephales promelas), sheephead minnow (Cyprinodon variegates) and zebrafish 
(Brachydanio rerio) (Fenner-Crisp et al., 2000; Folmar et al., 2000; Legler et al., 2002a). 
There are various approaches to determine estrogenic responses in these organisms, including 
morphological deformities, reproductive deficiencies, egg and offspring development, and 
serum protein production like vitellogenin (Table 2.7). Various fish species have been 
genetically engineered to respond to e-EDCs. Zebrafish has been bioengineered with 
luciferase expression coordinated to vitellogenin production (Legler et al., 2002a) and medaka 
fish (Oryzias latipes) was bioengineered to express a green fluorescence protein in response to 
vitellogenin production (Kurauchi et al., 2005). 
 
In vivo tests, like most other tests for e-EDC assays have a number of limitations. One 
example is that rodents do not synthesize sex-hormone binding globulin after parturition. This 
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protein is important for regulating the bioavailability of hormones and drugs that bind to them 
and is involved in their metabolic clearance. Rodent models are therefore often oversensitive 
to e-EDCS and some species and strain variation in sensitivity have been reported (Hisaw, 
1959). Large numbers of animals are often required to ensure statistically significant results 
(e.g. vaginal cornification).  The uterotrophic assay has also been shown to respond to non-
estrogenic substances such as progesterone, testosterone and epidermal growth factor (Korach 
and McLachlan, 1995). 
 
Table 2.7. Examples of whole organism studies as in vivo assay for e-EDCs 
Species Common 
name 
EDC effect Reference 
Chrysemys picta  Painted 
turtle 
Vitellogenin induction.  Irwin et al., 2001 
 
Oncorhynchus 
mykiss  
Rainbow 
trout  
Reproductive deficiencies, egg and 
offspring development, and vitellogenin 
induction. 
 
Fenner-Crisp et al., 2000, Folmar et al., 
2000, Anderson et al., 1996 
 
Pimephales 
promelas  
Fathead 
minnow  
Gonad development; reproductive 
deficiencies, development; vitellogenin 
induction. 
Fenner-Crisp et al., 2000, Folmar et al., 
2000 
 
Cyprinodon 
variegates  
Sheephead 
minnow  
Vitellogenin induction.  Legler et al., 2002a, Fenner-Crisp et al., 
2000, Folmar et al., 2000 
 
Danio rerio 
Brachydanio 
rerio 
Zebrafish  Gonad development; physiological 
development; vitellogenin induction, 
luciferine (luminescence). 
Maack et al., 1999, Legler et al., 2002a 
 
 
Oryzias latipes  Medaka 
fish  
Gonadal development; reproductive 
success; green fluorescence protein (GFP). 
Gray et al., 1999b, Kurauchi et al., 
2005 
 
 
Platichthys flesus  Flounder  Vitellogenin induction; gonad  
development; physiological development. 
Allen et al., 1999 
 
 
Salmo salar  Atlantic  Salmon Zona radiata protein and  
vitellogenin induction. 
Arukwe et al., 2000 
 
 
Halineetus 
leucocephalus  
Bald eagle  Reproductive and teratogenic effects.  Bowerman et al., 2000 
 
 
Coturnix coturnix 
japonica 
Colinus 
virginianus 
Japanese 
quail and 
bobwhite 
quail 
sexual behavior; embryo development; egg 
shell thickness. 
 
Lien et al., 1985, Berg et al., 1999 
 
 
 
Gallus domesticus  Domestic 
chicken  
Embryo development; egg shell thickness.  Berg et al., 1999 
 
 
Daphnia magna  Water flea  Physiological and biochemical disruption.  Baldwin et al., 1997 
 
Tisbe battagliai  Marine 
copepod  
Fecundity, longevity, and rate of 
development.  
Bechmann, 1999 
 
 
Rana pipiens  Leopard 
frogs  
Gonadal abnormalities.  Hayes, 1998, Hayes et al., 2002) 
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2.8 Objectives of the current study 
Contaminants in the environment may pose a health threat for humans and wildlife (USEPA, 
1997; Neubert, 1997). EDCs are widely distributed in the air, water, soil, as well as food that 
we eat, and have the potential to interfere with normal endocrine function (Ying and 
Kookana, 2002). Endocrine disruptors can act via a wide range of mechanisms, including 
receptor dependent and independent processes. Moreover, EDCs can demonstrate species, 
tissue- and cell-specific effects, as well as being influenced by metabolism (WHO/IPCS, 
2002). Yang (1994), made an observation that > 95 % of the resources in toxicological 
research are devoted to the study of single chemicals, with the almost complete neglect of 
complex mixture studies. In the last 10 years, many articles have been published on the 
combination effects of EDCs (Kortenkamp, 2007). EDCs found in the environment can have 
antagonistic or synergistic effect on a biological system. In other words, the combination 
effect of different chemicals may be smaller or larger than the sum of the individual effects of 
all components (Kortenkamp, 2007).  
 
Due to this, mass-based analytical techniques for example GCMS and HPLC, do not provide 
any data on estrogenic activity. In vitro test assays are powerful to use when screening a large 
number of chemicals/samples and can be used to characterize the mechanistic action and 
potency of specific compounds (Anderson et al., 1999; Beresford et al., 2000). However, in 
vitro assays do not always reflect the outcome of in vivo assays. This is due to differences in 
metabolic capabilities of the test systems (and lack of pharmacokinetics and 
pharmacodynamics) and the diverse range of mechanisms by which EDCs may act (Anderson 
et al., 1999; Beresford et al., 2000). In addition, no single in vitro assay is able to detect all 
properties of a hormonal active substance (Scrimshaw and Lester, 2004). Therefore, 
complementary in vitro and in vivo assays that assess both receptor and non-receptor mediated 
mechanisms seem to be the most appropriate way to assess the potential endocrine disrupting 
activities of a substance or environmental mixture. 
 
The aim of this study was the development, validation and implementation of a battery of in 
vitro and in vivo screens for environmental estrogenicity. In order to achieve the aim of this 
study, several objectives had to be reached. The first objective of this study was the validation 
of commercially available ELISA kits (designed for hormone quantification in human serum) 
to detect natural estrogenic hormones in water samples. The second objective was the 
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development of a multi biomarker cell culture assay that can be used as a rapid, sensitive and 
inexpensive screen for total environmental estrogenic activity as well as cytotoxicity. The 
third objective of this study was to development a direct ELISA on cultured MCF-7 cells to 
quantify ERα protein levels as a biomarker for estrogenicity. The forth objective of this study 
was to set up and validate a competition ELISA to quantify VTG from Oreochromis 
mossambicus (tilapia). The fifth objective of the study entailed using this quantitative ELISA 
for VTG to validate the use of tilapia juveniles (less than 70 days post fertilization) as a short 
term in vivo screen for estrogenicity. The sixth objective was the implementation of the 
battery of assays as a first tier screen to assess the Eerste River, South Africa for 
environmental e-EDCs. 
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3.1. Abstract 
Steroid hormones are naturally synthesized by both humans and animals and released into the 
environment. Significant levels of steroid hormones have been detected in sewage effluent 
around the world. The potential problem is that these hormones may interfere with the normal 
function of the endocrine systems, thus effecting reproduction and development in wildlife. 
Due to the major shortage of water in the Western Cape, South Africa there is a great need to 
recycle water by either direct or indirect methods. The treated sewage effluent – natural 
surface water mixture found in the Kuils and Eerste Rivers is used directly for irrigation of 
agricultural areas. Sewage effluent were collected from four sites (Jonkershoek, Belville, 
Zandvliet and Macassar) and subjected to C18 solid phase extraction. Commercially available 
rapid ELISA kits were validated for the quantification of estrogens in these sewage effluent 
samples. Analysis of estrone, estradiol and estriol levels showed a significant difference 
between the control site (Jonkershoek) and sewage effluent from the three sewage treatment 
works. Steroid hormone concentrations detected in these sewage effluents were similar to 
reports from Brittan, Italy, Germany, Canada and Netherlands. 
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3.2. Introduction 
Steroid hormones are a group of biological active compounds that are synthesized from 
cholesterol and have a cyclopentan-o-perhydrophenanthrene ring in common (Guang-Guo et 
al., 2002). The steroids include progestogens, glucocorticoids, mineralocorticoids, androgens 
and estrogens (Raven and Jonhson, 1999). Natural steroids are secreted by the adrenal cortex, 
testis, ovary and placenta in both humans and animals. Estrogens (estriol, estradiol and 
estrone) are predominantly female hormones and are responsible for the maintenance of 
reproductive organs/tissue, breasts, skin and brain. Androgens are predominantly male 
hormones and are responsible for tissue regeneration, especially the skin, muscle and brain. 
Progesterone can be thought of as a hormonal balance, especially of estrogens. 
Glucocorticoids (cortisol) are produced by adrenal glands in response to stressors such as 
emotional upheaval, exercise, illness, surgery or starvation (Guang-Guo et al., 2002).  
 
All humans and animals excrete hormones through their bodies, which can end up in the 
environment through sewage discharge or animal waste disposal (Lintelmann et al., 2003; 
Shore and Shemish, 2003; Wenzel et al., 1998). Many of these hormones are peptides and are 
rapidly destroyed. However, steroid hormones are chemically very stable and are excreted in 
the free form or as conjugates. Steroid conjugates very readily biotransform to the free form 
(Wenzel et al., 1998; Panter et al., 1999). Steroids have been detected in effluents from 
sewage treatment plants and surface water before (Desbrow et al., 1998; Kuch and 
Ballschmitter, 2001; Ternes et al., 1999a). The potential problem of these natural steroids 
ending up in the environment is that they may interfere with the normal function of the 
endocrine systems, thus affecting reproduction and development in wildlife (Jobling et al., 
1998). The steroids of major concern in the aquatic environment due to their endocrine 
disrupting potential are mainly estrogens (Guang-Guo et al., 2002). However, little research 
has been performed on androgens in the aquatic environment and their potential endocrine 
disrupting properties. It has only been recently that androgens were found in treated sewage 
(Kirk et al., 2002) and river water (Thomas et al., 2002). 
 
Several studies in the United Kingdom have shown that wild fish exposed to treated sewage 
water exhibit reproductive abnormalities consistent with exposure to estrogen and estrogen 
mimics (Jobling et al., 1998; Harries et al., 1996; Jobling and Tyler, 2003; Purdom et al., 
1994). Toxicity identification revealed that natural and synthetic hormones excreted by 
humans, as well as some alkylphenolic industrial chemicals in sewage effluent, were 
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responsible for the majority of estrogenic activity (Desbrow et al., 1998; Routledge et al., 
1998). This problem is not confined to the United Kingdom. Studies in continental Europe, 
Japan and North America confirmed that their sewage treated water also contains estrogenic 
chemicals (Körner et al., 2001; Onda et al., 2002; Solé et al., 2002) and that these may be 
impacting a wide range of fish species (Christiansen et al., 2002; Folmar et al., 2001; 
Hashimoto et al., 2000). The concentration of 17β-estradiol in sewage effluent range from 2.7 
– 48 ng/l (United Kingdom) (Desbrow et al., 1998), < limit of detection (LOD) – 3 ng/l 
(Germany) (Ternes et al., 1999a), < LOD – 64 ng/l (Canada) (Ternes et al., 1999a), 3.2 – 55 
ng/l (Japan) (Nasu et al., 2000).  
 
In British sewage treatment works (STWs), the concentrations of estrone in the effluents vary 
widely from 1.4 to 76 ng/l (Desbrow et al., 1998). Estrone has also been detected in sewage 
effluent in Italy (2.5 – 82.1 ng/l) (Baronti et al., 2000), Germany (< LOD – 70 ng/l) (Ternes et 
al., 1999a), Canada (< LOD-48 ng/l) (Ternes et al., 1999a) and Netherlands (<0.4 – 47 ng/l) 
(Belfroid et al., 1999). Estriol was only recently reported in Italian STW influents and 
effluents (0.43-18 ng/l) (Baronti et al., 2000). A survey of 139 polluted streams and rivers in 
the US found the following concentrations of steroids (in ng/l; maximum, median; LOD 5 
ng/l): testosterone (214, 111), estradiol (200, 160), estrone (112, 27), ethinylestradiol (831, 
73) and estriol (51, 31) (Kolpin et al., 2002). 
 
Estrogenic hormones in water matrix are usually quantified by techniques such as gas 
chromatography, mass spectrometry (GC–MS), GC–MS/MS, high performance liquid 
chromatography (HPLC), HPLC–MS and HPLC–MS/MS (Snyder et al., 1999; Snyder et al., 
2001). These methods are reliable but have several potential drawbacks such as expensive 
instrumentation, complex derivatization, extensive clean-up and purification, and also require 
a very high level technical expertise for operation. High cost and low throughput limit the use 
of these techniques. Thus there is a strong need for rapid, simple and cost-effective methods 
for quantitative analysis of estrogenic hormones, such as enzyme linked immunosorbent assay 
(ELISA). ELISA kits are commercially available for the quantification of estrogenic and 
androgenic hormones. Large numbers of samples can be analysed simultaneously and 
machines that do the readings are relatively cheap and also available in portable format that 
can be used in field studies. 
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Due to the major shortage of water in the Western Cape, South Africa there is a great need to 
recycle water by either direct or indirect methods. The treated sewage effluent – natural 
surface water mixture found in the Kuils and Eerste Rivers is used directly for irrigation of 
agricultural areas. The Western Cape has a high rainfall in winter with very low/no rain in 
summer. During summer most of the water in these rivers is treated sewage effluent. 
According to a recent report of the Cape Metropolitan Council (www.capetown.gov.co.za), 
Cape Town, South Africa has 19 wastewater treatment works, of which only 20 % comply 
with the quality requirements specified in their permits issued by the Department of Water 
Affairs and Forestry (www.cndv.co.za). Problems encountered by most of these plants include 
inadequate sludge disposal, maintenance of the plants and bacteriological quality of the 
effluents (www.capetown.gov.co.za). 
 
Three sewage treatment works were incorporated in this study for analysis of samples 
collected from respective sites, i.e. Belville, Zandvliet and Macassar. Effluents from these 
plants enter the Eerste River – Kuils River system. Jonkershoek was used as a negative 
control for it is situated near the origin of the Eerste Rivier, up in the Stellenbosch mountains. 
The aim of this study was firstly to validate rapid ELISAs for screening natural steroid 
hormones using commercially available ELISA test kits. Secondly, to use the validated 
ELISAs to determine the level of estrogens in treated sewage effluent. 
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3.3. Methods and Materials 
3.3.1. Collection of samples. 
Water samples were collected from three sewage plants on the Eerste River - Kuilsriver 
catchment area (E-KRCA) in March 2005 at the end of the dry season and again in April 2005 
after the first winter rains (Fig. 3.1).  A control sample was collected at Jonkershoek. The 
control site is near the origin of the river and upstream from all human activity.  The water 
was collected in clean 2,5 liter glass containers and immediately transported to the laboratory 
for extractions.  Extractions were done within 24 hours after sample collection.  Samples were 
stored at 4 °C until extraction. 
Figure 3.1. Water was collected from four sites along the Eerste- and Kuilsriver water 
catcment area: (1) Jonkershoek; (2) Belville STW effluent; (3) Zandvliet STW effluent; (4) 
Macassar STW effluent. 
 
3.3.2. Extraction of water samples. 
Water samples were extracted on C18 SPE columns (Anatech) using our in-house extraction 
procedure.  In brief: C18 columns were pre-washed with 4 ml of solvent mixture (40 % 
hexane, 45 % methanol and 15 %, 2-propanol), followed by another wash with 4 ml of 
ethanol.  The column was then washed with one column volume of reverse osmosis water 
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after which the water sample was applied onto the column.  The column was then air-dried.  
The bound hydrophobic substances were eluted with solvent mixture.  The eluate was dried 
under air and then reconstituted to 1/1000 th of the original sample volume with ethanol.  The 
samples were stored at –20 °C. 
 
3.3.3. ELISA Reagents 
All reagents required for the assays are supplied with the kits. 
 
3.3.4. ELISA for Estrone 
Working conjugate solution was prepared by mixing 100 µl estrone-biotin and 100 µl avidin 
peroxidase conjugate and 9.8 ml assay buffer. The working conjugate were mixed and 
incubated at room temperature for at least 20 minutes prior to addition to the ELISA plate. 
 
Concentrated (1000 x) water extracts were diluted 1/10 using 0.1 % (w/v) bovine serum 
albumin in 0.9 % NaCl. The diluted (100 x concentrated) extracts were assayed directly on the 
estrone ELISA kit (cat number DB52051, IBL, Germany) using the manufacturer’s 
instruction manual. In brief: microtitre plate strips precoated with rabbit anti-estrone was 
removed from the strip holder and firmly fixed in the ELISA plate. All assays were done in 
duplicate. Samples and standards were transferred to the wells (25 µl per well), followed by 
the addition of working conjugate solution (100 µl per well). The contents of the wells were 
mixed by tapping the plate. The ELISA plate was then incubated for one hour at room 
temperature, followed by washing the plate four times with wash buffer (300 µl/well). TMB 
substrate was dispensed at 150 µl per well after which the plate was incubated for 15 minutes 
at room temperature. The reaction was stopped by the addition of stop solution (50 µl per 
well). The optic density (OD) was measured at 450 nm using a plate reader. A standard curve 
was drawn using the OD readings obtained for the standards and the concentrations for the 
samples were read off this curve. 
 
3.3.5. ELISA for 17β-estradiol 
Concentrated (1000 x) water extracts were diluted 1/10 using 0.1 % (w/v) bovine serum 
albumin in 0.9 % NaCl. The diluted (100 x concentrated) extracts were assayed directly on the 
estradiol ELISA kit (catalogue number RE52041, IBL, Germany) using the manufacturer’s 
instruction manual. In brief: microtitre plate strips precoated with rabbit anti-estradiol was 
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removed from the strip holder and fixed firmly in the ELISA plate. All assays were done in 
duplicate. Samples and standards were transferred to the wells (25 µl/well). Estradiol – 
horseradish peroxidase conjugate was added to all the wells (200 µl/well). The solutions were 
mixed by gently tapping the plate, where after it was incubated for 120 minutes at room 
temperature. At the end of the incubation period the solutions in the wells were decanted after 
which the wells were washed three times with 300 µl/well of was solution. Substrate was then 
dispensed at 100 µl per well after which the plate was incubated for 15 minutes at room 
temperature. The reaction was stropped by addition of stop solution (100 µl/well). The OD 
was determined at 450 nm using a plate reader. A standard curve was drawn using the 
readings obtained for the standards and the concentration of the samples was read off this 
curve.  
 
3.3.6. ELISA for Estriol 
Concentrated (1000 x) water extracts were diluted 1/10 using 0.1 % (w/v) bovine serum 
albumin in 0.9 % (w/v) NaCl. The diluted (100 x concentrated) extracts were assayed directly 
on the estriol ELISA kit (cat number BM52011, IBL, Germany) using the manufacturer’s 
instruction manual. In brief: microtitre plate strips precoated with rabbit anti-estriol was 
removed from the strip holder and fixed firmly in the ELISA plate. All assays were done in 
duplicate. Samples and standards were transferred to the wells (10 µl/well) followed by the 
addition of 100 µl estriol – horseradish peroxidase conjugate. The solutions was mixed by 
gently tapping the plate after which it was incubated for 1 hour at room temperature. The 
contents of the wells were decanted and the plates were washed four times with wash buffer 
(300 µl/well). TMB substrate was then added and the plates were incubated for 30 minutes at 
room temperature. The enzyme reaction was stopped by the addition of stop solution. The OD 
was determined at 450 nm using a plate reader. A standard curve was drawn using the reading 
obtained for the standards and the concentration of the samples was read off this curve.  
 
3.3.7. Validation of assays 
Kits were assayed for accuracy as follows: A dilution series of a sample containing high 
steroid hormone concentrations was prepared using 0.1 % (w/v) bovine serum albumin in 0.9 
% (w/v) NaCl. The diluted samples were then assayed using the kit and the data obtained was 
plotted on the same graph as the standard curve to determine if the curves were parallel. Kit 
standard steroid hormones were also titrated with ethanol to determine the recovery of the 
ELISA assay on samples containing ethanol. The kits were assayed for intra-assay 
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reproducibility by assaying replicates of the same sample on a single assay plate. The kits 
were also assayed for inter-assay reproducibility by assaying the same sample on several 
plates. 
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3.4. Results 
3.4.1. Validation of assays 
Typical standard curve data for the estriol, estrone and estradiol ELISAs are presented in 
figure 3.2. The correlation coefficients for all three of the curves are between 0.97 and 0.99. 
The estriol ELISA has a detection range between 0.3 and 40 ng/ml. The estrone ELISA has 
range between 15 and 2000 pg/ml whereas the estradiol ELISA has a detection range between 
25 and 2000 pg/ml. Sensitivity (minimum detection limit) was determined by the supplier. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2. Standard curves for the ELISAs to determine estriol, estradiol and estrone 
concentrations in sewage effluent. 
 
Parallelism of the ELISA kits standard curves and environmental samples was established 
using Macassar sewage effluent after the first rains as an environmental sample. Curves 
produced by assaying environmental samples at various dilutions showed parallelism with the 
standard curve produced for estrone and estradiol (Fig. 3.3). Parallelism between the standard 
curve of the estriol ELISA kit and the Macassar sewage effluent after the first rains could not 
be establish because estriol concentrations in the C18 extraction were already near the 
detection limit of 0.3 ng/ml.  
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Figure 3.3. Parallelism between kit standard and sewage effluent sample.   
 
Sewage effluent was subjected to C18 solid phase extractions and finally dissolved in 
analytical grade ethanol as described in the section, methods and materials. The supplier 
optimized the ELISA kits for the analysis of the specific steroid hormone in human serum. 
The effect of ethanol on the recovery of the ELISA assay was analyzed by assaying 10 % of 
the kit’s maximum standard steroid hormone at 0 %, 10 % and 20 % ethanol. The estriol 
ELISA assay had a recovery of 98.3 ± 7.1 % at 10 % ethanol, whereas 87.7 ± 2.4 % could be 
established at 20 % ethanol (Table 3.1). There were no significant difference between the 
percentage recoveries (P = 0.125).  Ethanol had no effect on the estrone ELISA (P = 0.576) 
with recoveries of 105.3 ± 7.2 % at 10 % ethanol and 102.1 ± 6.5 % at 20 % ethanol (Table 
3.2). The estradiol ELISA had a recovery of 88.3 ± 3.9 % at 10 % ethanol and 98.6 ± 14.5 % 
at 20 % ethanol (Table 3.3). Ethanol again had no significant influence on the recovery of the 
estradiol ELISA (P = 0.346).  
 
Intra assay variation was less than 2.5 % at 0, 10 and 20 % ethanol for the estriol ELISA, 
whereas inter assay variation was 5.6 ± 0.3 % at 10 % ethanol (Table 3.1). Intra assay 
variation was less than 7 % at 0, 10 and 20 % ethanol, whereas intra assay variation was 8.2 ± 
0.7 % at 10 % ethanol for the estrone ELISA (Table 3.2). The estradiol assay had an intra 
assay variation of less than 8 % at 0 and 10 % ethanol. Intra assay variation is 13.9 ± 2.1 % at 
20 % ethanol. Inter assay variation is 3.9 ± 0.1 % at 10 % ethanol (Table 3.3). 
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3.4.2. The detection of estriol in sewage effluent 
Very low concentrations of estriol were detected in sewage effluent from all the STWs. All 
the samples tested had levels lower than 1.1 ng/l of estriol (Fig. 3.4). These values were near 
to the lower detection limit of the ELISA kit. Samples collected in April and March, at all the 
STWs, show significant higher levels of estriol (P = < 0.001) in comparison with the control 
site, except for Macassar in March. 
 
Table 3.1. Estriol ELISA validation. The effect of ethanol on recovery  
and intra assay variation as well as the inter assay variation at 10% ethanol  
on  the estriol ELISA kit. 
n % Ethanol % Recovery % Intra assay variation % Inter assay variation 
3 0 100.6 ± 9.2 2.5 ± 0.2  
3 10 98.3 ± 7.1 1.9 ± 0.1 5.6 ± 0.3 
3 20 87.7 ± 2.4 0.6 ± 0.02  
Table 3.2. Estrone ELISA validation. The effect of ethanol on recovery  
 and intra assay variation as well as the inter assay variation at 10% ethanol on 
 the estrone ELISA kit   
n % Ethanol % Recovery % Intra assay variation % Inter assay variation 
3 0 100 ± 3.3 3.3 ± 0.1  
3 10 105.3 ± 7.2 6.9 ± 0.5 8.2 ± 0.7 
3 20 102.1 ± 6.5 6.4 ± 0.4  
Table 3.3. 17β-estradiol ELISA validation. The effect of ethanol on recovery  
 and intra assay variation as well as the inter assay variation at 10% ethanol on  
the estradiol ELISA kit   
n % Ethanol % Recovery % Intra assay variation % Inter assay variation 
3 0 100.5 ± 8.7 8.4 ± 0.7  
3 10 88.3 ± 3.9 4.5 ± 0.2 3.9 ± 0.1 
3 20 98.6 ± 14.5 13.9 ± 2.1  
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Figure 3.4. Estriol quantification in water extracts. Water samples were collected from 
sites along the Kuils and Eerste Rivers in March and April. The samples were extracted using 
C18 chromatography and then assayed using the estriol ELISA kit 
 
3.4.3. The detection of estrone in sewage effluent 
Less than 0.2 ng/l estrone were detected in the Jonkershoek samples (Fig. 3.5).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5. Estrone quantification in water extracts. Water samples were collected from 
sites along the Kuils and Eerste Rivers in March and April. The samples were extracted using 
C18 chromatography and then assayed using the estrone ELISA kit. 
 
The levels of estrone was significant higher in the sewage effluents in comparison with the 
control site (P = < 0.001). Zandvliet had the highest level of estrone in both March and April, 
9.4 and 10.6 ng/l respectively. Effluent collect from Belville in March had the lowest level of 
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estrone (7.2 ng/l). Generally samples taken in April have higher levels of estrone in 
comparison with March, although statistically insignificant (P = > 0.001). 
 
3.4.4. The detection of estradiol in sewage effluent 
Very low levels of estradiol were detected in samples obtained from the control site in 
Jonkershoek (Fig. 3.6). There were significant higher levels of estradiol detected from the 
sewage effluents in comparison with the control site (P = < 0.001). Estradiol levels ranged 
between 0.8 ng/l (Macassar, April) and 4.7 ng/l (Zandvliet, April). At both Zandvliet and 
Macassar estradiol levels were higher in April then in March.  
 
Figure 3.6. 17β-estradiol quantification in water extracts. Water samples were collected 
from sites along the Kuils and Eerste Rivers in March and April. The samples were extracted 
using C18 chromatography and then assayed using the estradiol ELISA kit. 
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3.5. Discussion 
As stated in the introduction, the purpose of this work was to validate commercially available 
rapid ELISA kits for the quantification of estrogens in sewage effluent. One of the major 
potential obstacles to overcome was the fact that these ELISA kits are optimized for the 
quantification of estrogens in blood serum. Sewage effluents samples subjected to C18 solid 
phase chromatography extraction is ultimately reconstituted in ethanol before assayed using 
the ELISA kits in this study. Recovery analysis showed that ethanol had no significant effect 
on the sensitivity of the ELISA kits towards the specific steroid hormone assayed (Table 3.1, 
3.2, 3.3). One way analysis of variance (ANOVA) on the hormone recovery of the ELISA kits 
showed that no significant difference exist between samples containing 0, 10 and 20 % 
ethanol for the estriol, estrone nor estradiol kits. Moreover, intra- and inter assay variability 
was less than 5.6 %, 8.2 % and 4.5 % for the estriol, estrone estradiol ELISA kits respectively 
at 10 % ethanol in the sample (Table 3.1, 3.2, 3.3). This data illustrates that these ELISA kits 
are highly repetitive with minimal inter- and intra assay ELISA kit interference.  The 
validation of these ELISA kits used to determine steroid hormone levels in sewage effluent 
are further supported by good parallelism between dilution curves of the kit standards and 
sewage effluent samples (Fig. 3.3). 
 
Analysis of estrone, estradiol and estriol levels showed a significant difference between the 
control site (Jonkershoek) and sewage effluent from three STWs (Bellville, Zandvliet and 
Macassar) (Fig. 3.4, 3.5, 3.6). The control site contained very low or less than the lowest 
observable level of estrone, estradiol and estriol. This was to be expected because this sample 
site is situated in the mountains, near the origin of the Eerste River and is not exposed to any 
human activity except for occasional hikers. Estriol, estrone and estradiol concentrations were 
higher in April than in March, although this is not statistically significant. April samples were 
taken shortly after the first heavy winter rains. A possible explanation may be that the sewage 
plants were not able to handle the increased influent volumes of water. Therefore some 
overflowing or contamination of sewage effluent with raw sewage water may have occurred.  
 
Estriol had the lowest levels, less than 1.1 ng/l, of the three steroid hormones analyzed in this 
study. A study previously conducted by Baronti et al. (2000) showed the same trend where 
estriol was detected at much lower levels than estradiol and estrone. Zandvliet showed the 
highest levels of both estrone and estradiol. Estrone levels were between 7.2 and 10.6 ng/l, 
whereas estradiol levels range between 0.8 and 4.7 ng/l. These values are similar to the lower 
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range of estrone and estradiol concentrations detected in sewage effluent from Brittan 
(Desbrow et al., 1998), Italy (Baronti et al., 2000), Germany (Ternes et al., 1999a), Canada 
and Netherlands (Belfroid et al., 1999). Although the steroid hormone levels in our study may 
seem low, it is still quite concerning due to the fact that this water is used for agricultural and 
horticultural irrigation, drank by farm animals, farm workers as well as people from informal 
settlements along river banks. Concentrations as low as 1 ng/l of 17β-estradiol (natural 
estrogen) led to induction of vitellogenin in male trout (Hansen et al., 1998).  It was also 
observed that ova formed in the testis of Japanese medaka at concentrations as low as 4 ng/l 
17β-estradiol (Metcalfe et al., 2001).  Futhermore, Alfalfa plants irrigated with sewage 
effluent containing steroid hormones, display elevated levels of phytoestrogens (Shore et al., 
1995). 
 
To our knowledge, this is the first study conducted in South Africa to demonstrate the 
presence of significant amounts of steroid hormones released back into the environment from 
sewage treatment plants. Detailed surveys are necessary to understand the distribution of 
steroid hormones in the environment. Significant levels of these steroid hormones do have the 
potential to cause endocrine disruption, not only in animals but in humans as well. Future 
work must be directed to test whether these samples are biologically active through in vivo 
and ex vivo studies. 
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4.1. Abstract 
The occurrence of environmental chemicals with estrogenic activities are a major concern 
internationally. Studies have shown that these chemicals, or estrogenic endocrine disrupting 
chemicals (e-EDCs), can pose a health risk to both males and females. The aim of this study was 
to compare various biomarkers of the MCF-7 cell line as end-points for estrogenic activity. The 
MCF-7 cell line is an estrogen dependent cell line and has been used previously in the E-screen 
for estrogens. The biomarkers that we used were total cellular LDH, total cell protein and 
mitochondrial activity using the XTT assay. The current study shows that the total cellular LDH 
assay is the most sensitive assay for 17β-estradiol (E2) monitoring. The sensitivity of the total 
LDH assay with the MCF-7 cell line was 0.1-1000 nM E2.   
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4.2. Introduction 
Estrogens play an important role in the growth, differentiation and functions of many target 
organs. These organs include both male and female reproductive systems such as the mammary 
gland, uterus, vagina, ovary, testis, epididymis and prostate (Korach et al., 1995; Couse et al., 
1999). Every year a large number of diverse synthetic chemicals (xenobiotics) are released into 
the environment. This is due to increased agricultural and industrial activity. These chemicals 
include pesticides, insecticides, fungicides, herbicides, solvents, detergents styrenes, 
polychlorinated biphenyls, and penta- to nonylphenols that accumulate in the air, water and food 
chain (Colborn and Clement 1992; Colborn et al., 1993). The problem is that despite the 
structural diversity among these chemicals, they all have the ability to bind to estrogen receptors 
(ER) in cells of the body and can initiate (agonist) or inhibit (antagonist) estrogen-like actions 
(Soto et al., 1992; Eckert and Katzenellenbogen, 1982).  In doing so, they may disrupt normal 
endocrine function that may lead to reproductive failure in wildlife and humans (Sharpe and 
Skakkebaek, 1993; Hoyer et al., 1998). The chemicals that mimic the effect of natural estrogens 
are collectively referred to as estrogenic endocrine disruptors (e-EDCs). It has been reported that 
e-EDCs may be responsible for congenital malformations of the reproductive tract and increased 
incidences of cancer in estrogen responsive tissues (Colborn et al., 1993; Davis et al., 1993). 
Concerns regarding the adverse effects of e-EDCs on human health include reports of increased 
incidences of testicular (Osterlind, 1986), prostate and breast (Wolff and Toniolo, 1995) cancer.  
 
The incidence of testicular cancer has significantly increased over the last few decades (Forman 
and Moller, 1994). The tumors are primarily from germ cell origin. Testicular cancer is the most 
common malignancy among men of age between 25-34 years in Denmark, while in Finland the 
incidence is much lower (Adami et al., 1994). Cancer of the prostate is the second leading cause 
of cancer deaths in males in the USA. A meta-analysis found a positive correlation between 
prostate cancer and farming occupation (Keller-Byrne et al., 1997). Cancer of the breast is the 
most frequent tumor in women in the world. The increased risk of breast cancer has been 
suggested to be related to exposure to e-EDCs. Several case-control studies published in the last 
two decades have raised the issue that women exposed to organochlorine chemicals such as DDT 
and certain PCB congeners may have higher incidences of breast cancer than non-exposed 
women (Dewailly et al., 1994). Endometrioses is characterized by growth of endometrial cells 
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outside the uterus. The etiology of this disease is unknown. Exposure to estrogen-like compounds 
has been hypothesized to be involved in the disease process (Hill, 1992). An association between 
endometriosis and high levels of PCB in plasma has been reported (Gerhard and Runnebaum, 
1992). 
 
Estrogen responsive cancer tissues have been widely used for the development of in vitro assays 
to detect e-EDCs. The most common estrogen dependent human cell lines which are used for the 
development of estrogenic test assays are breast cancer cell lines such as MCF-7 (E-Screen) or 
T47D (Soto et al., 1992, 1995). In all of these in vitro systems, the ability of a specific chemical, 
or complex environmental mixture, to stimulate the growth of an estrogen dependent cell lines is 
measured (Soto et al., 1992, 1995). In vitro cell based bio-assays offer a rapid, sensitive and 
relatively inexpensive solution to some of the limitations of mass based chemical instrumental 
analysis such as HPLC, GC/MS, GC–MS/MS, and LC–MS/MS (Petrović and Barcelo, 2000; 
Huang and Sedlak, 2001; Petrović et al., 2002). They enable estimation of total biological activity 
of all compounds that acts through the same mode of action present in extracts of environmental 
medium. Bio-assays also integrate possible interactions among chemicals (Giesy et al., 2002).  In 
vitro whole cell bio-assays for estrogenicity are based on genetically engineered eukaryotic or 
wild type cells. The cells are used to asses the ability of individual chemicals or extracts of 
complex environmental mixtures to cause an ER mediated proliferation effect. The MCF-7 cell 
line is a human breast cancer cell line that has been derived from a patient with metastatic breast 
adenocarcinoma at the Michigan Cancer Foundation (Soule et al., 1973). Lipman and co-workers 
discovered  estrogen-responsive cell growth of MCF-7 cells in 1976 (Lippman et al., 1976). In 
the E-screen assay developed by Soto et al. (1992), proliferation of MCF-7 cells as a response to 
estrogen is measured. The E-screen is based on the following three premises: (i) factors in human 
serum inhibit the proliferation of MCF-7 cells, (ii) estrogens induce cell proliferation by negating 
this inhibitory effect, and (iii) non-estrogenic steroids and growth factors do not neutralize the 
inhibitory signal present in human serum (Soto et al., 1992, 1995; Sonnenschein et al., 1996; 
Zacharewski, 1997). 
 
The MCF-7 cell line has been extensively used to study the molecular interactions of estrogens 
and anti-estrogens with the ER (Brooks et al., 1973). Cellular bio-assays such as the MCF-7 
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breast cancer cell proliferation assay (E-Screen) measure the potency of a sample to induce cell 
proliferation (Soto et al., 1992 and Soto et al., 1995). Several methods have been developed to 
quantify cellular proliferation. Examples include the capability of the cells to incorporate a 
radioactively labeled substance ([3H] – thymidine). Total cellular protein synthesis and total 
cellular DNA synthesis have also been used as proliferation endpoints. An alternative assay is the 
XTT assay, which is based on the cleavage of the yellow tetrazolium salt XTT to form an orange 
fomazan dye by metabolically active cells (Gerlier and Thomasset, 1986). This conversion only 
occurs in viable cells and is therefore a sensitive assay to determine metabolically active cells. 
Another alternative assay for proliferation, as well as cytotoxicity, is the detection of the 
cytoplasmic enzyme, lactated dehydrogenase (LDH). LDH is a stable cytoplasmic enzyme 
present in all cells. It is rapidly released into the cell culture supernatant upon damage of the 
plasma membrane and therefore a valuable marker for cytotoxicity. Alternatively, when the cell 
culture supernatant is discarded and the remaining cells thoroughly washed and then lysed, LDH 
levels can be used as a alternative indicator of cell number (similar to total DNA/protein). Breast 
cancer proliferation assays provide a sensitive measure of estrogenicity and complement 
receptor-binding assays by providing a further dimension to estrogenicity evaluation. 
 
The aim of this study was to compare and evaluate multiple endpoints of the MCF-7 E-Screen 
assay as biomarkers for environmental estrogens and cytotoxicity. Total protein, LDH and XTT 
were evaluated as measurements of estrogen dependent proliferation effect. LDH activity 
released into the cell culture medium was also used as an indicator of cytotoxicity. In this study 
the E-screen assay was also simplified by establishing MCF-7 cultures a 96-well format without 
fetal bovine serum.  
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4.3. Methods and Materials 
4.3.1. Hydrophobic phase extraction of water samples 
The hydrophobic content of environmental water samples were extracted on C18 SPE columns 
(Anatech) using a method previously described by Swart and Pool (2007). In brief: C18 columns 
were pre-washed with 4 ml of solvent mixture (40 % hexane, 45 % methanol and 15 %, 2-
propanol), followed by another wash with 4 ml of ethanol.  The column was then washed with 
one column volume of HPLC grade water after which the water sample was applied onto the 
column.  The column was then air-dried.  The bound hydrophobic substances were eluted with 
solvent mixture.  The eluate was dried under air and then reconstituted to 1/1000 th of the 
original sample volume with dimethyl sulfoxide (DMSO). The samples were stored at –20 °C 
until further use. 
 
4.3.2. Cell culture reagents 
RPMI-1640 with L-glutamine and phenol red and RPMI-1640 modified without L-glutamine and 
phenol red were supplied from Sigma Aldrich. Glutamax (L-glutamine), fetal bovine serum 
(FBS), antibiotic-antimycotic solution, phosphate buffered saline (PBS) solution, serum 
replacement solution, trypsin ethylene diamine tetra-acetic acid (EDTA) solution and 17β-
estradiol were also supplied from Sigma Aldrich. Estradiol was prepared as a 1mg/ml stock 
solution in Dimethyl sulfoxide (DMSO). Estradiol (E2) and environmental extracts were diluted 
1/1000 (v/v) in culture medium for all assays. 
 
4.3.3. MCF-7 experimental cell culture 
MCF-7 cells were maintained and harvested as previously described by Soto et al. (1992, 1995). 
Confluent growing MCF-7 cells (70 %) were suspended in full medium (RPMI-1640 medium 
containing phenol red and L-glutamine and supplemented with 10 % (v/v) FBS and 1/100 diluted 
antibiotic-antimycotic solution) to a concentration of 5 x 105 cells/ml. The cell suspension were 
then dispensed at 200 µl per well in 96 well flat bottom tissue culture plates (Nunc, AEC-
Amersham). Cells were allowed to attach for a minimum of 5 hours before the medium was 
decanted and the wells rinsed twice with PBS pre-heated to 37 ˚C. The wells were then filled 
with 200 µl estrogen deprived medium (RPMI-1640 modified without L-glutamine and phenol 
red and supplemented with 1/100 diluted antibiotic-antimycotic solution, 1/100 diluted glutamax 
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and 1/50 diluted serum replacement). Cells were allowed to grow for 48 hours in order to deplete 
estrogen levels. Medium was then replaced with estrogen deprived medium containing the 
appropriate concentration of 17β-estradiol, environmental water extract diluents or dimethyl 
sulfoxide (DMSO) vehicle control. Cells were cultured for another 48 hours before any 
procedures were done. 
 
4.3.4. Lactate dehydrogenase (LDH) detection 
4.3.4.1. Culture supernatant  LDH for cytotoxicity 
Cell death was determined by measuring lactate dehydrogenase (LDH) activity released from the 
cytosol of damaged cells into the supernatant. LDH was measured using the instructions of a 
cytotoxicity detection kit supplied from Roche Applied Science. In short: Cells were grown in a 
in a 96 well format as described in the previous section. Following the final 48 hour culture 
period, culture supernatants were transferred to an optically clear 96-well flat bottom plate. LDH 
reaction mixture was prepared according to the manufacturer’s instructions immediately before 
use.  To determine the LDH activity, 100 µl of LDH reaction mixture were added to 100 µl of 1:2 
diluted culture medium (diluted with estrogen deprived medium) and gently tapped to mix. The 
absorbance was immediately measured at 492 nm to obtain a background reading. The plate were 
now incubated in the dark for 30 min at room temperature, where after the absorbance were again 
measured.  
 
4.3.4.2. Total cellular LDH indicative of cell number 
In order to obtain total LDH levels, culture supernatant was removed from the exposed cells after 
the last 48 hour incubation period. Estrogen deprived medium containing 2 % (v/v) Triton X-100 
was added at 200 µl/well. The plate was incubated on a shaker for 10 min at 300 rpm after which 
the cell lysates were assayed for LDH as described above.   
 
4.3.5. Total protein yield by MCF-7 culture determinations 
Following the last 48 hour culture period of the MCF-7 cells, culture supernatants were replaced 
with 100 µl of a 1 M NaOH solution. The 96 well plates were allowed to gently shake at room 
temperature for 30 minutes. A multi pipet was used to gently detach all cells after which the 
appropriate volume of cell lysate was transferred to clear 96 well plates. Total protein yield of the 
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cell lysate was determined according to the method of Bradford (1976) using Biovine Serum 
Albumin (BSA) as a standard protein (Sigma).  
 
4.3.6. XTT determinations 
The cell proliferation assay (XTT) was performed using a kit which was supplied from Roche 
Applied Sciences, according to the manufacturer’s instructions. In short: Cells were grown in a 
96 well format as described in the previous section. XTT reaction mixture was prepared 
according to the manufacturer’s instructions immediately before use. To determine the XTT 
activity, 50 µl of XTT reaction mixture were added to the each well after the final cell culture 
incubation period. The absorbance was immediately measured at 492 nm to obtain a background 
reading. The plate were now incubated in the dark for 2 hours, where after the absorbance was 
again measured.  
 
4.3.7. Cell number determination 
Cell counts were performed using a hemacytometer under a inverted phase microscope. 
 
4.3.8. Statistical analysis 
Differences in response of MCF-7 cells between controls groups and treatments were analyzed 
using analysis of variance (ANOVA). Tuckey’s HSD test was used for all pair wise multiple 
comparisons. 
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4.4. Results 
4.4.1 The effect of estrogen on MCF-7 cell growth 
MCF-7 cells were cultured for 48 hours in full medium as explained in the methods and materials 
section. Following the initial 48 hour culture, MCF-7 cells received three different medium 
treatments. The control treatment again received full medium (containing FBS and phenol red 
RPMI medium). The two other treatments were cultured in estrogen deprived medium 
complimented with the vehicle control or 10 nM E2 (cultures received commercially available 
serum replacement solution). After the 48 hour culture period, the number of cells (4.1A), total 
protein yield (Fig. 4.1B), total LDH (Fig. 4.1C) and XTT (Fig. 4.1D) were determined for each of 
the culture medium treatments. 
 
No significant differences in the cell number were observed between cells cultured in full 
medium and estrogen deprived medium complimented with 10 nM E2 (Fig. 4.1A.). Significantly 
lower cell numbers (P < 0.01) were observed for cells cultured in estrogen deprived medium. 
Similar results were observed when the total protein yield, total LDH- and XTT activity were 
determined for the three different cell culture treatments (Fig. 4.1 B,C,D.). Total LDH-, XTT 
activity and total protein were significantly lower for cells cultured in estrogen deprived medium 
compared to cells cultured in full medium or estrogen deprived medium complimented with 10 
nM E2. Cells cultured in full media resulted in similar total protein yield, total LDH- and XTT 
activity compared to cells cultured in estrogen deprived medium supplemented with 10 nM E2. 
 
4.4.2. E2 dose response on MCF-7 proliferation 
MCF-7 cells were cultured in estrogen deprived medium complimented with a 10 fold dilution 
series of E2. The same volume of the vehicle control (DMSO) was used with all E2 
concentrations so that the latter were the only variant. At the end of the culture period, culture 
supernatant LDH (results not shown), total cellular LDH (Fig 4.2A), total protein (Fig 4.2B), and 
XTT (Fig 4.2C), activity were determined for cells at each of the E2 concentration exposures. 
Statistical analysis shows that E2 does not have an effect on LDH release into the culture 
medium. The proliferation effect of estrogen dependent MCF-7 cells can be observed when total 
LDH, total protein yield and XTT activity were determined for the same cultures. 
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Figure 4.1. Culture of MCF-7 cells with serum replacement solution. MCF-7 cells were cultured in three different mediums. After 
96 hours of culture, the number of cells was counted using a hemacytometer (A); total protein yield was determined (B); total LDH 
activity (C); and XTT activity measured (D). Vertical error bars represent the standard deviation of the mean. 
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Figure 4.2. MCF-7 E2 dose responsiveness. MCF-7 cells were cultured in estrogen deprived medium after which it was exposed to a 
dilution series of E2. Total LDH (A), total protein (B), and XTT activity (C) were determined. Vertical error bars represents the 
standard deviation of the mean for ten replicates. 
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A direct linear correlation with an R2 value of 0.9 exists between the concentration of E2 exposed 
MCF-7 cells and total LDH levels. The linear range for the total LDH assay was between 0.1 – 
1000 nM E2. This is wider than the detection range obtained for total protein and XTT activities 
(10 – 1000 nM E2).  
 
4.4.3. Correlation of total LDH with total protein and XTT 
The total LDH levels obtained for MCF-7 cells exposed to a dilution series of E2 between 1 and 
1000 nM E2 were correlated with XTT activity (Fig. 4.3A) and total protein yield (Fig. 4.3B). A 
good correlation between total LDH and XTT activity with an R2 value of 0.93 were obtained. A 
good correlation between total LDH and total protein yield were also obtained with an R2 value 
of 0.97. 
Fig. 4.3. Correlation of total LDH activity with XTT and total protein yield. MCF-7 cells 
were exposed to a 10 fold concentration series between 1 and 1000 nM of E2. Total LDH activity 
are plotted again XTT activity (A) and total protein yield (B). Vertical and horizontal error bars 
represent the standard deviation of the mean for ten replicates. 
 
4.4.4. Analysis of environmental water extracts for estrogenicity and cytotoxicity  
Water samples were collected from a pristine site, which is situated in the mountains, and sewage 
effluent from a local town. The hydrophobic content of the water samples were extracted as 
explained in the methods and materials. MCF-7 culture supernatant LDH activity was measured 
in order to assess if the water extracts were cytotoxic (Fig. 4.4). Total LDH activity (Fig. 4.5A), 
total protein yield (Fig. 4.5B) as well as XTT activity (Fig. 4.5C) were used as endpoints to 
assess the estrogen dependent proliferation of MCF-7 cells exposed to these water extracts.  
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4.4.4.1 Cytotoxicity of environmental water extracts 
No significant differences in the culture supernatant LDH levels could be observed when 
comparing results obtained from cultures exposed to 0.1 nM E2 and 1000 nM E2 (Fig. 4.4). LDH 
levels obtained from MCF-7 cells exposed to water from the pristine site also showed no 
significant differences with the E2 standard and control. Medium LDH levels from cultures 
exposed to sewage effluent were significantly higher (42 %) than that of the pristine site.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.4. Cytotoxicity of water samples. Water samples collected from a pristine site and 
sewage effluent were subjected to the MCF-7 screen for estrogenicity and cytotoxicity. Culture 
supernatant LDH activity was determined in order to assess cytotoxicity. Vertical error bars 
represents the standard error of the mean of six assays. 
 
4.4.4.2 Estrogenicity of environmental water extracts 
A significant difference (P < 0.001) between the 0.1 and 1000 nM E2 standards were observed 
for total LDH (Fig. 4.5A), total protein (Fig. 4.5B) and XTT (Fig. 4.5C) activity. For each of 
these endpoints determined, no significant differences could also be observed between the 0.1 nM 
E2 standard and the pristine site. However, total LDH, total protein and XTT activity of MCF-7 
cells exposed to sewage effluent, were statically similar to that of MCF-7 cells exposed to the 
1000 nM E2 control. Total LDH activity and total protein yield of the MCF-7 cells exposed to 
water extracts from the pristine site were statistically similar to cells exposed to the sewage 
effluent. Total LDH and total protein yield of the pristine sites were however significantly lower 
than that of cells exposed to 1000 nM E2. 
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Figure 4.5. Estrogen induced proliferation of MCF-7 cells exposed to environmental water samples. Water samples collected 
from a pristine site and sewage effluent were subjected to the MCF-7 screen for estrogenicity and cytotoxicity. Total LDH levels (A), 
total protein yield (B) and XTT activity (C) was determined as indicators of MCF-7 estrogen dependent proliferation. Vertical error 
bars represents the standard error of the mean of six assays. 
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4.5. Discussion 
A large number of in vitro assays have been developed over the years for the screening of 
estrogenic EDCs (ECETOC, 1996; Holmes et al., 1998; Soto et al., 1992). The most recent 
literature regarding estrogenic EDCs have focused mainly on the development and evaluation of 
different detection methods (Soto et al., 2006). Bio-assays are useful alternatives (Campbell et 
al., 2006) for traditional mass based analytical assays such as HPLC, GC/MS, GC–MS/MS, and 
LC–MS/MS (Petrović and Barcelo, 2000; Huang and Sedlak, 2001; Petrović et al., 2002). The 
MCF-7 human breast cancer cell line has been extensively used to study the molecular 
interactions of estrogens and anti-estrogens with the ER (Brooks et al., 1973). This cell line has 
also been used in various in vitro cellular bio-assays, of which the cell proliferation assay (E-
Screen) first described by Soto et al., (1992) is probably the most common of them all. The aim 
of the present study was to evaluate several endpoints of the E-Screen assay as biomarkers for 
estrogenicity and cytotoxicity. Total LDH activity, total protein yield as well as XTT activity 
were evaluated as proliferation endpoints and biomarkers for estrogenicity. This study was 
concluded by screening environmental samples for estrogenicity and cytotoxic using the different 
validated biomarkers for estrogenicity and cytotoxicity.  
 
One of the aims of this study was to introduce some modifications and simplifications to the well 
known E-Screen. The culture of MCF-7 cells in a 96-well format using chemically defined serum 
replacement factors instead of FBS was validated. All of the E-screen protocols normally involve 
the maintenance of MCF-7 cells in medium containing human serum or FBS. In order then to use 
these cells in a screen for estrogens, medium has to be changed to estrogen deprived medium 
which consist of medium without phenol red and FBS that has been charcoal dextran treated 
(stripping FBS of hormones). In the current study we made use of an estrogen deprived medium 
that contains no FBS. In stead of going through all the effort, time and costs involved of stripping 
FBS with charcoal and dextran, we validated the use of a commercially available serum 
replacement solution in our estrogen deprived medium. MCF-7 cells were cultured as previously 
described by Soto et al., (1995). The results show that MCF-7 cells that were cultured in estrogen 
deprived medium (containg no FBS but serum replacement solution and phenol red free RPMI) 
resulted in 44 % reduction in cell number (Fig. 4.1A), 18 %  reduction in total protein yield 
(Fig.4.1B), 86 % reduction in total LDH activity (Fig. 4.1C) and 19 % reduction in XTT activity 
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(Fig. 4.1D) in comparison with cells cultured in maintenance medium (containing FBS and 
normal RPMI with phenol red). Cells that were cultured in estrogen deprived medium but 
complemented with 10 nM E2 again were able to yield the same number of cells, total protein, 
total LDH and also XTT activity as for cells cultured in full medium (Fig. 4.1A, B, C, D). It has 
been established many years ago that MCF-7 cells are dependent on estrogen for proliferation 
(Brooks et al., 1973; Soule et al., 1973). The differences observed in the cell number and total 
protein yield when MCF-7 cells are cultured in full medium, estrogen deprived medium and 
estrogen deprived medium complemented with E2 can be explained as a result of available 
estrogen to the MCF-7 cells. These results show that the use of commercially available serum 
replacement solution can be successfully used as an alternative to charcoal stripped FBS in the E-
screen assay. Unlike FBS that may vary from batch to batch, depending on herds that it was 
collected from, serum replacement solution is a chemically defined additive. This makes inter-
laboratory comparisons of this assay easier as the reagents can thus be standardized.  
 
The sensitivity of this E-Screen assay was assessed by exposing MCF-7 cells to a 10 fold E2 
concentration series. Total LDH, total protein yield as well as XTT activity were evaluated as 
biomarkers for estrogenic responses. Total LDH activity showed a direct linear correlation (R2 = 
0.97) with the E2 concentration that the cells were exposed to. The linear range for the total LDH 
assay was between 0.1-1000 nM E2. This is wider than the range obtained for total protein and 
XTT activity (10-1000 nM E2). Therefore, it appears that total LDH is 100 times more sensitive 
than total protein or XTT activity as a biomarker for estrogenicity in our E-Screen assay. 
Furthermore, a good correlation between total LDH activity and total protein (R2 = 0.93) and 
LDH with XTT activity (R2 = 0.97) where observed between 1 and 1000 nM E2 exposed MCF-7 
cells. Thus, similar to the use of total DNA, total protein or XTT activity previously used as 
indicators of cell number in the E-Screen, the total amount of LDH activity from viable cells can 
also be used as an indicator of cell number. It is important to note that total LDH refer to the 
amount of LDH measured after the culture supernatant has been discarded and the remaining 
cells have been lysed. Measuring LDH in this way therefore gives you an indication of the 
amount of protein or activity of a single protein from a well rather than the total protein or DNA 
as indicators of cell number from a well. 
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The use of LDH as a biomarker for estrogenicity in the E-screen assay therefore has a detection 
range for E2 between 100 pM E2 and 1000 nM E2. Previous investigations have found that the 
detection limit of the E-Screen varies between laboratories and detection limits ranging between 
30 pM (Soto et al., 1992) and 1 pM (Körner et al., 1998) have been reported. Various factors such 
as differences between cell line clones, culture conditions, receptor level differences,  differences 
in serum cell density and clone heterogeneity may influence the proliferation of MCF-7 cells and 
therefore the sensitivity of the E-Screen, including: (Zacharewski, 1997).  
 
The different biomarkers that we evaluated were used to screen environmental water extracts for 
estrogenicity and cytotoxicity. Water samples were obtained from a pristine site, previously 
described by Swart and Pool (2007) as well as sewage treatment work effluent from a local town. 
No significant differences in total LDH (Fig 4.5A), total protein (Fig 4.5B) or XTT activity (Fig 
4.5C) were detected when comparing the 0.1 nM E2 standard and pristine site data. Exposure of 
MCF-7 cells to water extracts from the sewage effluent resulted in significantly higher LDH, total 
protein and XTT activity in comparison with the 0.1 nM E2 standard. This data therefore 
suggests that water collected from the sewage effluent contains estrogenic properties. All three of 
the biomarkers analyzed showed statistically similar values compared to MCF-7 cells exposed to 
1000 nM E2. Analysis of the culture supernatant of MCF-7 cells exposed to the water extracts 
suggest that none of the samples are cytotoxic except for the sewage treatment work effluents 
samples that contained 46 % higher medium LDH compared to the other samples. 
 
In this study we showed that the classic E-screen for estrogenicity using MCF-7 cells can be 
successfully performed without the use of any serum. We showed that total LDH activity as a 
biomarker for estrogenicity in the E-Screen assay is much more sensitive than using total protein 
or XTT activity. These three biomarkers were successfully employed to assess two environmental 
water extracts for estrogenicity and cytotoxicity. The E-Screen assay that we have simplified and 
validated in this study is cost effective, easy to perform and large numbers of samples can easily 
be analyzed for both estrogenicity and cytotoxicity. 
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5.1. Abstract 
Estrogenic endocrine disruptors (e-EDCs) have been identified in soil, food, air and water, and 
may produce adverse health effects in both humans and wildlife. Various in vitro assays, 
including the E-screen that measures estrogen dependent proliferation of the MCF-7 human 
breast cancer cell line, have been developed and implemented to screen for environmental 
estrogenic EDCs. This study describes a new amendment to the well known E-screen. A direct 
ELISA to quantify ERα protein levels on MCF-7 cells cultured in a high through put 96-well 
format were validated as a biomarker for estrogenicity. The ELISA shows that there is an inverse 
correlation between ERα levels and 17β-estradiol (E2) concentration (R2 = 1). The detection 
range of the assay is between 1 and 1000 nM for E2. Results obtained with the ERα ELISA 
showed a good inverse correlation with total cellular LDH levels that is conventionally used to 
quantify MCF-7 cell proliferation. This ELISA was employed to assess environmental water 
extracts for estrogenicity. 
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5.2. Introduction 
There is an increased concern regarding the potential adverse effects of pollutants found in the 
environment and also food on human and wildlife health. In the environment, these compounds 
occur as complex mixtures containing different congeners and isomers of both natural and 
anthropogenic chemicals. Some of these compounds exert their adverse effects by disrupting the 
natural hormone balance of the animal (Phillips and Forster, 2008). These chemicals are 
collectively named endocrine disrupting chemicals (EDCs).  Most of the known adverse effects 
of these EDCs have been attributed to environmental estrogens (xenoestrogens) (Gellert , 1978a; 
Gellert, 1978b; Hammond et al., 1979; Kupfer and Bulger, 1987; Krishnan et al., 1993; White et 
al., 1994; Newbold 1995; Katzenellenbogen1995; Nimrod and Benson, 1996). Some of the 
reported diverse range of effects/defects that estrogenic EDCs may have on human and animal 
health include reduced fertility, congenital malformations of the reproductive tract and increased 
incidence of cancer in estrogen responsive tissues (Colborn et al., 1993; Davis et al., 1993).  
 
The molecular structure of exogenous natural and synthetic estrogens may be similar or 
extremely different from endogenous natural estrogens (Jordan et al., 1985; McLachlan, 1993; 
Safe 1995). Despite the vast structural diversity among environmental estrogens, estrogenic 
compounds can be characterized by their ability to bind to and activate the estrogen receptor 
(ER). Ingestion of xeno-estrogens results in either initiation (agonist) or inhibition (antagonist) of 
estrogenic responses (Soto et al., 1992; Eckert and Katzenellenbogen 1982). Upon binding of an 
estrogenic compound to the ligand binding domain of the ER (located predominantly in the 
nucleus of cells), the associated heat shock protein complex, which masks the DNA binding 
domain dissociates. The ligand occupied receptor undergoes conformational changes that allow 
the ER-hormone complex to bind as a homo- or heterodimer (Cowley et al., 1997) to specific 
sites on the DNA called the estrogen response element (ERE) (Walker et al., 1984; Gronemeyer, 
1992). Once bound to the DNA, this ER-hormone complex modulates the transcription of the 
specific target genes (Jensen, 1996; Tsai and O’Malley, 1995). ER complexes bound to an ERE 
may recruit additional transcription factors, leading to increased or decreased gene transcription 
and synthesis of proteins (Joyeux et al., 1997; Fielden et al., 1997). Other modes of actions of 
estrogenic EDCs include the binding of these chemicals to numerous other nuclear receptors 
and/or signal transduction pathways resulting in the modulation of steroidogenesis and 
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catabolism of active steroid hormones (Machala and Vondracek, 1998). To date, at least two 
subtypes of ERs have been identified and described namely ERα [NR3A1] and ERβ [NR3A2] 
(Nuclear Receptors Nomenclature Committee, 1999). Another subtype, ERγ, has been identified 
in fish (Drummond et al., 2002). ERα has been well characterized, whereas ERβ was later 
discovered in the rat (Kuiper et al., 1996), mouse (Tremblay et al., 1997) and human (Mosselman 
et al., 1996). 
 
The development of in vitro models for screening environmental samples for endocrine 
disrupting characteristics as a first screen has drawn continued interest over the past years 
(Scrimshaw and Leser, 2004). Many approaches have been used to identify EDCs using a variety 
of biological screening assays. There are four main categories of in vitro bio-assays available to 
assess estrogenic or androgenic activity of single compounds or complex mixtures, namely, 
competitive receptor binding assays, cell proliferation assays and reporter gene assays, and direct 
immunoassay detection of single active compounds (Kinnberg, 2003; Körner et al., 1998). As an 
alternative, in vitro assays could be based on the quantitation of estrogen-induced changes in the 
expression levels of endogenous genes and proteins.  Examples of estrogen-induced changes in 
the expression levels of endogenous genes and proteins as biomarker for EDCs include the 
induction of vitellogenin (VTG) by hepatocyte cultures of oviparous animals (Navas and Segner, 
2006). 
 
The MCF-7 cell line is a human breast cancer cell line that has been derived from a patient with 
metastatic breast adenocarcinoma at the Michigan Cancer Foundation (Soule et al., 1973). The 
MCF-7 cell line has been extensively used to study the molecular interactions of estrogens and 
anti-estrogens with the ER (Brooks et al., 1973). Cellular bio-assays such as the MCF-7 breast 
cancer cell proliferation assay (E-Screen), which measure the potency of a sample to induce cell 
proliferation, has been used as a screening assay for estrogenicity (Soto et al., 1992 and Soto et 
al., 1995). However, the quantification of ERα protein levels using a direct ELISA on cultured 
MCF-7 cells in a high throughput 96-well format has not been validated as a biomarker for 
estrogenicity before. The aim of this study was to development a direct ELISA to quantify ERα 
levels of cultured MCF-7 cells as a biomarker for estrogenicity.  
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5.3. Methods and Materials 
5.3.1. Reagents 
RPMI-1640 with L-glutamine and phenol red as well as RPMI-1640 modified without L-
glutamine and phenol red were supplied by Sigma Aldrich. Glutamax (L-glutamine), fetal bovine 
serum (FBS), antibiotic-antimycotic solution, phosphate buffered saline (PBS) tablets, serum 
replacement solution, trypsin in ethylenediaminetetraacetic acid (trypsin-EDTA) solution and 
17β-estradiol (E2) were also supplied from Sigma Aldrich. Estradiol was prepared as stock 
solution (1mg/ml) in dimethyl sulfoxide (DMSO). MCF-7 maintenance medium was prepared by 
adding 10 ml FBS and 1 ml antibiotic-antimycotic solution to 100 ml RPMI-1640 medium 
containing phenol red and L-glutamine. MCF-7 serum deprived medium were prepared by adding 
1 ml antibiotic-antimycotic solution, 1 ml glutamax and 2ml serum replacement solution to 100 
ml RPMI-1640 without L-glutamine and phenol red. Sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) was performed using a SDS-PAGE gel preparation kit supplied 
from Sigma Aldrich. Nitrocellulose membranes were supplied from AEC-Amersham 
International. All other protein blotting detection reagents, solvents and biochemicals were 
supplied by Roche International. The standard protein molecular mass markers were from Sigma 
Chemical Company.   
 
5.3.2. Solid phase extraction of hydrophobic molecules from water samples 
Water samples were collected from a pristine site and also from a sewage treatment plant outlet. 
The pristine site is a river site near the origin of the river and not impacted by human activity. 
Sewage water is from a sewage treatment plant servicing a population of approximately 40 000 
inhabitants. The hydrophobic content of environmental water samples were extracted on C18 
SPE columns (Anatech) using a method previously described by Swart and Pool (2007). In brief: 
C18 columns were pre-washed with 4 ml of solvent mixture (40 % hexane, 45 % methanol and 
15 %, 2-propanol), followed by another wash with 4 ml of ethanol.  The column was then washed 
with one column volume of reverse osmosis water after which the water sample was applied onto 
the column. The column was then air-dried.  The bound hydrophobic substances were eluted with 
solvent mixture.  The eluate was dried under air and then reconstituted to 1/1000 of the original 
sample volume with DMSO. The samples were stored at –20 °C until further use. 
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5.3.3. MCF-7 cell culture 
MCF-7 cells were maintained and harvested as previously described by Soto et al. (1992, 1995). 
MCF-7 cells were suspended in maintenance medium to a concentration of 5 x 105 cells/ml. The 
cell suspension were then dispensed at 200 µl per well in a 96 well flat bottom tissue culture plate 
(Greiner, AEC-Amersham). Cells were allowed to adhere to the wells for a minimum of 5 hours 
before the medium was decanted. The wells were then rinsed twice with PBS pre-heated to 37 ˚C. 
This was followed by the addition of 200 µl estrogen deprived medium per well. Cells were 
cultured for 48 hours in order to deplete estrogen levels. Medium was then replaced with 200 µl 
per well estrogen deprived medium containing 1 % v/v of the E2 standards, environmental water 
extracts or DMSO controls.  The cells were cultured for another 48 hours before analysis.  
 
5.3.4. SDS PAGE and Western blotting of ERα 
MCF-7 cell lysates were prepared according to a method described by Anitbodycam International 
(www.antibodycam.com/technical). Lysis buffer contains 150 mM NaCl, 1 % v/v Triton X-100, 
0.5 % w/v sodium deoxycholate, 0.1 % w/v SDS and 50 mM trishydroxymethylaminomethane 
(Tris) pH 8. A 10X concentrated stock of lysis buffer was prepared. Cells were harvested as 
described by Soto et al. (1992, 1995) and then suspended in PBS to yield 1 x 107 cells/ml. 
Concentrated lysis buffer was added to the cell suspension (100 µl lysis buffer for every 900 µl 
cell suspension). The suspension was gently agitated for 30 min at 4 ˚C after which it was 
centrifuged for 10 min 10 000 x g to remove cell rests. Supernatants were removed and aliquots 
of the supernatant were frozen at -80 ˚C until further use. Protein content of cell lysates were 
determined according to the method of Bradford (1976) using bovine serum albumin (BSA) as a 
standard protein (Sigma). SDS-PAGE gels and buffers were prepared according to the kit 
manufacturer’s instructions. MCF-7 protein preparations (5µg) were resolved in 10 % w/v 
polyacrylamide gels. Polyacrylamide gels were run at 120 V in a Hoefer Mighty Small II slab 
electrophoresis unit.  
 
Separated polypeptides were transblotted onto nitrocellulose in Towbin buffer (25 mM Tris-HCl, 
192 mM glycine and 20 % (v/v) methanol) at 15 Volts for 1 hour. Following transfer, the blots 
were stained in Ponceau-S (0.2 % w/v Ponceau-S, 3 % w/v trichloroacetic acid).  The blots were 
then thoroughly rinsed in saline and blocked for 1 hour at room temperature in blocking solution 
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containing 3 % w/v low fat milk powder in saline. All subsequent steps in the procedure were 
carried out at room temperature. Blots were incubated overnight in saline containing 0.3 % w/v 
low fat milk powder, 0.01 % v/v tween and 1/500 anti-ERα (Santa Cruz Biotechnology, INC.). 
The following day unbound antibody was removed by washing the nitrocellulose membranes 
four times for five minutes each in wash solution (saline and 0.01 % v/v tween). The 
nitrocellulose was then incubated for 1 hour in saline containing 1/2500 v/v horseradish 
peroxidase conjugated anti-mouse immunoglobulin and 0.1 % w/v serum albumin. The 
nitrocellulose was washed as before and finally it was stained using BM Blue precipitating 
peroxidase substrate. After staining the nitrocellulose, it was washed with distilled water, dried 
and stored in an aluminum foil envelope. 
 
5.3.5. ERα ELISA 
Following the culture of MCF-7 cells, medium was carefully removed from the wells and cells 
fixated to the tissue culture plate as previously described by Maggiolinie et al. (2002). In short, 
200 µl of 2 % v/v paraformaldehyde in PBS were dispensed in all the wells and the plate was 
then incubated for 45 minutes at room temperature. The paraformaldehyde solution was then 
replaced with 200 µl of 3 % v/v H2O2 in methanol and incubated for another 45 minutes. After 
fixation wells were washed twice with PBS. Protein adsorption sites in the well were then 
blocked with 3 % w/v low fat milk powder in PBS for 1 hour at room temperature with gently 
shaking. Anti-ERα was diluted 1/200 in saline containing 0.3 % w/v milk powder and dispensed 
at 50 µl per well. The plate was then incubated for 2 hours at room temperature. The wells were 
then washed 4 times with 200 µl PBS. Horseradish peroxidase conjugated anti-mouse 
immunoglobulin (AEC-Amersham International) was diluted 1/2500 with PBS containing 1 % 
w/v human serum albumin and 0.01 % v/v Tween and dispensed at 50 µl per well. Plates were 
incubated for another hour and the same wash procedure was followed. BM Blue soluble 
peroxidase substrate was heated to 37°C and dispensed at 50 µl per well. Plates were incubated at 
room temperature for 30 minutes followed by the addition of 50 µl per well of stop solution (0.5 
M H2SO4). The optical density was lastly determined at 450 nm. All ELISA readings were 
corrected for background. Background controls are wells that receive all procedures except that 
the anti-ERα step is replaced by an incubation step with 0.3 % (w/v) milk powder in saline. 
Results were expressed as ERα OD/mg cell protein which was calculated using the formula: ERα 
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OD/mg cell protein = (OD experimental well – OD background control) / cellular protein (mg). In order to 
compare the results of multiple plates with each other, ELISA results of the experimental wells 
being analyzed were expressed as a percentage of the ERα OD/mg protein obtained for the 0.1 
nM E2 exposure control used on all 96 well plates. 
 
5.3.6. Determination of total cellular protein 
Following the last 48 hour culture period of the MCF-7 cells, cultures were washed twice with 
PBS.  Each well then received 100 µl of a 1 M NaOH solution. The plates were allowed to gently 
shake (300 rpmi) at room temperature for 30 minutes. A multi-pipet was used to gently suspend 
all particulates by slowly pipetting well contents up and down.  Total protein concentration of the 
cell hydrolysates were determined according to the method of Bradford (1976) using bovine 
serum albumin (BSA) as a standard protein (Sigma). 
 
5.3.7. Determination of total cellular lactate dehydrogenase (LDH)  
Total LDH activity was determined as an indicator of total cell number or proliferation. LDH was 
measured using the instructions of a cytotoxicity detection kit supplied from Roche Applied 
Science. In short: Cells were grown in a 96 well format as described in the previous section. In 
order to obtain total LDH levels, culture medium was removed from the exposed cells after the 
last 48 hour incubation period. Estrogen deprived medium containing 2 % (v/v) Triton X-100 was 
then added at 200 µl/well. The plate was incubated on a shaker for 10 min at 300 rpm, after 
which the cell lysates were assayed for LDH. LDH reaction mixture was prepared according to 
the manufacturer’s instructions immediately before use.  To determine the LDH activity, 100 µl 
of LDH reaction mixture was added to 100 µl of 1:10 cell lysate preparation in an optically clear 
96-well flat bottom plate. The absorbance was immediately measured at 492 nm to obtain a 
background reading. The plate was then incubated in the dark for 30 min at room temperature, 
where after the absorbance was again measured. Absorbance readings were corrected by 
subtracting the background reading for the specific sample.  
5.3.8. Statistical analysis 
Differences in response of MCF-7 cells between controls groups and treatments were analyzed 
using analysis of variance (ANOVA). Tuckey’s HSD test was used for all pair wise multiple 
comparisons. 
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5.4. Results 
5.4.1. Anti ERα specificity 
In order to use the anti-ERα antibody in an ELISA system, the antibody specificity was first 
checked by protein blotting (Fig. 5.1).  
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1. SDS-Page and protein blotting of MCF-7 whole cell lysates. Commercially 
available anti-ERα antiserum was checked for specificity. MCF-7 cells were cultured in 
maintenance- and estrogen deprived medium where after their whole cell lysates were subjected 
to SDS-Page and protein blotting. Lanes 1, 2 and 3 are a SDS-Page gel stained with Coomassie, 
whereas lanes 4 and 5 are protein blot with anti-ERα. Lane 1, Molecular weight marker; lane 2, 
maintenance medium whole cell lysate; lane 3, estrogen deprive whole cell lysate; lane 4, 
maintenance medium whole cell lysate; lane 5, estrogen deprive whole cell lysate. 
 
The Coomassie stain of cells cultured in maintenance medium (lane 2) and estrogen deprived 
medium (lane 3) shows that equal amounts (10 µg) of protein were loaded onto lanes of the SDS-
Page gel. In lanes 4 and 5 it can be observed that the anti-ERα antibody recognized a single 
peptide with an apparent molecular weight of around 55 kDa. It can also be observed that the 
ERα protein levels are higher in cells cultured in estrogen deprived medium (lane 5) compared to 
cells cultured in medium containing FBS and phenol red (lane 4). 
 
5.4.2. ERα ELISA validation 
The optimum anti-ERα titer was determined using a direct ELISA as discussed in the materials 
and methods section. In order to obtain the optimum antiserum dilution, anti-ERα was added in a 
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two fold dilution series between dilutions ranging from 1/100 to 1/3200. An antiserum dilution of 
1/200 gave an OD response midway in the linear region of the titration graph (results not shown). 
This antiserum dilution factor was chosen to perform all direct ELISAs on the MCF-7 cells using 
ERα as the primary antibody. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2. Anti-ERα ELISA validation. The ERα antibody was employed in a direct ELISA 
on the cultured and then fixated MCF-7 cells. MCF-7 cells were exposed to the DMSO vehicle 
control (0 nM E2), 0.1 nM E2 and 10 nM E2. White bars represent the OD/mg protein obtained 
when the ELISA was performed with no 1˚ antibody (background OD/mg protein), grey bars 
with the ERα antiserum (1/200 diluted) as the 1˚ antibody (assay OD/mg protein) and black bars 
are the corrected OD/mg protein obtained using the formula described in the methods section.  
Each data bar represents three replicates. Vertical error bars represent standard deviations of the 
mean. Letters above the data bars of each treatment represent significant differences (P < 0.001). 
 
Figure 5.2 displays the results obtained (expressed as OD/mg protein) when the ELISA was 
performed with no 1˚ antibody (background OD/mg protein), 1/200 diluted anti-ERα antiserum 
(assay OD/mg protein) as well as the differences in OD/mg protein observed between the two 
antibody controls (corrected OD/mg protein). This ELISA was performed on MCF-7 cells 
exposed to estrogen deprived medium complemented with DMSO vehicle control (0 nM E2), 0.1 
and 10 nM E2. No significant differences in the background OD/mg protein (ELISA performed 
with no 1˚ antibody) can be observed between the three different treatments (0 nM E2, 0.1 E2 and 
10 nM E2). When this ELISA is performed with 1/200 anti-ERα antiserum, cells exposed to 10 
nM E2 displays significantly lower OD/mg protein compared to cells exposed to 0.1 and 0 nM 
E2. There was no statistical difference in the OD/mg protein for 0 nM and 0.1 nM E2 exposures. 
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5.4.3. The effect of E2 concentration on the ERα level 
MCF-7 cells were cultured in estrogen deprived medium supplemented with various 
concentrations of E2. The same volume of the vehicle control (DMSO) was used with all E2 
concentrations so that the E2 concentration was the only variant.  ERα-ELISA was done as 
described in the methods. The ERα OD/mg protein shows a good inverse correlation (R2 = 0.97) 
with the log of the E2 concentration to which the MCF-7 cells were exposed to (Fig. 5.3). The 
lowest concentration of E2 that result in a significant reduction in ERα OD/mg protein compared 
with the control (0 nM E2) was 1 nM E2. The range of the assay was between 1-1000 nM E2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3. ERα-ELISA and E2 dose responsiveness. MCF-7 cells were cultured in estrogen 
deprived medium after which it was exposed to a dilution series of E2. ERα protein levels were 
determined and is expressed as the ERα OD/mg protein as a percentage of the 0.1 nM E2 
exposure. Vertical error bars represents the standard deviation of the mean for ten replicates. 
 
5.4.4. Correlation of ERα and total LDH levels  
The total LDH levels obtained for MCF-7 cells exposed to the dilution series of E2 between 1 
and 1000 nM E2 were correlated with the ERα ELISA OD/mg protein (Fig. 5.4.). There is an 
inverse correlation between the ERα ELISA and total LDH activity (R2 = 1).  
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Fig. 5.4. Correlation of ERα ELISA and total LDH activity. MCF-7 cells were exposed to a 
10 fold concentration series between 1 and 1000 nM of E2. Total LDH activity is plotted against 
ERα OD/mg protein. Vertical and horizontal error bars represent the standard deviation of the 
mean for ten replicates. 
 
5.4.5. Analysis of environmental water extracts for estrogenicity  
ERα levels of MCF-7 cells exposed to extracts of environmental samples were measured as 
biomarkers for estrogenicity of the sample (Fig. 5.5).  Analysis of the ERα levels showed a 
highly significant (P < 0.001) decrease in ERα levels in the presence of 1000 nM E2 standard 
(55.01 % ± 3.15) compared with the 0.1 nM E2 standard (100 % ± 7.39). There is no significant 
difference between the ERα levels induced by the 0.1 nM E2 standard and the pristine site. 
However, extracts of the sewage effluent resulted in a significantly lower ERα level compared to 
the 0.1 nM E2 standard (P < 0.001) and also the 1000 nM E2 standard (P < 0.001). 
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Figure 5.5. ERα protein levels of MCF-7 cells exposed to environmental water samples.  
Water samples collected from a pristine site and sewage effluent were subjected to the MCF-7 
screen for estrogenicity and cytotoxicity. ERα protein levels were determined with the ERα-
ELISA. Vertical error bars represents the standard error of the mean of six assays. Different 
letters indicate significant differences among treatments (P < 0.001). 
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5.5. Discussion 
Several characterized EDCs have been reported to act in an estrogen-like manner in living 
organisms (Soto et al., 1995). When estradiol or estrogenic substances enter a target cells, it 
rapidly complexes with the ER, translocates into the nucleus where it binds to chromatin and 
induces gene activation and an acceleration of biosynthetic processes (O’Malley et al., 1974). 
Estrogenic EDCs such as phytoestrogens, mycoestrogens and xenoestrogens have the ability to 
interact with the ER which can then initiate (agonist) or inhibit (antagonist) estrogen-like actions 
(Eckert and Katzenellenbogen 1982; Soto et al., 1992). Various in vitro assays have been 
developed, based on the quantitation of estrogen-induced changes in the expression levels of 
endogenous genes and proteins in estrogen responsive tissues (Inoue et al., 2002). The human 
breast cancer cell line, MCF-7, has been well characterized as an in vitro screen for estrogenicity 
(E-Screen) (Soto et al., 1992, 1995). The E-Screen assay is based on the dose-response 
relationship between the proliferation of the cells and the concentration of estrogen to which the 
cells are exposed to (Soto et al., 1995).  Previous studies have reported that the molecular weight 
of ERα is in the region of 65 kDa (Green and Chambon, 1991). The antibody used for this study 
reacted with a single peptide with an apparent molecular weight of ± 60 kDa, similar to previous 
reports using this specific antibody (Morelli, 2003; Likhite, 2004). More over, protein blot 
analysis showed that ERα levels were elevated in estrogen deprived medium and suppressed in 
maintenance medium (containing E2).  Previous studies have shown that ERα expression is 
upregulated by estrogen deprivation (Villalobos et al., 1995). 
 
This antibody was used for the development of an ELISA to directly monitor ERα expression by 
MCF-7 cells cultured and subsequently fixed in 96 well trays.  When MFC-7 cells were cultured 
in serum free medium high levels of ERα was expressed.  The levels of ERα expression is down-
regulated by the addition of estrogen to the culture medium.  There is an inverse relationship 
between the ERα expression and log of the estrogen concentration (R2 = 0.97).  Previous studies 
using ERα expression by MCF-7 cells have employed ELISAs on cell homogenates of the 
cultured cells and obtained similar results (Villalobos et al., 1995).  
 
Results obtained using ERα protein levels as biomarker showed a good correlation (R2 = 1) with 
total LDH as biomarker for estrogenicity when MCF-7 cells were exposed to the same E2 
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dilution series. Previous investigations have found that the detection limit of the E-Screen varies 
widely and reported values are 0.03 nM (Soto et al., 1992) and 0.001 nM (Körner et al., 1999). 
Various factors may influence the sensitivity of MCF-7 for E2 including: differences between 
cell line clones; culture conditions; receptor level differences; differences in cell density and 
clone heterogeneity (Zacharewski, 1997).  
 
The newly developed ELISA was used to monitor ERα levels as a biomarker to assess the 
estrogenicity of environmental water extracts. Water samples were obtained from a pristine site, 
previously described by Swart et al., (2007) as well as sewage treatment work effluent from a 
local town. The level of ERα expression by MCF-7 cells cultured in the presence of hydrophic 
extracts of water collected from the pristine site was similar to the ERα expression by MCF-7 
cells cultured in the presence of the 0.1 nM E2 control (P > 0.05). This indicates that either the 
water from the pristine site does not contain estrogen or if this sample contains E2 or estrogenic 
compounds, it is well below the detection limit of the current assay. However as expected, the 
sewage treatment effluents resulted in significantly lower ERα levels compared to the E2 
negative control (P < 0.001). More over, the sewage treatment effluent also resulted in significant 
lower ERα levels compared with the 1000 nM E2 standard (P < 0.001). These results therefore 
suggest that the pristine site shows no signs of estrogenicity, whereas the sewage effluent samples 
induced estrogenic responses greater than that observed for MCF-7 cells exposed to 1000 nM E2.  
 
In this study we extended the range of end-points of the classical E-Screen by using ERα 
expression as a biomarker for estrogenicity. We validated the use of a commercially available 
anti-ERα antibody and showed that this antibody can be successfully employed in a direct ELISA 
on MCF-7 cells fixed to the 96-well culture tray. This assay has a broad detection range between 
1 and 1000 nM for E2.  This detection range is similar and lower then the detection range of the 
other in vitro and in vivo assays evaluated in this thesis (Chapters 3, 4 and 7). Previous studies 
have also investigated the use of ERα as a biomarker for estrogenicity using the MCF-7 cell line. 
Results obtained in our study corroborate the results obtained by Villabos et al (1995). However, 
the ELISA described by us is performed on cultured and fixated cells in a 96 well format and 
does not require protein preparation of cultured cells. The assay described by us is therefore less 
 
 
 
 
                                                                                                                                   Chapter 5 
 - 118 - 
time consuming, easy to use, sensitive and can be used as a high throughput in vitro screen for 
environmental estrogens. 
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Chapter 6 
The development and validation of a quantitative ELISA for in vivo 
and in vitro synthesized vitellogenin from Mossambicus tilapia 
(Oreochromis mossambicus) 
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6.1. Abstract 
The induction of vitellogenin (VTG), an egg yolk precursor found in most oviparious 
vertebrates, has been well established as a valuable biomarker for assessing estrogenic 
endocrine disruption. Oreochromis mossambicus is a tilapiine species indigenous to Southern 
Africa and therefore represents a potential African bio-indicator for the development of in 
vitro and in vivo screens for estrogenicity using VTG as biomarker. However, few ELISAs 
have been developed to quantify tilapia VTG protein levels. In the present study 
commercially available VTG antiserum that shows cross reactivity with tilapia VTG was used 
to setup and validate a quantitative competition ELISA for tilapia VTG. This ELISA has a 
broad detection range between 80 ng/ml – 5.4 µg/ml VTG and is able to detect both in vivo 
and in vitro synthesized VTG.  This ELISA is highly repeatable with intra- and interassay 
variations less than 3.4 % at the lowest detection limit.  
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6.2. Introduction 
Several toxicants found in the environment act by disrupting the endocrine system of animals 
and humans. Traditional chemical monitoring techniques have become very expensive, are 
time consuming and requires a high level of skill. Moreover, since it is not yet known which 
of the myriad of substances in the environment and combinations of them may cause 
endocrine problems, the measurement of biological effects seems to be the more appropriate 
way to go. A number of studies have concluded that in terms of cost effectiveness and to 
allow for screening of a large number of compounds, in vitro test methods are more 
appropriate (Beresford et al., 2000; Andersen et al., 1999). Vitellogenin (VTG) has become a 
very popular biomarker for environmental estrogen induced toxicity and is used in both in 
vitro and in vivo screening assays in oviparous vertebrates. 
 
VTG is a high molecular weight phospholipoglycoprotein (250-600 kDa) that is produced and 
secreted by the liver of oviparious vertebrates as the precursor to several egg yolk proteins 
(Wallace and Selman, 1985; Ho et al., 1980, Specker et al., 1994). During sexual maturation, 
the female fish synthesizes 17β-estradiol (E2) in the gonads, and the circulating E2 is 
subsequently taken up by hepatocytes where it binds to estrogen receptors (ER) leading to the 
transcription of the VTG gene. The VTG protein is then secreted from the hepatocytes, enters 
blood circulation and is taken up by growing oocyte through receptor-mediated endocytosis 
(Matozzo et al., 2007). Within the oocyte VTG is degraded to the yolk proteins, lipovitellin 1, 
lipovitellin 2 and phosphitin (Parks et al., 1999; Brion et al., 2000). These yolk proteins serve 
as a nutrient store for developing embryos (Matsubara et al., 1999). 
 
Investigations have shown that although VTG is normally expressed in female fish only, E2 
and a number of synthetic chemicals (e.g., ethinyl estradiol, nonylphenols) are capable of 
inducing VTG production in male fish (Purdom et al., 1994; Jobling et al., 1995; Sumpter,  
1995). This endocrine disruption phenomenon is due to the fact that these xenoestrogens may 
interact with estrogen receptors by mimicking natural estrogens (Stahlschmidt-Allner et al., 
1997). Exposure of fish to estrogenic sewage effluent may lead to reproductive impairment 
(Lomax et al., 1998; Gronen et al.,1999). Spermatogenesis is inhibited by estrogens and some 
exposed male fish have testisova (Gronen et al., 1999). Because of the sensitivity of this 
response, VTG detection in blood and/or liver from male oviparous verterbrates has become a 
common biomarker for monitoring environmental estrogen contamination (Gimeno et al., 
1997; Harries et al., 1997; Jobling et al., 1998; Cheek et al., 2001; Jobling and Tyler,  2003). 
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A number of methods have been developed for the quantification of VTG in blood plasma, 
liver tissue, or whole-body homogenates from several fish species. These methods include: 
radioimmunoassay (RIA), enzyme linked immuno sorbent assay (ELISA), single radial 
immunodiffusion (Specker et al., 1994) and real time PCR (Celius et al., 2000). These various 
methods differ in sensitivity, specificity, and technical difficulty. Currently, the most popular 
approach to measure VTG is some form of an ELISA, although RIAs may occasionally be 
employed (OECD, 2004). Fish VTG was quantified for the first time by ELISA in Solea 
vulgaris (Nuñez Rodriguez et al., 1989) and since then in various other species. The anti-VTG 
antibodies are very specific for each individual fish species and often require the production 
of specific antibodies for the selected species (Hansen et al., 1998). These antibody based 
procedures for VTG quantification may use antisera prepared against VTG from the fish 
species being studied. Although antisera can cross react with VTG from multiple fish species, 
the affinity can vary substantially (Silversand et al., 1993). 
 
The development of screening and testing programmes for endocrine disrupting effects of 
new chemicals are one of the priority focus areas of major organizations such as the 
Organization for Economic Cooperation and Development (OECD, 2004). The focus of these 
are use of small fish test species such as fathead minnow (Pimephales promelas), zebrafish 
(Danio rerio), stickleback (Gasterosteus aculeatus) and Japanese medaka (Oryzias latipes) as 
bio-indicators. These fish species share several characteristics that make them ideal test 
species for reproductive toxicity such as small size at maturity, relatively short generation 
times, asynchronous spawning, and overall ease of culture. Southern Africa, like most areas in 
the world, is also facing major aquatic pollution problems and these are posing a threat to 
human and animal health. Tilapia (Oreochromis mossambicus) also shares the same 
characteristics as the above mentioned fish species. Tilapia is found in the natural 
environment throughout Southern Africa and can potentially be used as an indigenous 
indicator species for this region. The aim of this study was to use commercially available 
antibodies to setup, validate and implement a competition ELISA to quantify Oreochromis 
mossambicus VTG.  
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6.3. Methods and Materials 
6.3.1. Experimental animals 
Juvenile and adult Tilapia were obtained from the breeding stock of the Welgevallen 
experimental farm from the University of Stellenbosch, Stellenbosch, South Africa. Tilapia 
juveniles were four weeks old, whereas adult fish used weighed in the order of 100g. 
 
6.3.2. Chemicals  
All auxiliary enzymes, cofactors and substrates used in this study were from either Sigma 
Chemical Company (St Louis, MO, USA) or Roche (South Africa). Sea Bream Vitellogenin 
polyclonal antibody (Anti-VTG) were supplied by Cayman Chemical Co. Anti-rabbit IgG 
(whole molecule) horseradish peroxidase conjugate (HRP) and Hybond-C Extra nitrocellulose 
were supplied by Amersham International. All other protein blotting detection reagents were 
supplied by Roche International. The standard protein molecular mass markers were from 
Sigma Chemical Company. All solvents and biochemicals were of analytical grade. 
 
6.3.3. Juvenile diethylstilbestrol (DES) exposure  
Four-week-old juvenile Tilapia fishes were obtained from the Welgevallen experimental farm 
and brought back to the lab. Juvenile tilapias were exposed to DES for seven days under static 
conditions in two-liter glass containers containing one liter of water. Water was not changed 
during the exposure period. DES was dissolved in dimethyl sulfoxide (DMSO) and did not 
exceed 0.1 ml per liter as per OECD, 2004 protocol agreement. Two treatment groups 
received 25 ng/l DES (n=20) and 250 ng/l DES (n=20) respectively. An additional group of 
20 fish were kept without DES and served as a control group. 
 
6.3.4. Tissue culture 
The medium used for tissue culture was RPMI 1640 containing L-glutamine, NaHCO3 and 25 
mM Hepes (Highveld Biologicals, South Africa). A mixture of penicillin, streptomycin, and 
fungizone (Highveld Biologicals) was added to the RPMI medium according to 
manufacturer's instructions. The RPMI medium containing the antibiotics will subsequently 
be referred to simply as “medium.'' 
 
Adult male fish were brought back to laboratory after which they were decapitated and placed 
in 70 % ethanol for three minutes in order to decontaminate the skin. All subsequent 
procedures were carried out aseptically in a laminar flow cabinet. Cubes of liver tissue, 
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measuring approximately 1mm3, were prepared and put into high quality 1.5 ml eppendorph 
tubes at one cube per tube. Four cubes were prepared for each DES treatment exposure. Cubes 
were covered with medium an incubated in the dark at a constant 27°C in a water bath. Cubes 
were incubated for four days and the medium was not changed during the exposure time. 
Aspirant medium, for the determination of VTG concentration, were stored at -80°C until use. 
 
6.3.5. Tissue sampling 
Adult Tilapias were anesthetized using 100 mg/l Benzocaine. Organs used for experiments 
were dissected out and placed in extraction buffer (saline containing 0.01 % (w/v) 
phenylmethylsulphonylfluoride) with a weight to volume ratio of 1:10. Samples were then 
sonicated at 14 watts (Virsonic-60) for six bursts of ten seconds each. Samples were allowed 
to stand for one-minute intervals on ice between bursts. Samples were then centrifuged at 12 
000 × g for 10 min at 4°C. Blood was collected using capillary tubes and dispensed in 1.5 ml 
tubes. After clotting the samples were centrifuged at 12 000 × g for 10 minutes at 4°C. The 
supernatants from both the blood and organ samples were, aliquoted and stored at -80°C for 
analysis.    
 
6.3.6. Protein determinations 
Protein contents of samples were measured according to the method of Bradford, (1976) using 
biovine serum albumin (BSA) as a standard protein (Sigma).  
 
6.3.7. SDS PAGE and protein blotting 
Proteins were resolved in a 10 % (w/v) polyacrylamide gel. Gels were prepared using a SDS-
PAGE gel preparation kit supplied by Sigma Chemical Company (St Louis, MO, USA). Gels 
and solutions were prepared according to the manufacturers instructions. Polyacrylamide gels 
were run at 120 V in a slab electrophoresis unit. 
 
Separated polypeptides were transblotted onto nitrocellulose in Towbin Buffer (25 mM Tris-
HCl, 192 mM glycine and 20 % (v/v) methanol) at 15 Volts for 1 hour and dried between 
filter paper. Following transfer, the blots were stained in Ponceau-S (0.2 % [m/v] Ponceau-S, 
3 % [m/v] trichloroacetic acid), to be able to mark the standard molecular weight bands. The 
blots were then thoroughly rinsed in saline and blocked for 1 hour at room temperature in 
blocking solution containing 1 % (w/v) human serum albumin (HSA) in saline. All 
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subsequent steps in the procedure were carried out at room temperature. Blots were incubated 
in saline containing 0.1 % (w/v) BSA, 0.01 % (v/v) Tween and 1/2000 anti-VTG. Unbound 
antibody was removed by washing the nitrocellulose 4 times for 5 minutes in wash solution 
containing saline and 0.01 % (v/v) Tween. The nitrocellulose was then incubated for 1 hour in 
wash solution containing anti-rabbit horse radish peroxidase conjugate (1/2500), 0.1 % BSA 
and saline. The nitrocellulose was washed as before and finally it was stained for horseradish 
peroxidase binding using BM Blue POD precipitating substrate. After staining the 
nitrocellulose it was washed with distilled water, dried and stored in an aluminium foil 
envelope.    
 
6.3.8. Tilapia vitellogenin competition ELISA 
Nunc-Immuno Maxisorp plates (Nalge Nunc, Denmark) were used for all ELISA assays. 
Plates were coated overnight at 4°C with 50 µl per well of 1/2000 diluted ovary homogenate 
in saline. At the end of the incubation period plates were washed four times with Saline. 
Following the wash procedure, remaining adsorption sites on the plate were blocked by 
dispensing 0.2 ml of block solution (1 % w/v HSA in Saline) per well and incubating the plate 
for one hour at room temperature. The same wash procedure was followed where after 
samples for analysis and the VTG standards were dispensed at 50 µl per well. Anti-VTG was 
diluted 1/1000 with Saline containing 1 % (w/v) HSA and were also dispensed at 50 µl per 
well. Samples were incubated for three hours at room temperature and the same wash 
procedure was followed again. Anti-rabbit horse radish peroxidase conjugate was diluted 
1/2500 with Saline containing 1 % (w/v) HSA and dispensed at 50 µl per well. Plates were 
incubated for one hour at room temperature where after it was washed eight times with Saline. 
BM Blue POD soluble substrate was heated to 37°C and dispensed at 50 µl per well. Plates 
were incubated at room temperature for thirty minutes followed by addition of 50 µl per well 
of stop solution (0.5 M H2SO4). The optical density was lastly determined at 450 nm. 
 
6.3.9. Expression of results and statistical analysis 
The percentage of maximum (percentage binding) in each standard or sample dilution was 
calculated using the following relationship:  
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% of maximum = (standard or sample absorbance / maximal binding absorbance) x 100. 
Results were statistically analysed using analysis of variance (ANOVA). Tuckey’s HSD test 
was used for all pair wise multiple comparisons. 
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A B 
6.4. Results 
6.4.1. Specificity of the Anti-VTG  
Polyclonal anti-VTG was bought from Cayman Chemical Co (catalog number: 170150). This 
antibody was produced from purified VTG of E2 treated Sea Bream (Sparus aurata). 
According to the manufacturer, this antibody recognized VTG from several fish species, 
including (Oreochromis niloticus). The specificity of this antibody was tested on 
Oreochromis mossambicus using protein blotting (Fig. 6.1).  
 
 
 
 
 
 
 
 
 
 
Figure. 6.1. Specificity of the Anti-VTG antiserum. SDS-Page (A) and Protein Blotting (B) 
of: Male plasma (1), DES treated female plasma (2) and Ovaries (3). SDS-Page gel was 
stained with Coomassie Blue. Plasma samples were diluted 1:100 and 20 µl of sample were 
used for SDS-Page and protein blotting. 
 
The antiserum immunostained both the plasma of DES treated females as well as ovary 
extracts, while there was no reaction with the control male plasma. The anti-VTG recognized 
peptides with apparent molecular weight of approximately 200 kDa (protein 1), 140 kDa 
(protein 2) and 130 kDa (protein 3) in the treated female serum. In the ovary extracts a protein 
with an apparent molecular weight of 110 kDa (protein 3) was immunodetected.  
 
6.4.2. ELISA Validation 
6.4.2.1. Anti-VTG and VTG antigen titration 
The optimal assay concentrations for VTG antigen and antibody were determined to obtain a 
maximum absorbance value near 1, since most plate readers have a linear response in the 
range 0.1-1.1 optical density units. The two-way titration of the VTG antiserum and antigen is 
displayed in figure 6.2. A double dilution series of both VTG antiserum and antigen were 
prepared to obtain optimal ELISA assay concentrations. The VTG coating antigen dilution 
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Figure 6.2. Determination of optimal concentrations of tilapia vitellogenin and 
antiserum for the validation of the tilapia ELISA. Tilapia ovary extracts were used as the 
VTG antigen, whereas seabream anti-VTG was used as the primary antibody. Abs = 
absorbance. 
 
started at 1:200, whereas VTG antiserum started at 1:500. VTG antigen dilution of 1:2000 and 
VTG antiserum dilution of 1:1000 were chosen for setting up the competition ELISA. These 
assay concentrations gave an absorbance value near 1, which is midway between the linear 
and plato area of the graph. At these assay concentrations very low background readings were 
obtained (Abs = 0.097). 
 
6.4.2.2. VTG antiserum specificity 
Blood from DES treated female tilapia and control untreated males were screened for VTG 
induction using the optimal ELISA assay concentration (Fig. 6.3). At a blood dilution factor 
of 1:2000 exposed females showed absorbance values of 1.6, whereas unexposed males 
showed very low background readings of 0.1. Blood from the exposed females was stored at -
80°C as an in-house standard for VTG. 
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Figure 6.3. Screen for VTG induction in sexually mature female tilapia blood exposed to 
DES as well as untreated males. Female, sexually mature female tilapia fish were exposed 
for 7 days to 60 ng/l DES. Male tilapias were kept under the same conditions without DES 
treatment. Blood were screened for VTG using the optimal ELISA assay concentrations. 
 
6.4.3. VTG competition ELISA  
A typical tilapia VTG competition ELISA standard curve is displayed in figure 6.4. The 
standard curve was linearized by plotting percentage of maximum values on a logarithmic Y-
axis. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.4. A typical tilapia VTG competition ELISA standard curve. In-house VTG 
standard were diluted from 84.1 ng/ml to 5.4 µg/ml VTG. The competition ELISA procedure 
was followed as explained in the methods and materials section. 
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The sensitivity of the ELISA (the amount of VTG which gave 90 % of binding) was 80 ng/ml 
VTG with a practical operating range betweem 80 ng/ml and 5.4 ug/ml VTG. The standard 
curve displayed in figure 6.4 is the result of six standard curves over a period of six months 
and the ELISA precision (intra- and interassay variation) was calculated from this (Table 6.1). 
Intra-assay variation was less than 3.4 %, whereas interassay variation was 8.4 % at 50 % 
binding and less then 2.9 % at 90 % and 80 %. 
 
                         Table 6.1. Characteristics of the tilapia VTG competition 
                         ELISAa 
 Binding  
 (Percentage of Maximum) 
  90 % 80 % 50 % 
CVb intra-assay (%) 3.4 1.2 1.1 
CV interassay (%) 2.9 2.2 8.4 
                           
a For routine measurement 1:2000 VTG antigen and 
                           1:1000 antibody dilution was selected. 
                           
b
 CV = coefficient of variation. 
 
6.4.4. Implementation of ELISA for in vivo induced VTG 
To validate the applicability of the competition ELISA for quantification of in vivo induced 
tilapia VTG, groups of 20 four-week-old tilapia fish were exposed to DES at various 
concentrations for 7 days and VTG concentrations determined using the ELISA (Fig. 6.5).  
 
 
 
 
 
 
 
 
 
 
 
Figure 6.5. VTG concentration of four-week-old juvenile tilapia whole body 
homogenates. Fish were exposed to different concentrations of DES over a period of seven 
days. Vertical bars are the average concentration obtained for six individual fish, whereas 
error bars represent standard deviations. Groups marked with different letter are significantly 
different (p < 0.001). 
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Exposure to DES did not significantly influence the mortality of exposed juveniles, 
suggesting that neither the solvents nor the tested concentrations of DES had an acute toxicity 
effect under our test conditions. Figure 6.5 displays VTG concentrations of the whole body 
homogenates measured by the competition ELISA after 7 days of exposure. In the control 
group, the measured VTG concentration was 2.1 µg VTG/mg protein. Exposure of juveniles 
to 25 ng/l and 250 ng/l DES resulted in VTG concentrations of 3 µg/ml and 9 µg/ml 
respectively. There was no significant difference in VTG concentration between the control 
and 25 ng/l DES groups. However, the 250 ng/l DES exposed tilapia have significantly higher 
VTG compared to the control (P < 0.001) and the 25 ng/l DES exposed group (P < 0.001). 
 
6.4.5. Implementation of ELISA for in vitro induced VTG 
Liver slice cultures from sexually mature male tilapia was used to validate the competition 
ELISA for in vitro VTG synthesis (Fig. 6.6). Liver slices were exposed to 0.5 µg/ml DES for 
a total of four days. VTG concentrations measured in the medium from the control samples 
did not change over the culture period (p > 0.01). After three days exposure to 0.5 µg/ml 
DES, VTG concentrations increased significantly from 1.3 µg/ml (control) to 4.3 µg/ml VTG 
(p < 0.001). VTG concentrations increased from 4.3 µg/ml to 14.6 µg/ml VTG after four days 
in culture. 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.6. Vitellogenin synthesis by sliced liver cultures exposed to 0.5 µg/ml DES over 
a period of four days. Vertical bars represent the mean of four independent experiments, 
whereas errors bars represent standard deviations. Different letters above the data bars 
indicate significant differences (p < 0.001). 
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6.5. Discussion 
In this study commercially available anti-seabream VTG was used to set up, validate and 
implement a competition ELISA which can be used for the quantification of in vitro and in 
vivo synthesized Oreochromis mossambicus VTG. Previous investigations have shown that 
anti-VTG is very species specific and therefore very often requires the production of species 
specific anti-VTG antiserum (Hansen et al., 1998). It is evident from the protein blot analysis 
(Fig. 6.1) that the anti-seabream VTG recognize tilapia VTG. The antibody reacted with 
peptides in DES treated plasma, whereas no reaction was visible with untreated male plasma. 
These results are supported by the ELISA on serum from DES exposed females and 
unexposed males (Fig. 6.3). The antibody reacted with the DES exposed serum whereas no 
crossreactivity is observed with the unexposed male fish. In a previous study conducted by 
Kishida and Specker, (1993) VTG were isolated by DEAE agarose ion-exchange 
chromatography from plasma of the tilapia, Oreochromis mossambicus. The monomers had 
apparent molecular masses of 200 and 130 kDa. SDS-PAGE of the oocyte extract showed a 
major protein band at 106.6 kDa. The anti-seabream VTG used for this study similarly 
detected three bands at molecular weight 200 kDa, 140 kDa and 130 kDa respectively. The 
140 kDa protein of tilapia may be a degradation product of a larger VTG molecule. Previous 
investigations have shown that VTG in many fish is rather unstable, and even the addition of 
protease inhibitors to a plasma sample cannot fully prevent its proteolysis (Tyler and Sumpter, 
1990; Silversand et al., 1993). A protein with a molecular weigh of approximately 110 kDa 
was detected in ovary extracts.  
 
The validated ELISA is a competitive-binding assay in which antibodies are preincubated 
together with the sample of analysis (or standards). The immobilized VTG on the plate and 
the soluble VTG in the sample or standard competes for antibody binding. The tilapia ELISA 
validated in the present study is sensitive and has a detection limit of 80 ng/ml VTG, which is 
comparable to radioimmunoassays for VTG (Tyler and Sumpter, 1990; Norberg and Haux, 
1988; Benfey et al., 1989). The working range of the ELISA is very broad (80 ng/ml - 5.4 
ug/ml VTG), which makes it suitable for VTG quantification when studying very weak as 
well as very potent estrogens. The ELISA is also very reliable and repeatable with intra- and 
interassay variation less than 3.4 % at the detection limit (Table 6.1) and is comparable to 
VTG ELISAs for other teleosts (Tyler et al., 1999; Bon et al., 1997; Kishida et al., 1992).  
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To test the applicability of the validated ELISA for in vivo analysis of VTG induction, four 
weak old tilapia juveniles were exposed to different concentrations of DES for seven days 
(Fig. 6.5). Due to the sensitivity of the validated ELISA, VTG concentration can be accurately 
determined in fish weighing as little as 10 mg. Exposure of juveniles to 250 ng/l DES induced 
significantly higher concentrations of VTG compared to control fish. A dose responsive effect 
to DES exposure can be observed where the juveniles induced higher VTG concentrations to 
higher DES levels. A similar induction of VTG has previously been shown for fathead 
minnow  (P. promelas) exposed to various concentrations of estradiol-17β until 30 days post 
hatching (Tyler et al., 1999). Control juveniles showed VTG concentrations of 2.1 µg 
VTG/mg protein. This baseline level of VTG may be because of estrogenic substances in the 
food or small amounts of natural estrogens secreted by female fish in the breeding tanks. The 
ELISA was tested for the quantification of in vitro synthesized VTG using tilapia liver 
cultures as model culture system. VTG was detectable after exposing liver slices for three 
days to 0.5 µg/ml DES. After four days of DES exposure, an 11.2-fold increase in VTG (from 
1.3 to 14.6 µg/ml VTG) was observed.  
  
In conclusion, a tilapia competition VTG ELISA was validated using commercially available 
anti-seabream VTG as the detecting antibody to quantify tilapia VTG. This ELISA is very 
specific for VTG, has a wide detection range, is very sensitive and has low inter- and intra-
assay variations. We showed that the ELISA can be used for both in vivo and in vitro 
quantification of VTG. Our results show that the validated competition ELISA can be used as 
a useful tool to detect environmental estrogen contamination and endocrine disruption using 
tilapia VTG as a biomarker. 
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Chapter 7 
The use of Mossambicus tilapia (Oreochromis mossambicus) juveniles 
as bio-indicators for environmental estrogenicity 
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7.1. Abstract 
Millions of tons of chemicals are released into the environment every year. Some of these 
may cause adverse health effects through disrupting normal endocrine function of humans and 
wildlife. Previous investigations have indicated that most of the adverse health effects 
observed are due to compounds found in the environment that mimic natural endogenous 
estrogens or inhibit the actions of estrogen. Several in vitro and in vivo bio-assays have been 
developed and validated to screen for environmental estrogens. Vitellogenin (VTG) is a well-
known estrogen induced yolk-precursor and is synthesized in the liver of oviparous animals. 
The induction of vitellogenin in many fish species is a sensitive biomarker for estrogenic 
activity. Because the use of adult fish may be problematic in terms of endogenous VTG levels 
as well as sensitivity to induce VTG upon estrogen exposure, the use of juvenile fish as a bio 
indicator needs investigation. The objective of this study was to develop VTG induction by 
juvenile tilapia (Oreochromis mossambicus) as a rapid in vivo bio-assay for estrogenicity. 
Natural as well as estrogen induced VTG protein levels were determined using a competition 
ELISA. Analysis of the natural VTG levels of an un-sexed population ranging from 15 to 70 
days post fertilization (dpf) juveniles revealed a sudden significant 5 fold increase in natural 
VTG levels at 50 dpf fish. This increase coincided with a significant 2 fold increase in natural 
17β-estradiol levels. No difference in total protein or albumin levels could be detected. It was 
also evident from this study that juvenile tilapias have the ability to induce VTG upon 
estrogen exposure from a very early stage (25 dpf). Juveniles exhibited the maximum ability 
to induce VTG, upon estrogen exposure between 35 and 45 dpf. At this age 200 ng/l of DES 
was the lowest observable concentration of estrogen that could induce significant VTG levels 
after 10 days of exposure. 
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7.2. Introduction 
Human and animal health is dependent on the state of the environment that we live in. Every 
year hundreds of new chemicals with unknown toxicity or subtle disruptive effects on human 
health are released into the environment. Scientific evidence increasingly suggest that 
exposure to some of these chemicals, both natural and synthetic have the potential of 
interfering (either by modulation or disruption) with an organism’s normal endocrine function 
(Kelce et al., 1995; Oehlmann et al., 1996; Milligan et al., 1998). These chemicals may be 
responsible for some of the physiological and anatomical defects seen in both wildlife and 
humans (Reviewed by Solomon and Schettler, 2000). Chemicals that potentially disrupt the 
functioning of the endocrine system are categorized as endocrine disrupting chemicals 
(EDCs) (Krimsky, 2000). EDCs enter the aquatic environment as either point and/or non-
point sources of contamination. Point sources of contamination refer to specific sources, for 
instance sewage treatment plants, pulp mills and industrial effluent (Folmar et al., 2002). 
Non-point sources of contamination are for instance urban and agricultural runoffs (Folmar et 
al., 2002). Both of these two sources of contamination may include natural and 
pharmaceutical hormones excreted in the urine of humans and domestic livestock (Giesy et 
al., 2002). It may also include a wide spectrum of chemicals like organochlorine pesticides, 
polychlorinated biphenyls, polynuclear aromatic hydrocarbons, dioxins plasticizers and 
surfactants that can interact with hormone receptors or affect steroidogenesis (Ying et al., 
2002). Water bodies, including rivers and dams may act as a sink for chemicals which are 
discharged via different routes into the environment. As a result much of the evidence for 
endocrine disruption has come from organisms living in the aquatic environment (Jobling et 
al., 1998; Rodgers-Gray et al., 2000). 
 
The majority of the reported cases of endocrine disruption have been estrogenic effects caused 
by substances that mimic endogenous estrogen responses or affecting estrogen action (Panter 
et al., 2002). Therefore, substances with estrogenic activity have received a lot of attention 
during the last two decades (Aherne and Briggs, 1989; Shore, 1993; Stumpf et al., 1996, 
Andersen et al., 2003). The European scientific community, the Organization for Economic Co-
operation and Development (OECD) and the United States Environmental Protection Agency (US 
EPA) are in the process of validating test assays to be incorporated in a screening and testing 
program to detect certain types of EDCs with special emphasis on estrogen-mimicking 
chemicals (U.S. EPA 1998a). Various in vitro and in vivo test assays have been validated to 
screen for environmental estrogens or associated biological estrogenic responses which 
 
 
 
 
                                                                                                                                Chapter 7 
 - 144 - 
includes whole organism assays, cellular- and non-cellular assays (Reviewed by Campbell et 
al., 2006). In vitro systems such as recombinant yeast assays and several estrogen-responsive 
cell lines have proved to be valuable assay systems to determine possible estrogenic 
compounds as well as assessing their modes of action (Soto et al., 1995; White et al., 1994; 
Zacharewski et al., 1995; Beresford et al., 2000). The shortfall of in vitro assays is that they 
do not take into account bioaccumulation and bio-metabolism of the compound. Moreover, 
they exclude all metabolic effects that are not mediated via the estrogen receptor. In 
vivo/whole animal studies includes these parameters. The mouse uterotrophic assay is one of 
the oldest and most widely used in vivo assays for estrogenic activity. This assay is sensitive 
and can account for additive activity of multiple estrogens but exposure to androgens or 
progestins can also produce false positive results (Kupfer, 1988).   
 
Several aquatic species have been studied and proposed as bio-indicators for low 
concentration EDCs (Bruton & Boltt, 1975; Nagahama, 1990; Helbing et al., 1992; 
Nagahama, 1994; Kloas, 2002; Noaksson et al., 2003; Hahlbeck et al., 2004; Sharpe et al., 
2004; Zhong et al., 2005; Piferrer et al., 2005; Kuhl et al., 2005; Tao et al., 2006; Zhang et al., 
2006; Filby et al., 2007; Cheshenko et al., 2008). The OECD fish screening assays suggests 
the use of three core endpoints or biomarkers as indicators of estrogenic endocrine disrupter 
activity in fish, namely: 1) gross morphology (i.e., secondary sexual characteristics), 2) 
vitellogenin (VTG) levels (Emmersen et al., 1979; Jobling and Sumpter, 1993; Purdom et al., 
1994; White et al., 1994; Folmar et al., 1996, 2000; Hyllner et al., 1991; Oppen-Bernsten et 
al., 1992; Larsson et al., 1994; Arukwe et al., (1997, 1998); Denslow et al., 1997; Murata et 
al., 1997; Celius and Walther (1998a,b); Knudsen et al., 1998; Hemmer et al., 2001), and 3) 
gonadal histology (Gimeno et al., 1996; Jobling et al., 1996; Gray and Metcalfe, 1997; Panter 
et al., 1998; Metcalfe et al., (2000, 2001)).  
 
Several fish based biomarker assays, measuring the expression of estrogen-regulated gene 
products such as VTG have been validated. Synthesis of one such product, vitellogenin (the 
egg yolk precursor phospholipoglycoprotein), is generally associated with oviparous 
reproduction and forms the basis of many screening programs for estrogenic compounds in 
aquatic systems (Sumpter and Jobling, 1995; Hiramatsu et al., 2005; Porte et al., 2006). VTG 
is normally only present in the plasma of female fish. Male fish do have the VTG gene and 
when exposed to estrogens, VTG can be expressed and accumulate in the plasma of male fish 
(Copeland et al., 1986; Purdom et al., 1994). A very useful feature of VTG as a biomarker for 
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estrogenicity is its magnitude of induction when an oviparous animal such as fish is exposed 
to estrogens. Reports have indicated that VTG plasma levels can change up to a million fold 
from nanogram per millilitre to milligram per millilitre when exposed to estrogens (Purdom et 
al., 1994; Tyler et al., 1996). This biomarker can be used for both in vitro (e.g., hepatocyte 
cultures) and in vivo (animal whole body) studies (Tyler et al., 1999). VTG as a biomarker 
can be equally as valuable in females for screening anti-estrogens by both directly (i.e., 
estrogen receptor agonists; Panter et al., 2000a) and indirectly (e.g., inhibitor of aromatase, 
Ankley et al., 2002) as well as for some types of androgens (Ankley et al., 2003).  
 
In many fish species VTG protein induction is extremely sensitive to estrogen exposure 
(Sumpter and Jobling 1995; Porte et al., 2006; Hiramatsu et al., 2005). However, it seems that 
sensitivity differs between species and is also dependent on the specific stage of sexual 
development. The most sensitive species (minimum exposure period to lowest estrogen 
concentration that significantly induce VTG) found until now is sexually mature male trout 
(OECD, 2004). These fish synthesized significantly higher VTG than control fish upon 
exposure to 0.3 ng/l EE2 for 28 days (Sheahan et al., 1994). Juvenile fathead minnow exposed 
from 24 hours post fertilization to 30 days post hatch showed a lowest observed effective 
concentration (LOEC) for VTG induction at 50 ng/l 17β-estradiol (E2) (Tyler et al., 1999). In 
comparison, mature fathead minnow males that were exposed for 21 days showed significant 
VTG induction compared to the controls with a LOEC of 320 ng/l for E2 (Panter et al., 1998). 
In another study conducted by Panter et al. (2000), mature male fathead minnow exposed to 
E2, showed a LOEC of 30 ng/l for VTG induction. Mature male Medaka exposed for 4 days 
to E2 showed a LOEC for VTG induction of 20 µg/l (Foran et al., 2000). Zebrafish juveniles 
exposed for 21 days to E2 showed a LOEC for VTG induction at 100 ng/l, whereas adults 
also exposed for 21 days showed a LOEC at 25 ng/l (Brion et al., 2004).  
 
The use of small teleosts fish species is preferred for the investigation of endocrine disrupting 
chemicals (Environmental Agency, 2000). Fathead minnow (Pimephales promelas), medaka 
(Oryzias latipes), stickleback (Gasterosteus aculeatus) and zebrafish (Danio rerio) has been 
proposed by the OECD as the most likely species to be used as bio indicators for endocrine 
disruption. The fathead minnow has a strong regulatory history in the United States, whereas 
the zebrafish has been similarly used in Europe and the medaka in Japan (OECD, 2004). 
These species tolerate a wide range of water-quality and water-temperature conditions, 
require small culture space, overall easy to culture, produce the required number of embryos 
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needed for testing and have a small size at maturity, which reduces maintenance costs. The 
tilapiine species, Orechromis mossambicus, (Mozambique Tilapia), is extensively used in 
aquaculture (Trewavas, 1983) around the world. Tilapia, similar to fathead minnow, medaka 
and zebrafish, is easy to culture, tolerate a wide range of water-quality and importantly, is 
native to Southern Africa. Tilapia juveniles and their ability to induce VTG upon estrogen 
exposure, have not yet been investigated as an in vivo screen for estrogenicity. In order for 
tilapia juveniles to be used in an in vivo screen for estrogenicity, it is necessary to investigate 
natural as well as E2 inducible VTG protein levels during early development.  
 
The aim of this study was to evaluate an un-sexed population of tilapia juveniles as a bio-
indicator for estrogenicity using VTG as a biomarker. One of the objectives of this study was 
to determine the endogenous VTG levels of tilapia hermaphroditic juveniles to give us a 
better understanding of the natural biomarker background. This objective complies with 
OECD recommendations which states: it is important to have a better understanding for the 
“noise of the VTG biomarker” to clarify the range of endogenous VTG levels in both juvenile 
and adult fish (OECD, 2006). The second objective of the study was to determine the critical 
stage where juveniles are most sensitive for estrogen exposure and VTG induction. If 
exposure to estrogenic endocrine disruptors during early development is sufficient to be 
manifested by VTG induction, this may considerably lower the costs as well as make the 
maintenance of fish easier when testing environmental samples for estrogenic effects. The 
third objective of this study was to determine the lowest concentration of the synthetic 
estrogen, diethylstilbestrol (DES) that induces VTG expression in juvenile tilapias (less than 
70 days post fertilization). Although the OECD recommends the use of ethinylestradiol as a 
positive control, we used DES as an alternative because of difficulty obtaining 
ethinylestradiol in South Africa.  
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7.3 Methods and Materials 
7.3.1. Test Fish 
Fourteen days post fertilization (dpf) swim-up fry stage Oreochromis mossambicus juveniles 
were obtained from the Welgevallen experimental farm, University of Stellenbosch, South 
Africa. The juveniles used for each experiment were derived from a single breeding hatch of a 
single adult breeding pair (one female and male) tilapias for each experiment. Fish were kept 
in 10 litre stock tanks (30 x 22 x 16 cm) filled with tap water. The water was constantly 
aerated and filtered through activated charcoal. Fish were maintained in water of similar 
quality for all exposure experiments, but without activated charcoal filters. Fish were 
maintained at a temperature of 27 °C (± 1 °C) with a light regime of 14:10 (light:dark) 
throughout the duration of all experiments. Fish were fed daily with crushed commercial 
tilapia pellets (AquaNutro, South Africa). Water was replaced every 5 days. 
 
7.3.2. Test chemicals and exposure design 
All chemicals in this study were from either Sigma Chemical Company (St Louis, MO, USA) 
or Roche (South Africa) unless otherwise stated. All solvents and chemicals used were of 
analytical grade. Diethylstilbestrol (DES) was used for all estrogen exposures and was 
supplied by Sigma Chemical Company (St Louis, MO, USA). DES stock solutions were 
prepared to a concentration of 1mg/ml using either analytical grade ethanol or dimethyl 
sulfoxide (DMSO) as a solvent. The final solvent concentration never exceeded 0.01 % (v/v) 
according to OECD recommendations (OECD, 2004). Estrogen exposures were performed 
under semi static conditions. Exposures were performed in 1 litre glass bottles filled with 500 
ml of water. Half the volume of the test solution was exchanged every five days. Prior to 
experiments, all glass containers were washed with Neptune Liquid salt (Bell Products, 
www.bellchemicals.com). Before all experiments, fish tanks and exposure systems were 
washed with Hibitane (5 % antiseptic) washing agent soap, followed by a thorough rinse with 
water that has been charcoal filtered. Tanks were then stripped with 100 % methanol followed 
by a rinse with charcoal filtered water. Tanks were filled with the required amount of water 
and aerated at 27 °C for 48 hours prior to putting fish into it. 
 
Juvenile tilapias were transferred to the 1 liter exposure tanks. DES or vehicle control was 
added to the water and the fish were then exposed for 5 days. At the end of the exposure 
period the fishes were anaesthetized with MS-222 (100 mg/l water containing 200 mg 
NaHCO3). The fish were then used for further analytical procedures. The exposures were 
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done with groups of fish at various days post fertilization. The age of fish used for this study 
ranged between 15 to 70 days post fertilization. 
  
7.3.3. Fish weight and length measurement 
Fish were photographed using a Leica EZ4D microscope and measurements taken (to the 
nearest µm) using Leica Version 2.4.0 image analysis software (Leica Microsystems 
(Switzerland) Limited). The mass of juvenile fish was determined with a bench top precision 
scale (Ohaus Precision Scale) to nearest 0.01g. 
 
7.3.4. Protein extraction and quantification 
All the protein extraction procedures were carried out on ice. Protein extraction buffer (saline 
(0.9 % (w/v) NaCl in distilled water) and 0.01 % (v/v) PMSF) was added to the juvenile fish 
at a weight to volume ratio of 1g per 10 ml extraction buffer. Sample were then sonicated 
(Omni-Ruptor 400; Omni International INC.) at 40 % power. Samples were sonicated for 15 
seconds in total, 5 second bursts at a time, followed by 1 min incubation on ice. Cell rests 
were removed by centrifugation at 12000 x g for 10 minutes at 4 ˚C. Cell pellets were 
discarded and the supernatants were aliquoted and stored at -80 ˚C until further use. Protein 
concentrations of the samples were measured according to the method of Bradford, (1976) 
using biovine serum albumin (BSA) as a standard protein (Sigma).  
 
7.3.5. Vitellogenin quantification 
The VTG content of the whole body homogenate preparations was determined using a 
competition ELISA. An ELISA system similar to the one described in chapter 6 was used to 
quantify VTG in juvenile fish. In this ELISA an in-house VTG antibody was used to detect 
VTG. Results and specifications regarding this ELISA system have been submitted elsewhere 
for publication (Journal of Immuno Assay and Immunochemistry). Nunc-Immuno Maxisorp 
plates (Nalge Nunc, Denmark) were used for all ELISA assays. Plates were coated overnight 
at 4°C with 50 µl per well of 1/2000 diluted anti-VTG antiserum in saline. At the end of the 
incubation period the antiserum was decanted and the plate was washed four times with 
saline. Following the wash procedure, the remaining adsorption sites were blocked by 
dispensing 0.2 ml of block solution (2 % v/v human serum albumin [HSA] in saline) per well. 
The plate was then incubated for one hour at room temperature. The plate was washed as 
before where after samples or purified VTG standards (50 µl) as well as 50 µl biotinylated-
VTG were added to each well. Plates were then incubated for three hours at room 
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temperature. The plate was washed using the same procedure as earlier described. Avidin 
horse radish peroxidase (AV–HRP) was diluted 1/2000 with saline containing 1 % (w/v) HSA 
and dispensed at 50 µl per well. Plates were incubated for one hour at room temperature 
where after it was decanted and washed eight times with saline. BM Blue POD soluble 
substrate were heated to 37°C and dispensed at 50 µl per well. Plates were incubated at room 
temperature for twenty minutes followed by addition of 50 µl per well of stop solution (0.5 M 
H2SO4). The optic density was lastly determined at 450 nm. A standard curve was drawn from 
the VTG standards. The VTG concentration of juvenile tilapia homogenates were calculated 
using the standard curve. 
 
7.3.6. 17β-estradiol quantification 
Estradiol was quantified using a commercial ELISA kit (catalogue number RE52041, IBL, 
Germany) using the manufacturer’s instruction manual. In brief: microtitre plate strips 
precoated with rabbit anti-estradiol was removed from the strip holder and fixed firmly in the 
ELISA plate. All assays were done in duplicate. Samples and standards were transferred to 
the wells (25 µl/well). Estradiol – horseradish peroxidase conjugate was added to all the wells 
(200 µl/well). The solutions were mixed by gently tapping the plate, after which it was 
incubated for 120 minutes at room temperature. At the end of the incubation period the 
solutions in the wells were decanted. The wells were then washed three times with 300 
µl/well of wash solution. Substrate was then dispensed at 100 µl per well after which the plate 
was incubated for 15 minutes at room temperature. The reaction was stropped by addition of 
stop solution (100 µl/well). The absorbance was determined at 450 nm using a plate reader. A 
standard curve was drawn using the reading obtained for the standards and the concentration 
of the samples was read off this curve.  
 
7.3.7. Statistical analysis 
Variation in body mass, length, total protein concentration, VTG concentration during 
development, as well as fold induction of VTG following exposure to DES and 17β-estradiol 
was assed by using single factor ANOVAs and pairwise multiple comparison procedure 
(Student-Newman-Keuls Method). A Pairwise multiple comparison procedure (Tukey’s 
HSD) was used to indicate significant different groups (P < 0.05).  
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7.4. Results 
7.4.1. Growth of juvenile Mozambique tilapia   
The incremental average body length of juvenile tilapia fish between 15 and 70 dpf is 
displayed in figure 7.1. Two way analysis of variance of the average length between the 
control group and exposed group showed no statistical (P > 0.05). 
Figure 7.1. Length of juvenile tilapias determined at 5 day intervals. Tilapia juveniles were 
exposed to 100 µg/l DES and to the same volume of vehicle control (DMSO). At the end of the 
exposure period fish were sacrificed and measured. Vertical error bars represent the standard error of 
the mean. Each data bar is the average length obtained for 10 fish. Small letters above the data bars 
represent statistical comparison among the control group, whereas capitalized letters represents 
statistical comparison among DES exposed fish. 
 
The body length of both the control and exposed group increased exponentially between 15 
and 70 dpf. Data obtained for the body lengths of the juveniles fit exponential plots with an R2 
value of 0.89 and 0.92 for the control and exposed group respectively. The average body 
length of the control group of juveniles at 15 dpf was 9.0 mm (± 0.2). These fish showed no 
significant difference (P > 0.05) in body length compared to fish measured at 20 and 25 dpf. 
Fish measured at 30 dpf was 11.4 mm (± 0.5) long and showed no significant difference with 
fish measured at 35 and 40 dpf. Fish measured at 45 dpf was 14.5 mm (± 0.7) and showed no 
significant difference (P > 0.05) in length with fish measured at 50 and 55 dpf. Fish measured 
at 70 dpf was 23.3 (± 1.2) in length and was significant higher than the previous group 
measured. It can be observed from this graph that juvenile tilapia fish between 15 and 70 dpf 
in a laboratory environment takes on average 10 days to significantly increase in length. 
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Figure 7.2. Wet weight of juvenile tilapias weighed at 5 day intervals. Tilapia juveniles were 
exposed to 100 µg/l DES and to the same volume of vehicle control (DMSO). At the end of the 
exposure period fish were sacrificed and measured. Vertical error bars represent the standard error of 
the mean. Each data bar is the average length obtained for 10 fish. Small letters above the data bars 
represent statistical comparison among the control group, whereas capitalized letters represents 
statistical comparison among DES exposed fish. 
  
7.4.2. Wet weight of juvenile tilapias 
The average body mass of juvenile tilapia fish weighed between 15 dpf and 70 dpf is 
displayed in figure 7.2. Two way analysis of variance of the average wet weight between the 
control group and exposed group showed no statistical (P > 0.05). At 15 dpf juveniles had a 
body mass of 8.5 mg ± 0.3 which increased to 115.6 mg ±  16.6 at 70 dpf. The body mass of 
juvenile tilapias between 15 and 70 dpf, weighed at 5 day intervals increased exponentially. 
Data obtained for the fresh weight of both the control and exposed groups fit exponential 
plots with R2 values of 0.91 and 0.94 respectively. Statistical analyses (ANOVA) of the data 
show that tilapia weight between 15 and 40 dpf in both the control and exposed group show 
no significant differences. Tilapia weight between 45 and 55 dpf again showed no significant 
differences but were significantly higher than fish weighed between 15 and 40 dpf. Fish 
weight at 70 dpf was statically the heaviest.  
 
7.4.3. Total protein yield of juvenile tilapias 
At the end of each 5 day exposure period fish were sacrificed. Total protein was extracted and 
this was quantified using Bradford assays (Fig. 7.3).  
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Figure 7.3. Total protein yield of juvenile tilapias determined at 5 day intervals. Tilapia juveniles 
were exposed to 100 µg/l DES and to the same volume of vehicle control (DMSO). At the end of the 
exposure period fish were sacrificed total protein yield determined. Vertical error bars represent the 
standard error of the mean. Each data bar is the average total protein yield obtained for 10 fish. Small 
letters above the data bars represent statistical comparison among the control group, whereas 
capitalized letters represents statistical comparison among DES exposed fish. 
 
Pair wise analysis (Tukey’s HSD) of control and DES exposed fish at each dpf data point 
showed no statistical variation in total protein yield. Moreover, the total protein yield of 
juveniles between 15 and 55 dpf also showed no statistical differences (ANOVA, P > 0.05).  
However, control fish at 50 dpf showed a protein yield significantly higher (ANOVA, P < 
0.05) than the younger fish. The total protein yield from 70 dpf fish was significantly higher 
(ANOVA, P < 0.05) than all the other sampling points. At this dpf the total amount of 
extracted protein were approximately 5 times higher than the average total protein extracted 
from 50 dpf sampling fish. 
 
7.4.4. Vitellogenin in juvenile tilapias 
Fish that received the DMSO vehicle control showed no significant differences (P > 0.05) in 
VTG protein levels compared to fish that were maintained in water without DMSO and 
therefore represent natural VTG levels in juvenile tilapias (Results not shown). Natural VTG 
levels showed little/small variation (1.3 - 10.7 µg VTG/mg total protein) between 15 dpf 
through 45 dpf.   
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Figure 7.4. VTG protein levels in juvenile tilapias. Tilapia juveniles were exposed to 100 µg/l DES 
and to the same volume of vehicle control (DMSO) for 5 days per exposure. At the end of the 
exposure period fish were sacrificed and VTG protein levels quantified. Vertical error bars represent 
the standard error of the mean for 10 individual fish. Small letters above the data bars represent 
statistical comparison among the control group, whereas capitalized letters represents statistical 
comparison among DES exposed fish. Significant VTG levels of the exposed fish in comparison with 
the control group at a specific dpf is indicated by a (*) above the appropriate data bar. 
 
Statistical analyses (ANOVA) of the VTG protein levels showed that this variation was non-
significant (P > 0.05) among these treatment groups. At 50 dpf there was a 5 fold increase in 
natural VTG protein levels that were significantly (ANOVA, P < 0.001) higher than the other 
dpf analyzed. However, VTG levels obtain from 55 dpf were again reduced and showed no 
significant differences (P > 0.05) compared to VTG levels observed in fish from 30 – 45 dpf 
and 70 dpf (see figure 7.4).  
 
VTG levels in fish exposed to DES were significantly higher compared to their respective 
control groups at all the dpf analyzed, except for 20 dpf. Similar to the results obtained for the 
natural VTG levels, DES induced VTG levels varied between 10.9 and 57.4 µg VTG/mg total 
protein between 20 and 45 dpf. Statistical analysis showed no significant differences between 
VTG levels at the different time points (ANOVA, P > 0.05). Again a 14 fold increase in VTG 
levels in DES exposed fish was observed at 50 dpf that were significantly (P < 0.001) higher 
than VTG levels between 20 and 45 dpf. In contrast with the natural VTG levels a similar 
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stimulatory effect was observed for 55 dpf fish (6 fold induction). DES induced VTG levels 
decreased and returned to levels similar to the pre – 50 dpf levels at 70 dpf. 
 
7.4.5. Fold VTG induction 
The ratio of DES induced VTG over the natural VTG (fold VTG induction) was calculated for 
each time point as explained in the Methods and Materials section (Fig. 7.5). The fold VTG 
induction was determined in order to assess at which stage of tilapia juvenile development 
fish are most sensitive for estrogen dependent VTG induction. The fold VTG induction of fish 
between 20 and 35 dpf revealed no significant differences, except for fish at 25 dpf that were 
significantly higher. However, the fold VTG induction of fish exposed to DES from 40 to 55 
dpf were significantly higher than fish between 20 and 35 dpf. The fold VTG induction of fish 
from 40 to 55 dpf ranged between 5.3 to 8.0 fold, whereas 20, 30 and 35 dpf fish showed 
VTG induction levels of 1.0, 2.2 and 1.1 respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
                            
 
 
 
Figure 7.5. Fold VTG induction of juveniles during development. Tilapia juveniles were exposed 
to either 100 µg/l DES, or to the same volume of vehicle control (DMSO) for 5 days per exposure. At 
the end of the exposure period fish were sacrificed and VTG protein levels quantified. The fold VTG 
induction was calculated as the DES induced VTG protein concentration of 10 individual fish divided 
by the average natural VTG concentration of 10 fish from that respective dpf.  Vertical error bars 
represent the standard error of the mean for 10 individual fish. Letters above the data bars represent 
significant differences in VTG levels among different dpf compared. 
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7.4.6. Albumin levels in juvenile tilapias 
Albumin (Alb) levels were determined in the same whole body homogenates that were used 
for total protein preparations and VTG quantifications and are displayed in figure 7.6. Alb 
concentrations were expressed as mg Alb/mg total protein. No significant differences in the 
Alb levels were observed when DES exposed fish and control fish were compared at all of the 
dpf analyzed (ANOVA, P > 0.05). Alb concentrations significantly increased (P < 0.05) from 
0.4 – 0.9 mg Alb/mg total protein from 15 – 25 dpf in control fish. No significant differences 
(P > 0.05) in Alb levels however, could be observed between 25 and 55 dpf, although Alb 
concentrations varied between 0.65 and 0.95 mg Alb/mg protein in the control fish. At 70 dpf 
Alb levels decreased again and showed no significant differences (P > 0.05) in comparison to 
Alb concentrations of 15 and 20 dpf fish. Similar trends in Alb concentrations can be 
observed for fish exposed to DES compared to the control group. Alb levels steadily increase 
from 15 to 25 dpf reaches a plato and then decrease from around 50 – 55 dpf to 70 dpf in our 
study. 
Figure 7.6. Albumin protein levels in juvenile tilapia. Tilapia juveniles were exposed to 100 µg/l 
DES and to the same volume of vehicle control (DMSO) for 5 days per exposure. At the end of the 
exposure period fish were sacrificed and Alb protein levels were determined. Vertical error bars 
represent the standard error of the mean for 10 individual fish. Small letters above the data bars 
represent statistical comparison among the control group, whereas capitalized letters represents 
statistical comparison among DES exposed fish.  
 
7.4.7. 17β-estradiol (E2) levels in juvenile tilapia 
E2 concentrations were determined in tilapia whole body homogenate preparations that 
ranged between 45 - 70 dpf (Fig. 7.7). E2 levels were 10.5 ± 1.1, 22.4 ± 2.5, 9.7 ± 3.5 and 4.3  
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± 0.4 pg E2/mg total protein at 45, 50, 55 and 70 dpf respectively. No significant differences 
(P > 0.05) in E2 could be detected in fish at 45, 55 and 70 dpf. A significant (P < 0.001) two 
fold increase in E2 was observed at 50 dpf fish compared to the other time points investigated.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.7. 17β-estradiol levels in juvenile fish. Estradiol levels were determined in the 
same control fish that were used for VTG quantification. Vertical error bars represent the 
standard error of the mean for 10 individual fish. Letters above the data bars represent statistical 
comparison of estradiol levels between the different dpf. 
 
 
7.4.8. The effect of DES dose on VTG induction by tilapia juveniles 
In this experiment tilapia juveniles were exposed for a period of 5 and 10 days to a series of 
different DES concentrations (Fig. 7.8). Exposure of the juveniles for 5 days to a series of 
different DES concentrations showed that only fish exposed to 100 µg/l DES were able to 
induce significantly higher (P < 0.001) VTG compared with the DMSO control. A three fold 
induction of VTG was observed after 5 days exposure to 100 µg/l DES. An exposure period 
of 10 days shows that the minimum DES concentrations that could induce significantly higher 
(P < 0.001) VTG compared to the control was 0.2 µg/l. 
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Figure 7.8. DES dose responsive induction of VTG in tilapia juveniles. Tilapia juveniles (35 dpf) 
were exposed for 5 and 10 days to a series of different DES concentrations. At the end of the exposure 
period, WBH protein preparations were prepared, followed by the quantification of VTG. Vertical 
error bars represents the standard error of the mean of 10 individual fish. Significant differences (P < 
0.001) in VTG levels at a certain DES concentration in comparison with the DMSO control is 
indicated by (*). 
 
A 6-,10- and 4-fold induction of VTG protein levels compared to the control was observed 
after exposing fish for 10 days to 0.2, 20 and 100 µg/l DES respectively. Exposure of 
juveniles for 10 days to a series of DES concentrations ranging from 0.02 – 100 µg/l DES 
show that 20 µg/l DES induced the highest levels of VTG protein (46.0 ± 9.5 µg VTG/mg 
protein), whereas 100 µg/l DES induced the lowest levels of VTG protein (17.3 ± 5.0 µg 
VTG/mg protein) compared to the control group (4.2 ± 0.3 µg VTG/mg protein). 
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7.5. Discussion 
The administration of E2 to male tilapia, Oreochromis mossambicus has previously been 
reported to induce VTG synthesis in the liver with a subsequent increase in plasma VTG 
(Takemura and Kim, 2001). The aim of this study was to investigate VTG induction in 
juvenile tilapias as a potential in vivo screening assay for environmental estrogens. Tilapia is 
indigenous to Southern Africa (Matthews and Brandt, 2004). This species is also indigenous 
to other parts of Africa as well as the Middle East and is used for mainly aquaculture 
purposes. Tilapias are hardy fishes, with a wide environmental tolerance and they reach 
sexual maturity at a relatively young age, which allows for rapid population growth ideal for 
aquaculture (Trewavas, 1983; Matthews and Brandt, 2004).  
 
Exposure of juveniles to DES had no significant effect on somatic growth (wet weight, length 
and total protein yield) (Fig. 7.1, 7.2, 7.3) between 15 and 70 dpf. Although we have used a 
static exposure system in our study, previous studies using flow through systems have also 
found that DES at these relevant concentrations have no significant effect on somatic growth 
(Lye, 1998; Panter et al., 2002). However, longer exposure periods to xenoestrogens may 
influence somatic growth. For instance a study conducted by Länge et al. (2001) on fathead 
minnows showed that the potent synthetic estrogen 17α-ethynylestradiol significantly 
inhibited somatic growth over an exposure period of 305 days at 4 ng/l. In our juvenile tilapia 
study, the longest period that fish were exposed to DES was 10 days. Therefore, it is unlikely 
that DES exposure will influence somatic growth over such a short exposure period. 
 
In order to validate a biomarker for endocrine disruption using whole animals, it is necessary 
to know the endogenous level of the biomarker during the specific developmental stage being 
characterized. Natural endogenous VTG levels of fish were determined every 5 days from 15 
- 70 dpf. VTG concentrations were statistically similar (P > 0.05) between 15 and 45 dpf and 
varied between 1.3 - 10.7 µg VTG/mg total protein (1.3 - 10.7 µg/ml VTG) (Fig. 7.4). Inter 
study comparisons of VTG levels are always difficult when VTG protein concentrations are 
expressed as the amount of protein/ml whole body homogenate as the ratio of fish wet weight 
to protein extraction buffer differs between studies. The natural baseline VTG levels for 
juvenile tilapia fish in our study correspond to values reported in previous studies. For 
example, Panter et al. (2002) reported plasma VTG concentrations around 1 µg/ml, in fathead 
minnow (between 45 and 100 days post hatch), Brion et al. (2004) reported 0.1 µg/ml at 21 
dpf and 1 µg/ml VTG at 42 dpf in zebrafish. However, the five fold increase in natural VTG 
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levels at 50 dpf has not yet been reported before. These elevated VTG levels, however, 
returned to the baseline VTG concentration at 70 dpf. Similar to the peak in VTG levels found 
at 50 dpf in control fish, this peak was also observed in juveniles exposed to 100 µg/l DES at 
50 dpf (Fig. 7.4).  
 
Further investigations showed that this peak in VTG at 50 dpf may have been a result of 
natural endogenous E2 levels. Tilapia juvenile whole body homogenates from 45, 50, 55 and 
70 dpf were used to determine endogenous E2 concentrations. The increment of VTG protein 
levels at 50 dpf coincide with a two fold increase of endogenous 17β-estradiol at this specific 
dpf. In order to rule out the possibility that there may have been a discrepancy with the 
protein extraction or determination assay at 50 dpf (both VTG and E2 concentrations are 
expressed per mg total protein), albumin levels were determined in WBH (Fig. 7.6). In figure 
7.6 it is clear that there was no significant difference (P > 0.05) in albumin levels between 45 
– 55 dpf. Moreover, the total protein yield of 50 dpf juveniles was significantly higher than 
that of 45 and 55 dpf. VTG and E2 data, although significantly higher, may thus appear even 
lower than their actual levels because protein concentrations are also elevated at 50 dpf. The 
increase in both plasma E2 and VTG concentrations at 50 dpf may mark the onset of female 
sex differentiation. In support hereof, histological gonadal differentiation in juvenile tilapia 
has been reported to occur around 55 dpf (Esterhuyse et al., 2008). Moreover, the latter study 
reports an increase in aromatase gene expression around 25 dpf thus illustrating the possible 
onset of steroidogenesis preceding vitellogenesis observed at 50 dpf in the present study. The 
timing of sexual differentiation differs widely among species. In the Japanese medaka, sex 
differentiation of the female occurs before hatching while, in the male, differentiation of the 
testis takes place around 13 days post hatch (Yamamoto, 1953, 1975). In carp sexual 
differentiation in the females normally occurs between 50 and 60 dph while the male gonad 
remained undifferentiated until 90 dph (Komen et al., 1995). In zebrafish sex differentiation 
began between 21 and 28 dph and was completed at approximately 40 dph (Takahashi, 1977; 
Uchida et al., 2004). This phenomenon however needs to be further investigated in tilapias.  
 
Although the peak in endogenous VTG expression was observed at 50 dpf, a significant VTG 
induction upon estrogen exposure was observed at 25 dpf (Fig. 7.4). Legler et al. (2000) 
demonstrated in transgenic zebrafish that the estrogen receptor subtypes α and β mRNA is 
detectable in all developmental stages as early as 1 dpf. This study showed that zebrafish ER 
α mRNA expression reached a peak at 35 dpf, whereas ER β mRNA were the highest from 28 
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– 35 dpf during development. Esterhuyse et al. (2008) showed that ER gene expression is 
detectable from 20 dpf in tilapia juveniles. Expression of the ER subtypes is a physiological 
prerequisite for VTG expression. In fathead minnow VTG protein synthesis was shown to 
occur in fish exposed to E2 from 24 h post fertilization to 30 d post hatch in a dose-dependent 
manner (Tyler et al., 1999). One of the major objectives of the present study was to identify 
the developmental stage of juvenile tilapias, between 15 and 70 dpf, where fish can be used as 
an in vivo screen for estrogens. The ability of juveniles to produce the maximum VTG 
concentrations in comparison with control fish was used as a measure to identify this 
developmental stage. Fish were exposed to the maximum sub-lethal level of DES (OECD, 
2004) for the minimum time period and the fold VTG induction compared to natural VTG 
levels were calculated (Fig. 7.5). DES exposure of juveniles for a 5 – 10 day period ending 
between 40 and 55 dpf show the highest VTG induction compared to non-exposed controls (5 
– 8 fold inductions). Although younger fish (less than 40 dpf) revealed some VTG induction 
potential, the DES induction response was much lower (1 - 2 fold) compared to the controls. 
A possible explanation may be that endogenous VTG during this stage is relatively high on 
account of various physiological needs (Hiramatsu et al., 2005)   
 
Juvenile tilapias (35 dpf) were exposed to a series of DES concentrations in order to 
determine what the lowest concentration of DES is that can induce significant VTG levels 
(Fig. 7.8). Our results support previous findings that the concentration and time of estrogen 
exposure to induce VTG are inversely correlated. For example, the lower the concentration of 
estrogen the longer the exposure period required to significantly induce VTG (OECD, 2004). 
Exposure of juveniles for five days revealed that the lowest level of DES that can induce 
significantly higher levels of VTG compared to the control is 100 µg/l, whereas 200 ng/l DES 
was the minimum concentration of DES that could induce significantly higher VTG levels 
after 10 days of exposure. It was observed from figure 7.8 that 10 day exposure of juveniles to 
100 ug/l DES suppressed VTG induction compared to 20 µg/l DES. In previous studies the 
minimum concentration of E2 that could induce significant VTG levels in juveniles or adults 
(rainbow trout (Oncorhynchus mykiss) ranged between 10 ng/l (Thorpe et al., 2001) to 
between 27 and 100 ng/l in other cyprinid fish (fathead minnow; Kramer et al., 1998; Panter 
et al., 1998; roach, Rutilus rutilus; Routledge et al., 1998). In cyprinodont fish (sheepshead 
minnow, Cyprinodon variegates), the least effective concentration for plasma vitellogenin 
induction was 200 ng/l (Folmar et al., 2000).  
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In summary this study shows that exposure of juvenile tilapias to DES between 15 and 70 dpf 
does not influence somatic growth. Tilapia juveniles at this very early stage of development 
have the ability to express significant amounts of VTG when exposed to DES for a period of 
5 days. Analysis of the natural VTG levels of a mixed sex population of juveniles between 15 
and 70 dpf shows a peak in VTG expression at 50 dpf. This peak in VTG expression 
coincides with a peak in endogenous E2 levels and may mark the start of sexual 
differentiation and puberty. In order to use tilapia juveniles as an in vivo screen for 
estrogenicity it is important to identify the developmental stage where animals are most 
sensitive for estrogen and VTG induction. We showed that tilapia juveniles used for in vivo 
estrogenicity assays should be between 35 – 45 dpf for maximum sensitivity. This is a very 
short window period of 10 days where juvenile tilapias shows the maximum ability to induce 
VTG upon E2 exposure. Dose response experiments revealed that the lowest concentration of 
DES that induces VTG is 200 ng/l after an exposure period of 10 days. In this study we 
showed that juvenile tilapias can be successfully employed as a screen for estrogenicity. We 
identified the age at which juveniles are most sensitive for estrogen exposure to induce VTG. 
We also established the baseline VTG levels of a mixed sex population of juveniles. In future 
studies this in vivo screen for estrogenicity should be validated for other identified synthetic 
estrogens, anti-estrogens, as well as environmental water extracts. 
 
We propose further studies on the development of Oreochromis mossambicus as indigenous 
Africa indicator species for environmental estrogens. 
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Chapter 8 
Assessment of water collected from the Eerste River for estrogenicity 
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8.1. Abstract 
To evaluate the estrogenic activity of environmental water samples a panel of in vitro and in 
vivo bio-assays, which are based on different action mechanisms, are required. In the current 
study a test battery containing four assays were used to analyse water from the Eerste River, 
South Africa for estrogenicity. Three sites were used for analysis, namely Jonkershoek 
(control site situated in the mountains at the origin of the Eerste River), sewage effluent from 
Stellenbosch sewage treatment works and Spier (sampling site on the Eerste River 
downstream from Stellenbosch). Estrogenicity was determined using the estrone ELISA, 
estrogen induced proliferation of MCF-7 cells (E-screen), estrogen induced suppression of 
ERα in MCF-7 cells (ERα assay), and by monitoring estrogen induced vitellogenin synthesis 
in juvenile Oreochromis mossambicus (VTG assay). Low levels of estrone were detected in 
samples collected from Jonkershoek. Water from this site shows no estrogenic activity when 
the E-screen, the ERα assay, nor the VTG assay was used for monitoring. The estrone levels 
in the sewage effluent extracts, as well as Spier extracts, ranged between 14.76 and 19.42 
ng/l. The assays using ERα induction by the MCF-7 cell line, MCF-7 proliferation and in vivo 
VTG synthesis by juvenile tilapia showed that these samples are estrogenic. Results obtained 
for the assays in the battery are comparable. 
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8.2. Introduction 
The occurrence of estrogenic compounds in the environment is a well studied phenomenon 
(Gellert 1978; Hammond et al., 1979; Kupfer and Bulger, 1987; Krishnan et al., 1993; White 
et al., 1994; Newbold 1995; Katzenellenbogen 1995; Nimrod and Benson, 1996). Most 
environmental estrogens are synthetic compounds produced as a result of industrial, domestic 
and agricultural activities (Kuiper et al., 1998). However, not all estrogenic compounds are 
man-made. Some environmental estrogens originate from natural sources (Kuiper et al., 1998; 
Giesy et al., 2002). Examples of these are the phyto- and the myco-estrogens. Several studies, 
including the previous chapters of this thesis, have focused on the development and 
implementation of assays to monitor environmental estrogens.  Pollutants can act at several 
points on the endocrine/reproductive system to give estrogenic or anti-estrogenic effects 
(Reviewed by Baker, 2001). Some pollutants mediate their action by directly binding to the 
estrogen receptor, while other pollutants act by for instance modulating the estrogen 
biosynthesis pathways resulting in either increased or decreased circulatory estrogen levels 
(Sharpe and Irvine, 2004). Moreover, several pollutants demonstrate effects that are species, 
tissue- and cell-specific, as well as being influenced by metabolism (WHO/IPCS, 2002). Due 
to the varied biological actions of estrogenic pollutants, current strategies for monitoring 
estrogens favour the use of a battery of tests, representative of several potential points on the 
estrogenic response pathways, for monitoring (Reel et al., 1996; Shelby et al., 1996; Baker et 
al., 1999a,b, 2000). 
 
South Africa, like most countries in the world, faces ecological challenges due to EDCs found 
in the aquatic environment. The aim of the current study is to implement a newly developed 
bio-monitoring battery of tests as a first tier screen for estrogenicity of a river. This battery 
consists of three in vitro and one in vivo screen for estrogenicity. Water samples were firstly 
analysed for the specific female hormone, estrone. Total estrogenicity of the water samples 
were determined using two more in vitro screens, namely a modified MCF-7 proliferation 
assay (E-Screen) and a MCF-7 ERα determination ELISA. Vitellogenin induction in juvenile 
tilapias was used as a short term exposure in vivo assay. The river that was selected for this 
study is the Eerste River, Stellenbosch, South Africa. Several studies have investigated this 
river system. A study conducted by Reinecke et al., (2003) found significant concentrations of 
Mn, Cu, Pb, Cd and Zn in both the water (ranging between 0.006 – 0.222 mg/l) and sediment 
(ranging between 0.43 – 184.7 mg/kg). The same study reported total coliforms 
concentrations of 1.2 x 105 / 100ml as well as faecal coliforms concentrations of 1.5 x 104 / 
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100 ml from water that passed through Stellenbosch town centre. In another study, all the 
water samples collected from the Eerste River showed inflammatory potential using 
interleukin 6 syntheses by whole blood cultures as biomarker (Pool et al., 2000). Figure 8.1 is 
a map of the river indicating the sites that were used for this study.  Sites were selected to 
include water not affected by human activity (Jonkershoek) as well as samples from sites 
severely affected by agricultural, industrial and domestic pollution. 
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8.3. Methods and Materials 
8.3.1. Study Area 
The origin of the Eerste River is in the Jonkershoek Valley of the Western Cape in South 
Africa. It flows through the Jonkershoek Forest Reserve, the Assegaaibosch Nature Reserve 
and several vineyards before reaching the town of Stellenbosch (33˚56’10”S; 18˚51’34”E). 
For the rest of its course the river is bordered by agricultural land, industrial areas, formal and 
informal housing before reaching the sea on the False Bay coast (Fig. 8.1.). Eerste River water 
samples were collected at Jonkershoek, Stellenbosch sewage treatment works (Stellenbosch 
STW) and near Spier wine estate. 
Figure 8.1. Map of the Eerste River in Stellenbosch, South Africa. Water samples were 
collected at Jonkershoek, Stellenbosch STW and Spier. Water samples were collected in 
January during high summer as well as April after the first winter rains. Water samples were 
collected in 2007 and 2008 for analysis. 
 
8.3.2. Water collections  
Water samples were collected in clean glass bottles. The bottles were cleaned by washing 
with soap, followed by rinsing with tap water. The bottles were then rinsed with HPLC grade 
water and finally it was rinsed with HPLC grade ethanol (Merck, Germany). The bottles were 
then allowed to dry up-side down in a dry rack. Samples were collected in January, at the 
peak of the dry summer season and at the beginning of the rain season in April. Water 
samples were taken to the laboratory and were processed immediately.  
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8.3.3. Water hydrophobic content extractions  
Extracts were prepared as previously described by Swart and Pool, (2007).  The dried water 
extracts were reconstituted in dimethyl sulfoxide (DMSO) to give a final volume 1/1000 
times that of the original sample volume.  
 
8.3.4. Estrone ELISA 
The estrone levels of the water extracts were quantified as previously described by Swart et 
al., (2007). 
 
8.3.5. MCF-7 assays 
The MCF-7 total cellular protein, total cellular LDH and ERα levels were determined as 
described in chapters 4 and 5 of this thesis.  
  
8.3.6. Juvenile tilapia in vivo bio-assay for estrogenicity 
The induction of vitellogenin by juvenile tilapias was used as an in vivo bio-assay for 
environmental estrogenicity and toxicity.  The tilapias were exposed to estrogen controls or 
samples as described previously (Chapter 7). At the end of the exposure period, juveniles 
were sacrificed and protein was extracted from whole body homogenates. In short, fish were 
weighed, placed in protein extraction buffer (Saline containing 0.01 % (w/v) 
Phenylmethylsulphonylfluoride [PMSF]) pre-cooled to 4 ˚C, at 10 ml buffer per gram body 
mass). Samples were then sonicated (Omni-Ruptor 400; Omni International INC.) at 40 % 
power. Samples were sonicated for 15 seconds at 5 second bursts followed by 1 min 
incubation on ice. Cells rests were removed by centrifugation at 12000 x g for 10 minutes at 4 
˚C. Cell pellets were discarded and the supernatants were aliquoted and stored at -80 ˚C until 
further use. Protein was measured according to the method of Bradford (1976) using bovine 
serum albumine (BSA) as a standard protein (Sigma).  
 
8.3.7. Tilapia VTG ELISA 
The VTG concentrations of the whole body homogenates were determined using a 
competition ELISA. An ELISA system similar to the one described in chapter 6 was used to 
quantify VTG in juvenile fish. In this ELISA, an in-house VTG antibody was used to detect 
VTG. Results and specifications regarding this ELISA system have been submitted elsewhere 
for publication (Journal of Immuno Assay and Immunochemistry). Nunc-Immuno Maxisorp 
plates (Nalge Nunc, Denmark) were used for all ELISA assays. Plates were coated overnight 
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at 4°C with 50 µl per well of 1/2000 diluted anti-VTG antiserum in Saline. At the end of the 
incubation period wells were decanted and washed four times with Saline. Following the 
wash procedure, remaining adsorption sites were blocked by dispensing 0.2 ml of block 
solution (2 % v/v human serum albumin [HSA] in Saline) per well. The plate was then 
incubated for one hour at room temperature. The plate was washed as before where after 
samples or purified VTG standards (50 µl) as well as 50 µl biotinylated-VTG were added to 
each well. Plates were then incubated for three hours at room temperature. The plate was 
washed using the same procedure as earlier described. Avidin horse radish peroxidase (AV–
HRP) was diluted 1/2000 with Saline containing 1 % (w/v) HSA and dispensed at 50 µl per 
well. Plates were incubated for one hour at room temperature where after it was decanted and 
washed eight times with Saline. BM Blue POD soluble substrate were heated to 37°C and 
dispensed at 50 µl per well. Plates were incubated at room temperature for twenty minutes 
followed by addition of 50 µl per well of stop solution (0.5 M H2SO4). The optical density 
was lastly determined at 450 nm. A standard curve was drawn from the VTG standards. The 
VTG concentration of juvenile tilapia homogenates were calculated using the standard curve. 
 
8.3.8. Statistical analysis 
The results were analysed by using single factor ANOVAs and pairwise multiple comparison 
procedure (Student-Newman-Keuls Method). A Pairwise multiple comparison procedure 
(Tukey’s HSD) was used to indicate significant different groups (P < 0.001).  
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8.4. Results 
In the present study, water from three sites of the Eerste River namely: Jonkershoek, 
Stellenbosch STW and Spier were analysed for estrogenicity using a battery of biological 
assays as described in the introduction section. Water samples were collected in 2006 and 
2007 during January (Jan: high summer) and April (Apr: after first winter rains). Table 8.1 
displays the total rainfall and average temperature data obtained from the South African 
weather office (www.weathersa.co.za) for the area at the sample collection times. No rain was 
reported for both Jan 2006 and 2007 whereas 41 mm and 88 mm of rain were reported for Apr 
2006 and 2007 respectively. The average maximum temperature was 32˚C and the average 
minimum temperature 18˚C for Jan, during both 2006 and 2007. The average maximum 
temperature was 26˚C and the average minimum temperature was 13˚C for Apr, during both 
2006 and 2007. 
 
Table. 8.1. Rainfall and temperature recorded. Total rainfall and temperature recorded for 
Boland area (Stellenbosch) during Jan and Apr for both 2006 and 2007 
2006 2007 
 
Jan Apr Jan Apr 
Total Rainfall (mm) 0 41 0 88 
Average Max temperature (˚C) 32.08 26.18 32.88 26.04 
Average Min temperature (˚C) 18.09 13.25 18.22 12.9 
 
8.4.1. Jonkershoek analysed for estrogenicity 
Table 8.2 displays the results obtained for assessing water samples collected from 
Jonkershoek for estrogenicity using the battery of assays. The concentration of estrone in the 
control site was very low, near the detection limit of the assay and was statistically similar (P 
> 0.05) to the assay negative control. Similar to the results obtained for estrone, none of the 
samples collected at Jonkershoek were estrogenic when analysed with the MCF-7 total LDH 
assay or the MCF-7 ERα assay because test assay values obtained with the latter two assay 
were statistically similar (P > 0.05) to their respective assay negative controls. Exposure of 
juvenile tilapias to water extracts collected during Apr 2006 and Apr 2007 resulted in 
statistically similar (P > 0.05) VTG concentrations compared to the control fish. However, 
exposure of juveniles to water extracts collected during Jan 2006 and Jan 2007 showed 
significantly (P < 0.001) higher VTG levels in comparison with the assay negative control. 
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Table 8.2. Jonkershoek analysed for estrogenicity using the battery of assays. Water samples were collected from Jonkershoek in Jan (high 
summer) as well as Apr (after first rains) during 2006 and 2007. Water samples were analysed for estrone, estrogen dependent proliferation of 
MCF-7 cells using LDH as biomarker, estrogen dependent reduction of ERα expression by MCF-7 cells as well as estrogen dependent induction 
of VTG in Tilapia juveniles. Samples significantly higher (P < 0.001) than the –ve control are indicated with **.  
Jonkershoek 
 
 2006 2007 
Assay -ve Jan Apr Jan Apr 
Estrone (n = 4) 
(ng/l) 1.823 ± 0.320 1.430. ± 0.492 2.234 ± 0.433 1.659 ± 0.398 1.809 ± 0.457 
MCF-7 total LDH (n = 8) 
(% of –ve) 100.000 ± 2.879 101.021 ± 6.065 96.086 ± 5.892 106.109 ± 7.3123 106.049 ± 8.275 
MCF-7 Erα  (n = 8) 
(OD/mg protein, % of –ve) 100.000 ± 7.385 98.636 ± 14.265 97.39 ± 6.204 94.814 ± 12.604 91.727 ± 11.535 
Tilapia VTG (n = 8) 
(µg/mg total protein) 6.786 ± 1.447 11.506 ± 1.649 ** 9.811 ± 1.825 13.066 ± 1.195 ** 9.114 ± 1.092 
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8.4.2. Stellenbosch STWs analysed for estrogenicity 
Estrone concentrations were significantly higher (P < 0.001) compared to the assay negative 
control ranging between 14.756 ± 0.519 ng/l and 19.421 ± 0.066 ng/l for water samples 
collected during Jan and Apr of 2006 and 2007 at Stellenbosch STWs (Table 8.3). The estrone 
concentration was significantly higher (P < 0.001) in water samples collected during Jan 2006 
compared to Apr 2006. Water samples collected in Jan 2007 contained significantly higher (P 
< 0.001) estrone concentrations compared to Apr 2007. 
 
Stellenbosch STWs extract collected Apr 2006 was the only sample that tested positive with 
the MCF-7 proliferation assay. MCF-7 cells exposed to water extracts from this sampling date 
at Stellenbosch STWs resulted in a 1.3 fold increase (P < 0.001) in total LDH compared to the 
assay negative control. No significant differences (P > 0.05) in the total LDH levels could be 
detected comparing MCF-7 cells exposed to water extracts collected during Jan 2006 and Jan 
2007. The total LDH levels of MCF-7 cells exposed to water extracts collected in Apr 2007 
were significantly (P < 0.001) lower compared to that of the assay control. MCF-7 cells 
exposed to water extracts from Apr 2006 resulted in significantly higher (P < 0.001) total 
LDH levels compared to Jan 2006. 
 
Stellenbosch STW water extract collected in Jan 2006 was the only sample that resulted in a 
statistically similar (P > 0.05) ERα expression value compared to the assay negative control. 
STW water extracts collected in Apr 2006, Jan 2007 and Apr 2007 all resulted in significantly 
lower (P < 0.001) ERα expression values compared to the assay negative control. ERα 
expression values were significantly lower (P < 0.001) for MCF-7 cells exposed to water 
extracts collected during Apr 2006 compared to Jan 2006, whereas no significant differences 
(P > 0.05) could be detected comparing ERα expression values of MCF-7 cells exposed to 
water extracts collected during Jan and Apr 2007.  
 
Tilapia juveniles exposed to Stellenbosch STWs water extracts collected in Jan 2006 
synthesized statistically similar (P > 0.05) VTG concentrations compared to control fish. 
Exposure of tilapias to Stellenbosch STW water extracts from all the other sampling dates 
resulted in significantly higher (P < 0.001) VTG concentrations. Juveniles exposed to water 
extracts collected during Apr 2007 resulted in significantly higher (P < 0.001) VTG 
concentrations compared to Jan 2006.  
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Table 8.3. Stellenbosch STWs analysed for estrogenicity using the battery of assays. Water samples were collected from Jonkershoek in Jan 
(high summer) as well as Apr (after first rains) during 2006 and 2007. Water samples were analysed for estrone, estrogen dependent proliferation 
of MCF-7 cells using LDH as biomarker, estrogen dependent reduction of ERα expression by MCF-7 cells as well as estrogen dependent 
induction of VTG in Tilapia juveniles. Samples significantly higher (P < 0.001) than the –ve control are indicated with **. Assay values printed 
in bold indicates significant higher values (P < 0.001) of a specific assay compared between the Jan and Apr samples analysed for a specific year. 
Stellenbosch STW 
 2006 2007 
Assay -ve Jan Apr Jan Apr 
Estrone 
(ng/l) 1.823 ± 0.320 17.814 ± 0.215 ** 16.513 ± 0.431 ** 19.421 ± 0.066 ** 14.756 ± 0.519 ** 
MCF-7 total LDH (n = 8) 
(% of –ve) 100.000 ± 2.879 108.794 ± 2.439 130.163 ± 1.800 ** 103.016 ± 6.399 69.875 ± 5.984 ** 
MCF-7 ERα (n = 8) 
(OD/mg protein, % of –ve) 100.000 ± 7.385 87.447 ± 6.630 61.946 ± 3.756 ** 33.300 ± 1.576 ** 28.265 ± 1.283 ** 
Tilapia VTG (n = 8) 
(µg/mg total protein) 6.786 ± 1.447 7.752 ± 1.753 12.894 ± 1.720 ** 17.167 ± 2.108 ** 10.636 ± 1.299 ** 
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8.4.3. Spier analysed for estrogenicity 
Table 8.4 displays the results obtained for assessing water samples collected at Spier for 
estrogenicity using the battery of assays. The results obtained among the test assays were 
similar for all the assays when water samples collected at Spier was analysed. All the test 
assays showed significant different (P < 0.001) values for each of the sampling dates being 
analysed compared to their respective assay negative controls. Estrone concentrations ranged 
between 10.316 ± 0.570 ng/l and 22.989 ± 0.078 ng/l for water samples collected in Jan and 
April during both 2006 and 2007. Water samples collected in Jan 2006 contained significant 
higher (P < 0.001) estrone concentrations compared to April 2006, whereas water samples 
collected in April 2007 contained significant higher estrone concentrations compared to Jan 
2007.  
 
MCF-7 cells exposed to water extracts from Spier resulted in an significant increase in total 
LDH ranging between 15.196 % and 29.851 % compared to the assay negative control for 
water samples collected in both 2006 and 2007. No significant differences could be observed 
(P > 0.05) comparing total LDH levels of MCF-7 cells exposed to water extracts of Jan and 
Apr 2006. The latter is also true comparing total LDH levels of MCF-7 cells exposed to water 
extracts collected during Jan and Apr 2007.  
 
Exposure of MCF-7 cells to water extracts from Spier also resulted in a significant (P < 
0.001) decrease in ERα expression levels ranging between 51.504 ± 3.078 % and 11.564 ± 
4.721 % compared to the assay negative control. MCF-7 cells exposed to water extracts from 
Spier, April 2006 resulted in significantly (P < 0.001) lower ERα expression levels compared 
to Jan 2006. No significant differences (P > 0.05) in ERα expression levels could be observed 
for the Jan 2007 and Apr 2007 water extracts. 
 
Tilapia juveniles exposed to water extracts from Spier collected during Jan and Apr 2006 and 
2007 synthesized significantly higher (P < 0.001) VTG compared to control fish. VTG 
concentrations ranged between 12.988 ± 2.014 and 13.958 ± 1.563 µg/mg. Fish exposed to 
water extracts collected during Apr 2006 induced significantly (P < 0.001) higher VTG 
concentrations compared to water collected during Jan 2006. No significant differences in 
VTG concentrations were observed for tilapia juveniles exposed to water extracts collected 
during Jan and Apr 2007. 
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Table 8.4. Spier analysed for estrogenicity using the battery of assays. Water samples were collected from Jonkershoek in Jan (high summer) as 
well as Apr (after first rains) during 2006 and 2007. Water samples were analysed for estrone, estrogen dependent proliferation of MCF-7 cells 
using LDH as biomarker, estrogen dependent reduction of ERα expression by MCF-7 cells as well as estrogen dependent induction of VTG in 
Tilapia juveniles. Samples significantly higher (P < 0.001) than the –ve control are indicated with **. Assay values printed in bold indicates 
significant higher values (P < 0.001) of a specific assay compared between the Jan and Apr samples analysed for a specific year. 
Spier 
 2006 2007 
Assay -ve Jan Apr Jan Apr 
Estrone 
(ng/l) 1.823 ± 0.320 16.050 ± 0.280 ** 10.316 ± 0.570 ** 12.077 ± 0.065 ** 22.989 ± 0.078 ** 
MCF-7 total LDH 
(% of –ve) 100.000 ± 2.879 115.196 ± 8.377 ** 115.840 ± 3.214 ** 122.970 ± 4.366 ** 129.851 ± 5.418 ** 
MCF-7 Erα 
(OD/mg protein, % of –ve) 100.000 ± 7.385 51.504 ± 3.078 ** 11.564 ± 4.721 ** 28.394 ± 3.217 ** 35.701 ± 5.844 ** 
Tilapia VTG 
(µg/mg total protein) 6.786 ± 1.447 10.119 ± 2.014 ** 12.988 ± 1.894 ** 13.076 ± 1.884 ** 13.958 ± 1.563 ** 
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8.5. Discussion 
Earlier studies have indicated that seasonal variation in river water quality and EDCs 
concentration do occur (Ouyang et al., 2006; Eun-Joung et al., 2007). Climatic data from the 
Stellenbosch area for 2006 and 2007 (Table 8.1) show that there are major difference in the 
total rainfall and average temperature between Jan and Apr. The run rates as well as quality of 
the river water differ between Jan and Apr (Ngwenya F., 2006). During Jan the river contains 
very little or no water and high concentrations of sewage and industrial effluents. During the 
winter the concentration of sewage and industrial effluents are highly diluted because of the 
high rainfall. Due to this, water was collected during high summer (Jan) and after the first 
winter rains (Apr) to analyse for estrogenicity using a battery of assays. The Eerste River was 
chosen to implement this battery of assays, because several previous studies have investigated 
contaminants in this river (Pool et al., 2000; Reinecke et al., 2003). The Eerste River also 
provides an ideal study area because of various degrees of domestic, agricultural and 
industrial activities along the river. Water samples were firstly analysed for the specific 
female hormone, estrone. Total estrogenicity of the water samples were determined using two 
more in vitro screens namely a modified MCF-7 proliferation assay (E-Screen) and a MCF-7 
ERα protein determination ELISA. Vitellogenin induction in juvenile tilapias was used as a 
short term exposure in vivo assay. 
 
Analysis of the water samples collected at Jonkershoek was negative for the estrone ELISA, 
MCF-7 LDH assay as well as the MCF-7 ERα assay. Each of the above mentioned assays 
produced assay results statistically similar (P > 0.05) compared to the respective assay 
negative control. The VTG ELISA suggests that samples collected from Jonkershoek Jan 
2006 and Jan 2007 was estrogenic. However, none of the other test assay could confirm this 
result. Moreover, significant VTG induction was only observed for fish exposed to water 
samples collected during Jan which is high summer when water flow is restricted and fungal 
growth was observed in the water. No human, agricultural or industrial activity occurs at 
Jonkershoek. Therefore, a possible explanation for the induction of VTG in juvenile tilapias 
exposed to water samples collected during Jan 2006 and 2007 may be that the water was 
contaminated with estrogenic mycotoxins produced by fungi or even phytoestrogens.  
Estrogenic mycotoxins produced by Fusarium species have previously been detected in  river 
water and sediment samples (Wu et al., 1990). It is also well known from previous studies 
that phytoestrogens do have the ability to disrupt endocrine disruption (Kuiper et al., 1998; 
Giesy et al., 2002). However, the sensitivity of juvenile tilapias towards phytoestrogens 
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exposure and estrogenic mycotoxins in comparison with other in vitro assays for estrogenicity 
for instance the E-Screen assay has not been investigated before.  
 
Analysis of the sewage treatment works’ effluent entering the Eerste River for estrogenicity 
resulted in very consistent data using the battery of assays. All the assays except for the 
estrone ELISA suggested that water collected during Jan 2006 are not estrogenic. In contrast, 
all the assays suggested that water samples collected from Stellenbosch STWs during April 
2006 are estrogenic. Similar, all the assays except for the MCF-7 LDH assay also suggests 
that water samples collected during Jan 2007 and Apr 2007 are estrogenic. The estrone 
concentrations detected in water samples collected from Stellenbosch STWs  are similar to the 
lower range of estrone concentrations detected in sewage effluent from Britain (Desbrow et 
al., 1998), Italy (Baronti et al., 2000), Germany (Ternes et al., 1999a), Canada and 
Netherlands (Belfroid et al., 1999). No apparent trend could be detected, comparing the 
estrogenicity of water samples collected during Jan and April for 2006 and 2007 respectively.  
 
The Spier collection site is on the Eerste River, downstream from Stellenbosch and water at 
this point in the Eerste River contains pollutants from formal and informal housing 
development, agricultural and industrial activities (Fig 8.1.). All of the assays used to assess 
the estrogenicity of the water samples collected at all four sampling dates during 2006 and 
2007 suggest that the water was estrogenic. Water samples analysed with the estrone ELISA, 
MCF-7 LDH assay, MCF-7 ERα assay and the juvenile tilapia VTG assay resulted in 
significantly different (P < 0.001) assay results compared to the respective assay negative 
control, suggesting that the samples are estrogenic. The estrone concentrations detected in 
water samples collected from Spier are similar to the estrone concentrations detected in river 
water samples from previous studies. A study conducted by Xiao et al., (2001) on the river 
Thames in England reported estrone levels ranging from 0.2 – 17 ng/l. A study on two lakes 
and three streams in Denmark that receive no or little sewage effluent reported estrone levels 
ranging from 0.2 – 3 ng/l (Christiansen and Plesner, 2001). Similar to the analysis of 
Stellenbosch STWs, no apparent trend could be noticed when comparing the estrogenicity of 
samples collected during Jan and April for 2006 and 2007 respectively. 
 
It is evident from this study that a single test assay is insufficient to prove if a water sample is 
estrogenic or not. The use of a combination of assays dependent on different modes of action 
are required to confidently analyse water samples as a first tier screen for estrogenicity. It is 
 
 
 
 
                                                                                                                          Chapter 8 
 - 185 - 
evident from this study that the different assays that were used can be successfully employed 
as a battery of assays to screen environmental water samples for estrogenicity. Results 
obtained from this battery of assays should be interpreted as a first tier screen for estrogenicity 
and not monitoring of the Eerste River for estrogenicity. Samples that tested positive should 
be further investigated using second and third tier screens with routine sampling in order to 
monitor the Eerste River for estrogenicity.   
 
To our knowledge this is the first study that has evaluated the estrogenicity of a river in South 
Africa and more specifically Stellenbosch, using a battery of assays consisting of both in vitro 
and in vivo screens. Inefficient sewage treatment works, industrial as well as agricultural 
activities are polluting our natural environment. The development and implementation of both 
in vitro and in vivo screens for estrogenicity, which are applicable to the Southern African 
context, i.e. rapid assays that are affordable and uses indigenous species is of cardinal 
importance to monitor our environment. 
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Chapter 9 
9.1. General Conclusion 
The hypothesis regarding the concerns that chemicals found in the environment may display 
estrogenic effects as well as the ability to disrupt normal endocrine function, is not new at all 
(Allen and Doisy, 1923. Burlington and Lindeman, 1950). Various reports have linked 
adverse health effects in humans and wildlife to estrogenic endocrine disrupting chemicals (e-
EDCs) (Kavlock et al., 1996). One of the major concerns is that these e-EDCs have been 
found in wastewater, surface waters, sediments, groundwater and even drinking water 
(Benfenati et al., 2003; Petrović et al., 2003; Snyder et al., 2003; Peterović et al., 2004). 
Consequently, organizations such as the US Environmental Protection Agency (EPA) and 
Organization for Economic Cooperation and Development (OECD) have taken great interest 
in the development of test assays as well as guidelines for monitoring EDCs. As a result, a 
large number of in vitro and in vivo tests have been developed for the screening of 
environmental EDCs (ECETOC, 1996; Holmes et al., 1998; Kavock et al., 1996). The 
continued development and inter laboratory evaluation of assays to detect and routinely 
monitor e-EDC are some of the major goals of the EPA and OECD. 
 
For this reason, the aim of our study was the development and validation of a battery of 
screens encompassing both in vitro and in vivo assays to monitor e-EDCs. The secondary aim 
of this study was to implement this battery of assays to evaluate the Eerste River, South 
Africa for environmental e-EDCs. In order to achieve the aims of this study, several 
objectives had to be reached. The first objective of this study was the validation of 
commercially available ELISA kits to quantify natural estrogenic hormones in complex 
environmental mixtures. These ELISA kits were originally designed by the manufacturer to 
quantify natural hormones in human plasma. The ELISA kits were validated to quantify 
estrone, estriol and 17β-estradiol in hydrophobic extracts of water. These ELISA assays 
proved to be highly repeatable with inter- and intra assay variation of less than 5.6 %, 8.2 % 
and 4.5 % for the quantification of estriol, estrone and 17β-estradiol respectively. The 
applicability of these ELISA kits to determine steroid hormone levels in sewage effluent were 
further supported by good parallelism between dilution curves of the kit standards and sewage 
effluent samples. Analysis of sewage effluent entering the Kuils River water catchment area 
revealed similar estriol, estrone and 17β-estradiol concentrations to those obtained for sewage 
effluents from Britain (Desbrow et al., 1998), Italy (Baronti et al., 2000), Germany (Ternes et 
al., 1999a), Canada and Netherlands (Belfroid et al., 1999). 
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The second objective of this study was the development of a multi biomarker estrogen 
receptor (ER) dependent whole cell bio-assay to assess total environmental estrogenicity. The 
human breast cancer cell line, MCF-7 was used to introduce some modification to the well 
known E-screen assay described by Soto et al., (1992). The culture of MCF-7 cells in a 96-
well format using chemically defined serum replacement factors instead of FBS was 
validated. Several endpoints of the E-Screen assay as biomarkers for estrogenicity and 
cytotoxicity were also evaluated. Total LDH activity, total protein yield as well as XTT 
activity were evaluated as proliferation endpoints and biomarkers for estrogenicity. Total 
LDH activity of MCF-7 cells was the most sensitive biomarker of these three endpoints and 
had a detection range for E2 between 100 pM E2 and 1000 nM E2. The third objective of this 
study involved the setting up and validation of an ELISA to quantify ERα levels as a 
biomarker for estrogenicity. This is a novel amendment to the E-Screen assay for this ELISA 
is performed on cultured MCF-7 cells (exposed to estrogen standards or environmental water 
extracts) that have been fixed to the 96-well culture plates. The sensitivity of this screen for 
environmental estrogens was assessed by determining ERα levels of MCF-7 cells that were 
cultured at different E2 concentrations. The linear range for the ERα direct ELISA was 
between 1 – 1000 nM E2. This bio-assay was successfully implemented to determine the total 
estrogenicity of a pristine site as well as sewage effluent from Stellenbosch sewage treatment 
works.  
 
The fourth objective of this study was to setup and validate a competition ELISA to quantify 
vitellogenin (VTG) from Oreochromis mossambicus (tilapia). VTG, which is the precursor to 
several egg yolk proteins in oviparous vertebrates, has been identified as a valuable biomarker 
to detect e-EDCs in several fish species (Purdom et al. 1994; Jobling et al. 1995; Sumpter, 
1995). However, few quantitative VTG ELISAs for tilapia have been validated using 
commercially available anti-VTG that shows cross reactivity with tilapia VTG. The newly 
developed ELISA uses commercially available seabream anti-VTG that shows cross reactivity 
with several fish species. A competition ELISA was developed to quantitatively assess tilapia 
serum and liver culture supernatants for VTG. This tilapia VTG competition ELISA has a 
broad detection range between 80 ng/ml – 5.4 µg/ml VTG. The ELISA is highly repeatable 
with intra- and interassay variations less than 3.4 %. We also showed that this ELISA can be 
used to quantify VTG that has been produced in vitro (sliced liver cultures) and in vivo 
(juvenile whole body homogenates).  
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The fifth objective of the study entailed using this quantitative VTG ELISA to validate the 
use of tilapia juveniles (less than 70 dpf) as a short term in vivo screen for estrogenicity. It is 
evident from this study that juvenile tilapias have the ability to produce VTG upon estrogen 
exposure from a very early stage of development (25 dpf). This observation is in agreement 
with studies conducted in zebrafish (Legler et al., 2000) and fathead minnow (Tyler et al., 
1999). Our study shows that juvenile tilapias aged between 35 – 45 dpf synthesized the 
highest concentration of VTG upon estrogen exposure. At this age 200 ng/l of DES was the 
lowest concentration of estrogen that could induce significant VTG levels after 10 days of 
exposure. The detection limit of this short term in vivo assay for estrogenicity is in the same 
range that was found for other cyprinodont fish species (Folmar et al., 2000). Analysis of the 
natural VTG levels of a mixed sex population of tilapia juveniles from 15 to 70 days post 
fertilization (dpf) juveniles revealed interesting results. A sudden significant 5 fold increase in 
natural VTG levels was observed in fish that are 50 dpf of age. This sudden increase in VTG 
protein levels coincided with a significant 2 fold increase in natural 17β-estradiol levels. This 
observation may possibly mark the onset of sexual differentiation of hermaphroditic juvenile 
tilapias.  
 
Our study was concluded by implementing this battery of assays to screen the Eerste River, 
South Africa for e-EDCs. In this study, three sites were used for analysis namely Jonkershoek 
(control site situated in the mountains), sewage effluent from Stellenbosch sewage treatment 
works and Spier (sampling site on the Eerste River downstream from Stellenbosch). These 
three sites were analysed for the specific steroid hormone estrone. The MCF-7 breast cancer 
cell line was used to assess the ability of water extracts from these tree sites to induce cellular 
proliferation as well as reduce ERα protein levels, which are both biomarkers for 
estrogenicity. Juvenile tilapias were also exposed to water extracts from these sites and were 
analysed for VTG protein levels (short term in vivo assay). Estrone in the control site ranged 
between 0.7 and 1.8 ng/l whereas Stellenbosch STWs contained estrone levels ranging 
between 14.76 and 19.42 ng/l. Water samples analysed from Spier contained estrone levels 
ranging between 12.08 and 16.05 ng/l. Results obtained from the other three assays i.e., the 
quantification of ERα protein levels expressed by MCF-7 cells, the MCF-7 proliferation assay 
as well as the tilapia juvenile short term in vivo assay gave similar results. It was concluded 
that water samples collected from Stellenbosch STWs and Spier were estrogenic based on the 
analyses using this battery of assays. 
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Endocrine disrupting chemicals can act via a wide range of mechanisms, which includes 
receptor dependent and independent process. EDCs may display species, tissue- and cell-
specific effects, as well as being influenced by metabolism. EDCs may also display 
synergistic or antagonistic effects when present in complex environmental mixtures. The use 
of a battery of assays that encompasses both in vitro and in vivo tests is therefore essential to 
comprehensively assess the estrogenic potential of complex environmental mixtures. In this 
study we developed, validated and also implemented a battery of assays encompassing both in 
vitro and in vivo assays, based on different biological mechanisms, to detect estrogenic EDCs. 
To our knowledge, this is the first study that has used a battery of bio-assays to specifically 
assess the estrogenicity of South Africa rivers. Studies like these are necessary to develop and 
evaluate test assays using species which are applicable to the country of origin. In order for us 
to preserve our natural environment and also ourselves, it is necessary for the continued 
development of test assays to detect EDCs.  
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